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Significant gaps in the practical transformation of clinical knowledge into practices, 
increasing healthcare costs, costly medical errors, healthcare institutions’ obligations 
towards improving safety, clinical outcomes, and efficacy of care from one side; and the 
rise of disruptive innovations, the adoption of electronic health records and novel 
diagnostic tools, and the plethora of data from the other side has made the need for a new 
approach in managing the U.S healthcare systems an imperative. Continuous learning has 
been utilized to mitigate some of these issues have been in healthcare organizations. 
Continuous learning is especially important in the research centers that act as innovation 
hubs within University Hospitals. These centers align with learning and improving current 
systems and practices in a specific area of healthcare with goals of better serving the 
population in need of those specific services or treatments. Maturity Models are 
organizational management tools that have been used as a way of responding to the 
constant pressure of trying to achieve and maintain competitive advantage through 
concurrent innovation, quality improvement, and cost reduction. In the context of 
continuous learning in healthcare organizations, a mature system can be defined as a 
system that generates timely actions to the information that it derives from internal and 
external data to create meaningful measurement regarding system learning and increased 
efficacy and effectiveness in health outcomes. However, there is a lack of a model that 
provides managers and decision-makers with a systematic, multi-criteria, validated, 
quantifiable, and repeatable maturity model to assess and enhance health organizations' 




a multi-criteria model to assess technology management maturity and continuous learning 
in research centers within university hospitals by using Hierarchical Decision Model 
(HDM). The model can help these research centers with pinpointing their strengths and 
opportunities in terms of continuous learning from the data they have access to while giving 
them organizational self-awareness and guide them in setting their strategies and resource 
allocation. The model will serve as a much-needed technology management tool for 
healthcare organizations to assess their technology management maturity and continuous 
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In 1983 the prospective payment system (PPS) was introduced as a part of the Social 
Security Amendments Act of 1983 with the goals of addressing the high cost of healthcare 
by establishing fixed fees for provided services which were later modified to include a 
prospective payment system for Medicaid and Medicare in 2000 (CMS.gov, 2020). These 
changes have forever changed the way healthcare systems are managed in the United 
States (Ginter, Duncan and Swayne, 2013). Externally, the healthcare environment has 
been constantly changing in terms of technology, economy, and socio-political context 
and with each election (congress, senate, or presidential), different healthcare 
organizations are faced with new opportunities and risks due to the new political and 
legislative directions (Santilli and Randy Vogenberg, 2015; Shaygan, 2018). Internally, 
healthcare practices deal with long delay times for the transfer of clinical knowledge to 
clinical practice in the US (about 17 years) (Balas and Boren, 2000; Morris, Wooding and 
Grant, 2011; Kitson and Harvey, 2016). Furthermore, there are also studies indicating that 
adult patients receive only approximately half of recommended therapies (McGlynn et 
al., 2003). An Institute of Medicine report refers to this problem as “Too much care that 
is important is often not delivered, and too much care that is delivered is often not 
important.”(Institute of Medicine (IOM), 2007; National Health Service (NHS), 2014). 
To pile on these challenges, medical errors are the third leading cause of death in the US 
(Makary and Daniel, 2016). The United States consumes more health care services as a 
proportion of its total economic output than any other country in the world while having 




economic output (Shi and Singh, 2019). The cost of care that has been increasing in US 
is signified by both per capita payments, and also by measuring health care expenditures 
as a percentage of the Gross Domestic Product (GDP) (Weiss and Lonnquist, 2000; 
Conklin, 2002). The US care spending has grown from $3708 (per capita) to $9990 from 
1996 to 2015 (CMS.gov, 2016). Some studies suggest that up to a third of this spending 
is avoidable waste (IOM, 2011). As researchers form Stanford Medical school point out, 
in the healthcare system, “we do a lot, without knowing what works” at scientific, 
medical, and practice levels (Shah, 2016). In his book, Graban also mentions that the US 
has world-class doctors and treatments parallel to an utterly broken system (Graban, 
2016). There is also the public health concern which with all the new technology and 
methods, the already disadvantaged are going to be even further disadvantaged in their 
access to the clinical and medicinal innovations (Faden et al., 2013). Moreover, the 
problem of health disparities based on Racial Ethnicity and Language (REAL) and Sexual 
Orientation and Gender Identity (SOGI) needs to be addressed. Although the healthcare 
systems in the United States have the ability to provide some of the best clinical care in 
the world, they lack delivering equitable services to every American. The healthcare 
system in the US certainly fails in terms of providing cost-efficient services (Shi and 
Singh, 2019). Due to the mentioned changes, there have been many attempts at improving 
managed care systems.  
The United States has a unique system of healthcare delivery. The term “delivery” refers 
to the provision of healthcare services by various providers (Shi and Singh, 2019). Almost 




by the government and financed through taxes and almost all their citizens are entitled to 
receive healthcare services. This is not the case in the United States, where Americans 
are not automatically covered by health insurance (Shi and Singh, 2019). Wolinsky 
(1988) disagrees with calling the American health care delivery a “system” as a true, 
cohesive system that does not exist in the US but for the sake of consistency, the research 
is going to use the word “system” for the US healthcare. One of the other significances 
of the healthcare system in the United States is that employs a significant amount of 
people with total employment that exceeded 16.4 million people in 2010 in various health 
delivery settings. This number included more than 838,000 professionally active Medical 
Doctors (MDs), 70,480 osteopathic physicians (DOs), and 2.6 million active nurses (U.S. 
Census Bureau, 2012). The majority of healthcare and services professionals (5.98 
million) work in ambulatory health service settings, such as the offices of physicians, 
dentists, and other health practitioners, medical and diagnostic laboratories, and home 
health care service locations. Smaller proportions of these professionals are employed by 
hospitals (4.7 million) and nursing and residential care facilities (3.13 million). The wide 
spectrum of health care organizations in the United States includes around 5,795 
hospitals, 15,700 nursing homes, and 13,337 substance abuse treatment facilities (US 
Census Bureau, 2012). 
There have been some offered solutions for different challenges in US healthcare. Health 
IT adoption and diffusion of meaningful use can expedite the purgatory time for newly 
discovered knowledge (CMS.GOV, 2017).  As a result of the new technologies and 




generates timely actions to the information that it derives from data to create meaningful 
measurement regarding systematic learning and increase efficacy and effectiveness in 
health outcomes. Challenged by internal and external factors, health care organizations 
need guidance regarding how to achieve improved maturity (Shaygan and Daim, 2019). 
Continuous learning may be one of the keys leading to more mature systems (Ainsworth 
and Buchan, 2015; Singer, Benzer and Hamdan, 2015; Priestman et al., 2019).  
One of the ways in which health organizations can apply continuous learning into their 
practices is to use the acquired data beyond its original purpose (delivery of care) to 
increase the rate of speed from applying knowledge from laboratories to patient’s rooms 
in hospitals (Friedman, Wong and Blumenthal, 2010). This change in looking at data can 
be implemented in any health system regardless of its level and scale by self-studying and 
self-improving continuously and routinely (Friedman et al., 2014, 2017).  By using the 
data from drugs, diseases, clinical processes, devices, claims and with the newer data 
generated from technologies such as genomics and wearable devices, there is a volume 
of data that health systems can learn from like never before. Continuous feedback of 
learnings from data to patients, clinicians, managers, and policymakers can act as a 
catalyst for change while generating evidence and a science base for bolstering clinical 
practice and quality of care (Deeny and Steventon, 2015; Bhandari et al., 2016)  
However, as interesting as the idea of this self-learning system sounds, its practical 
implementation is indeed a daunting and developing task. Morrain et al. (2016) pinpoint 
leadership, funding, regulatory and political influences, and company culture as some of 




Grossmann, 2017). Friedman et al. (2013) stress the importance of technology, policies, 
and standards in turning the learning health system into reality (Bloomrosen and Detmer, 
2010; Blumenthal, 2010; Friedman, Wong and Blumenthal, 2010).  
Continuously learning health systems are being studied from a wide range of different 
perspectives in terms of adoption and implementation (Kelley et al., 2015; Brooks et al., 
2017; Cahan and Cimino, 2017; Daniel et al., 2017; Kraft et al., 2017; Okun and 
Goodwin, 2017; Rubin, 2017; Tegenege et al., 2017). However, there is a need to look at 
these perspectives together to gain some insights on the bigger picture opportunities and 
barriers surrounding these health systems. In other words, although many health 
organizations are trying to bolster their continuous improvement and consequently their 
maturity, there is no particular way for them to know or assess if they are on the right path 
or the extent to which they are adopting or implementing this way of doing things.  
With the current unaddressed deficiencies and the new groundbreaking innovations, there 
are hopes of a paradigm shift in US healthcare systems like never before. Continuous self-
studying and self-improving healthcare systems can be the answer to many of these 
problems by leveraging many of the discussed technologies and innovations. However, 
as a substantially complex environment due to the many involved stakeholders, health 
organizations face many challenges and are provided with many opportunities from 
different aspects in the area of continuous learning and improvement. Although 
researchers should keep on studying this topic from detailed and specific perspectives, a 
multi-perspective study of the different impacting aspects of this promising and nascent 




continuous learning can help provide a bigger picture of what needs to be considered to 
initiate the constantly improving and waste eliminating healthcare systems. One of the 
goals of this study is to act as the first step in the multi-perspective study of this topic. 
There is imperative to look deeper and with further detail into the political (regulatory, 
organizational), economic, social (patient, public health), and technical factors 
contributing to how successful health organizations are in terms of technology 
management maturity. Challenged by internal and external factors, health organizations 
need guidance regarding how to achieve improved maturity (Shaygan and Daim, 2019). 
Continuous learning in different areas specific to the health organizations may be one of 
the keys to this improvement (Singer, Benzer and Hamdan, 2015; Priestman et al., 2019). 
 There is also a need for studies on how the new technologies, innovations, and policies 
affecting healthcare should be managed in order to raise the chances of success for this 
nascent area. The potential positive results of studies in the field of continuous learning 
health organizations (in terms of increased quality of care, decreased medical errors, and 
cost) may encourage knowledge cross-pollination and further adoption and diffusion of 
the culture of continuous learning across the United States. It should however be 
understood that becoming a continuously learning health organization is not something 
that its effects can be felt immediately, and it may take years of cultural adaptation and 
practice concurrent to the sufficient funding and socio-technical infrastructure to start 
fulfilling its promises. 
From the organizational self-awareness point of view, there is a need for health 




contribute to the adoption, implementation, and management of the technologies they 
possess. It is also important to take a deeper look into the multi-perspective management 
of technology maturity in health organizations. This need for maturity has become more 
important with advances in technology, the plethora of data, and an increase in the 
pressure to be more effective and consistent.  
1.1.Problem Statement   
 
As it was explained in the previous section, significant-gaps in the practical 
transformation of clinical knowledge into clinical practices ever-increasing healthcare 
costs, high rates of medical errors, healthcare institutions’ obligations towards improving 
safety, clinical outcomes, and efficacy of care, the extrinsic fluctuant nature of the 
healthcare industry, and the advances in technology and available information has put 
more pressure on healthcare organizations to adopt new ways of doing things to cut costs, 
bolster care in terms of quality, safety, accessibility among other goals. Some of these 
goals include engaged patients and patient-centered communication, evidence-based care 
to include clinical trial and comparative effectiveness research, learning health IT system, 
turning evidence into practice and improvement in performance and quality, and 
affordable care for all patients (IOM, 2013; Shah et al., 2016). Some of the other goals 
based on literature include the promotion of improvement science, the impact of research 
findings, and faster implementation and translation of research findings and evidence-
based treatment in practice (Kilbourne et al., 2017).  
There has also been research on quality improvement in specific administrative and 




the benefits of adopting quality dashboards and the adoption of continuous quality 
improvement strategies in adherence to institutional standards and delivery of renal 
replacement therapy while Fried et al. (2011) applied a lean improvement process to 
further improve process and outcomes in successful sepsis protocols. Moreover, there has 
been literature focusing on quality improvement in other clinical and administrative issues 
such as diabetes care in populations and outpatient clinics (Solberg et al., 1997; Nicolucci 
et al., 2008), minimizing medical and medication errors (Becher and Chassin, 2001; Lee, 
2013), improving care in patients with severe sepsis and septic shocks (Seoane et al., 
2013; Armen et al., 2016), reducing avoidable readmissions (Kripalani et al., 2014), 
nephrology (Nunes et al., 2016; Mottes, Goldstein and Basu, 2019), outpatient cancer 
surgery centers (French et al., 2019), chemotherapy wait times in pediatric oncology 
clinics (Elsaid et al., 2019), TNM classification in cancer (Gospodarowicz et al., 2004), 
management of Chronic Obstructive Pulmonary Disease (COPD) (Tiep et al., 2018), 
supply chain performance measurement (Swinehart and Smith, 2005), and complications 
and cost after high-risk surgeries (Dimick et al., 2003). 
One of the ways of addressing these changes and moving towards the mentioned goals is 
to increasing efficiency by generating more timely actions to the information that they 
derive from the available data to generate meaningful conclusions regarding fields such 
as systematic learning in order to increase efficacy and effectiveness in health outcomes. 
The systematic continuous learning by health organizations can be aligned with 
continuous improvement and innovation from scientific, informatics, incentives, and 




and embedded within the system. Moreover, continuous feedback of learnings from data 
to patients, clinicians, managers, and policymakers can act as a catalyst for change while 
generating evidence and a science base for bolstering clinical practice and quality of care 
(Morain, Kass and Grossmann, 2017). A paradigm shift in looking at data can be 
implemented in any health system regardless of its level and scale by self-studying and 
self-improving continuously and routinely (Deeny and Steventon, 2015; Friedman et al., 
2017).  Health IT adoption and diffusion of meaningful, and using the acquired data 
(drugs, diseases, clinical processes, devices, claims and with the newer data generated 
from technologies such as genomics and wearable devices (Shah, 2016))  beyond its 
original purpose (delivery of care) can expedite knowledge transfer from laboratories to 
patient’s rooms.  
With all this promise, this concept mostly remains as a concept than a reality (Budrionis 
and Bellika, 2016). Many health organizations have some idea of how to become a 
learning health system or think that they are one while they are not. A lot of these 
problems are caused due to the lack of a systematic assessment tool for health 
organizations to measure and assess their maturity in terms of adoption, implementation, 
and management of technologies and in this case, becoming a continuous learning 
practicing health organization. Moreover, there needs to be a multi-criteria decision-





Therefore, there is a need for a model to give health organizations a sense of self-
awareness in terms of adoption, implementation, and management of these new socio-
technological mentalities. This model should be able to: 
 
• Identify potential common factors that have a major impact on the maturity of a 
health organization’s continuous learning approach while considering its 
complexity and multi-perspectives. 
• Assess the health organization’s performance against each of those factors 
potentially leading to important conversations around the next steps and 
improvement initiatives. 
• Help in identifying the areas of strength and where there is a need for 
corrective/preventive actions based on the assessment, giving the organization a 
sense of self-awareness and direction. 
• Assist decision-makers in their strategic management and leadership and resource 
allocation. 
 
Health organizations can get a better sense of direction in order to prioritize their 
improvement paths and agenda while having a better grip on their performance and 








2. Literature Review 
 
2.1  Healthcare Landscape in United States 
 
Shi and Singh (2019) posit that U.S. health care delivery does not function as a rational 
and integrated network of components designed to work together coherently. They 
describe it as a kaleidoscope of financing, insurance, delivery, and payment mechanisms 
that are not integrated efficiently as they represent a mixture of the public (government) 
and private sources. The public sector, finance and ensure health care for eligible groups 
of people while delivering direct care services (less volume) to certain groups such as 
veterans, military personnel, American Indians/Alaska Natives, and some uninsured 
people. Outside of this, however, the majority of financing, insurance, payment, and 
delivery services remain private in the United States. Private financing, mostly via 
employers, accounts for around 52% of total health care expenditures while the 
government finances around 48% (DeNisco, 2019). Moreover, as the United States 
possesses a market-driven economy, private entrepreneurs seek to profit from it by 
improving important functions of the delivery of health. Most people in the United States 
receive health services through the private sector as the health insurance is bought by the 
employers while the government provides public insurance for health services through 
programs like Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) for 
a significant portion of the country’s low-income, elderly, disabled, and pediatric 
populations (although being public, the health services for the enrollees of these programs 
are provided through private health organizations and providers such as maintenance 
organizations (HMOs). In general, in this research, the term provider refers to any entity 




supported through tax revenues such as physicians, dentists, optometrists, and therapists 
in private practices, hospitals, and diagnostic and imaging clinics, and suppliers of 
medical equipment. 
The healthcare delivery system in the US lacks standardization as a system that is 
functionally not centralized with non-integrated parts since a central agency such as the 
government does not govern its coordination. This can cause challenges such as 
duplication, overlap, inadequacy, inconsistency, and waste and consequently a costly and 
complex system that lacks planning, direction, coordination, and efficiency manipulated 
by private entrepreneurial system trying to change the monetary incentives towards their 
goals without worrying about the effects on the system as a whole resulting cost control 
to be merely a mirage (Shi and Singh, 2019).  
Some of the other characteristics of the healthcare delivery system in the United States 
which makes it different than other countries on top of the absence of the central 
governing agency are insurance coverage-based access to health, and the presence of 
third-party insurance companies and multiple payers. Moreover, the US healthcare 
system deals with legal risks as influencers of the practice behavior or physicians through 
“defensive medicine” by prescribing additional diagnostic tests, follow-up visits, shy 
away from using the newer technologies due to lack of experience with those technologies 
and creating comprehensive documentation to avoid litigation risks. The United States is 
the world leader in terms of research and development and innovation in the field of 
medical technology and as helpful as these new technologies are, they create demands 




technologies. Therefore, managing these new technologies is a very critical task 
especially in the health organizations in the United States. 
In the last several decades, the healthcare industry in the US has become more complex 
and difficult to manage (Guterman and Dobson, 1986; Zook, 2007; Ginter, Duncan and 
Swayne, 2013). Some of the factors influencing this state are the changes in legislative 
direction with each election, domestic and global economic climate, social changes, and 
emergence and improvement of related technologies which can affect the health care 
delivery dramatically. In the light of these changes, the healthcare manager’s task of 
comprehending the surrounding environment and hence, preparing the organization to 
cope with or strategically take advantage of the changes in it becomes vital. Since the 
changes in the healthcare industry in the early 80s, managers have found out that focusing 
solely on financial aspects of planning is not enough and health organizations should be 
dynamic in order to deal with the dynamic environment (Zook, 2007).  
Taking the made points into account, the U.S. health care delivery system is a gargantuan 
thing that is almost impossible for any single entity to manage or control (Shi and Singh, 
2019). In short, this costly system is not effective in the most important missions of an 
acceptable health care delivery system which are: 
• Enable all citizens to obtain needed health care services.  





While the U.S. healthcare delivery system falls short of both these basic ideals, the United 
States leads the world in providing the latest and the best in medical technology, training, 
and research. It offers some of the most sophisticated institutions, products, and processes 
of health care delivery Thus, the constant analysis and assessment of strategy is 
imperative to healthcare organizations in the US. In order to do this, managers should 
have a clear understanding of the prospective changes to act proactively and plan. 
However, since the dynamic healthcare environment is affected by multiple elements, 
identifying these changes poses a big challenge to organizations. 
2.2 Healthcare External Environment 
In the turbulent environment of US healthcare, like any other business or organization, 
identifying ways to add more value compared to competitors in order to gain a vying 
advantage is an important task and challenge (Mallard et al., 2004). This is a big problem 
for care organizations as value creation is the perceived relationship between 
contentedness and price (Hart and Milstein, 2003). Going through a smooth appointment 
and billing system, high quality of professionals and equipment, good insurance alliances 
are just some of the ways health organizations can create value internally (Mallard et al., 
2004; Testik et al., 2017a). However, concurrent to these internal issues and 
opportunities, care organizations should pay immense attention to the factors happening 
and changing in their external environment. Out of date management styles, disregarding 
demographic changes and emerging legislations and technologies are some of the telltales 
of organizations that are either unable to anticipate changes, ignoring them, or resisting 




changes and opportunities is not feasible, health organizations and managers can bolster 
their chances of dodging or taking advantage of changes by keeping abreast of the 
possible changes in the healthcare environment. Perera and Peiro (2012) proposes 
“Analyzing the external environment” as the first stage in strategic planning for health 
organizations (Rodríguez Perera and Peiró, 2012).  
It is important to mention that different entities existing in the healthcare environment 
have impacts on each other and can affect healthcare organizations both directly and 
indirectly. Figure 1 shows the interrelationships of different components of healthcare’s 
external environment. As an example of these interrelationships, government institutes 
regulate laws for businesses and education while funding some research institutions while 
research institutions provide R&D for businesses and a chance of better quality or access 
to individuals. Education institutes provide researchers for research institutes and have 
the power to raise care awareness for individuals. Businesses provide the government 
with tax money and researchers, hospital and education establishments with real-life data, 
sponsorship, and funding as well as jobs, products, and services for individuals. 
Individuals shape the demographic aspect of the environment in general while providing 
revenues and workforce for business, tax money for governments, individuals for 
education, and data for research centers. Other than government’s regulative impacts 
(Department of Health and Human Services, Center for Medicare, and Medicaid 
Services), organizations such as “Public Health Department”, “State Health Planning 
Agency”, “Joint Commission on Accreditation of Healthcare Organizations” and 




healthcare organizations. These interrelationships would pose great impacts on hospitals 
and healthcare organizations in both direct and indirect manners. Hence, a better look into 
these approaching changes in order to better understand and consequently prepare to 
mitigate their harms or benefit from them is critical to health organizations. For this 





Figure 1:External Components of Healthcare Environment 
 
2.2.1 External Change Perspectives 
 
It is a difficult task to categorize the different perspectives affecting healthcare 
organizations due to the complexity and inter-relationships of different categories and 
criteria. Schuman (2001) points out that more studies have focused on external 




the internal environment of the respective organizations (Such as management styles and 
policies (Suchman, 2001). However, the literature on healthcare external environmental 
analysis is not an abundant one. Casalino et al. (2003) discuss the effects of incentives, 
IT, and structured process in order to bolster the quality of care for chronic patients 
(Casalino et al., 2003). Also Ginter (2013) groups the external change categories as 
“Legislative”, “Economic”, “Technological”, “Social”, and “Competitive” (Ginter, 
Duncan and Swayne, 2013). Although this book mentions some of the sub-categories 
relating to the perspectives, it does not offer clear explanations on what those sub-criteria 
are. Santilli et al. also identify the trends affecting decision-making processes and roles 
in healthcare organizations in order to bolster firms’ ability to act better in market 
transformations (Guterman and Dobson, 1986). This study continues to use the 
perspectives from Ginter and Santilli while exploring the current change catalysts falling 
under each category. 
2.2.1.1 Legislative/Political Changes 
The legislative and political changes can significantly affect the environment for 
healthcare organizations and each change in administration or swing in senate power can 
mean big changes coming healthcare’s way. The passing of the Affordable Care Act 
(ACA) for instance, undoubtedly restructured the role of healthcare stakeholders. 
Healthcare providers have a more serious role in terms of contributing to savings, risk, 
and establishing relationships compared to the time before ACA. 
Since being passed on March 23, 2010, the Patient Protection and Affordable Care Act 




tended to transform hospitals’ way of doing things financially, technologically, and 
clinically in order to achieve a better quality of care and its accessibility at fewer costs. 
As an example, ACA paved the way for the emergence of accountable care organizations, 
switching from fee-for-service to bundled payments (CMS.gov, 2019a), Hospital 
Readmissions Reduction Program (HRRP) (CMS.gov, 2019b), and new insurance 
standards, among other things. Also, it has had a great impact on the technological 
structures of hospitals due to cost/quality initiatives in terms of electronic health/medical 
records. In 2013, about 93% of hospitals had certified EHR technology, increasing by 
29% since 2011 (Charles, Gabriel and Searcy, 2015). This number rose to 96% percent 
by 2015 in terms of EHR systems with functionality, capability, and security measures of 
the Department of Health and Human Services (Henry et al., 2014). The Medicare and 
Medicaid EHR Incentive programs incentivize professionals, eligible hospitals, and 
critical access hospitals to adopt and implement meaningful use of certified EHR 
technology. As mentioned in the previous section, ACA rebuilt the role of healthcare 
organizations by giving them a bigger role in terms of contributing to savings, risk, and 
establishing relationships. A more efficient system would allow hospitals to cut costs by 
focusing on preventive care and wellness in long term. ACA has also paved the way for 
more trends such as consumers with stronger roles, more structured quality measures, and 
healthcare consolidations which will be discussed in the next sections (Santilli and 
Vogenberg, 2015). Also, post-ACA, the attention has switched to outcomes as quality 
metrics such as the success rate of treatments, morbidity rate, length of hospital stays, and 




Although ACA has had many great impacts on the way healthcare is provided in the 
United States and its shift from transaction-based rewards to outcome-based ones, it is 
not a panacea for the problems in the healthcare structure and needs reforms.  However, 
like insurance and financing for healthcare is mostly employment-based in the United 
States, it has left some employed individuals uninsured due to some small businesses’ 
inability to afford group insurance (therefore not offering insurance to their employees) 
and/or voluntary participation in health insurance programs in some work settings (Shi 
and Singh, 2019). Some employees choose not to sign up, mainly because they cannot 
afford the cost of health insurance premiums. Moreover, some individuals cannot afford 
the premium cost-sharing provided by their employees (paying a portion of the cost to 
their employers) and some have to deal with higher individual rates as self-employed 
people and other individuals who are not covered by employer-based plans.  
Although ACA greatly has somewhat mitigated the rise in the percentage of healthcare in 
US GDP, it has been the constant repealing by the republican party. This kind of volatility 
poses a great uncertainty for healthcare organizations in terms of strategic management 
and finding ways of achieving competitive advantage in a highly volatile unstable 
environment. The changes inherent in legislative reforms offer stakeholders numerous 
opportunities and threats that have to be analyzed and ways to prepare for them or take 
advantage of them thought through. Executive, legislative, and judicial branches of the 
US government will all have effects on future bill changes, and companies should pay a 
great amount of attention to changes and prepare themselves in terms of strategies for 




inevitable effects it will have in different change perspectives for healthcare companies 
in terms of the external environment (Shaygan, 2018). 
Politics have significant effects on the lack of balance socioeconomic health as well 
(Borrell et al., 2007). Changes brought up by the elections and union densities have the 
power to affect labor markets and welfare states resulting in income and socioeconomic 
disparities and consequently impacting healthcare and the organizations in that area. This 
means that not only legislations and politics can have direct effects on healthcare, but they 
can also have indirect impacts by influencing other change perspectives such as 
social/cultural. 
2.2.1.2 Economic Changes 
Issues such as increasing average age of the population, health care, and treatment costs, 
and changes in the number of insured people can have effects on the country’s economy 
and certainly be affected by it.  Many of the changes that have led to a managed care 
system can be traced back to economic changes. The increasing cost of health care in the 
US is signified by both per capita payments, and also by measuring health care 
expenditures as a percentage of the Gross Domestic Product (GDP) (Weiss and 
Lonnquist, 2000; Conklin, 2002).  The US care spending has grown from $3708 (per 
capita) to $9990 from 1996 to 2015 which is about 70 times bigger than the per capita 
health spending of $141 in 196 (CMS.gov, 2016). Moreover, faster growth in total health 
care spending in 2015 was caused by bigger growth in private health insurance, hospital 
care, physician and clinical services expenditures, and the growth in Medicaid and retail 




Many of the factors that have had impacts on this growth can be rooted back to other 
change perspectives such as social, technological, and legislative. US population has had 
an increase of 79.25% between 1960 and 2015 (Bureau, no date), and based on Kinsella 
and Gist (1995), the percentage aged 65 and older in the United States will be tripled from 
1944 to 2033 (Kinsella and Gist, 1995; Shaygan, 2018). Some of the other factors which 
affect the economic perspective and consequently the health care environment are the rise 
in the cost of insurance, increase in the alliance of health care organizations, 
improvements in technology, and rise in malpractice insurance and case settlements 
(Weiss and Lonnquist, 2000).  
 
2.2.1.3 Social/Demographic Changes and Disparities 
In 1991 Stromborg pointed out the dramatic change that is going to happen in the balance 
of the American population (Frank-Stromborg, 1991). This change in the composition of 
the population in terms of Social and demographic diversification is happening much 
faster today. As an example, the Hispanic population has gone from around 6 million to 
52 million from 1960 to 2012 and Asian and Pacific Islander population from 980 
thousand to 15 million in the same time frame (US Census Bureau Public Information 
Office, 2012). From the age aspect, based on Day (1992), from 2010 to 2030 the 
population of 65 and over is estimated to go from about 40 million to 70 million 
accounting for more than 20 percent of the population (Day, 1992). With the increase in 
the number of insured people in the Obama administration, many people who were added 
to the insurance pool had a lot of health conditions due to avoiding medical care for the 




this experience curve costs money and time. Although in short term the number of 
increased insured people has had dramatic effect on the cost of care, it will become 
smoother as time goes by. These shifts will pose great demands on US health-care 
organizations. In a 2010 report issued by the Institute of Medicine, the healthcare 
workforce is estimated to be too small and under-equipped to satisfy the demands of the 
rising and aging population (Stall, 2010). 
Parallel to these changes, health organizations need to address the racial and ethnic 
disparities that are extremely prevalent today. Racial disparities in health care delivery 
and patient outcomes exist and persist in the health care system in the United States  
(Haider and Pronovost, 2011). Minorities tend to receive lower-quality health care even 
when insurance status and income are controlled (Baker, 2001).  Fiscella et al. (2000) 
discuss that Black patients receive less intensive hospital care such as receiving fewer 
cardiac procedures, lung resections for cancer, and kidney and bone marrow transplants 
(Fiscella et al., 2000). Similarly, Haider et al. (2012) argue that minority patients tend to 
seek care at a relatively small number of lower-performing institutions (sometimes due 
to location) and due to that, are disproportionately affected by the suboptimal quality of 
care by looking at 434 hospitals and concluding that trauma patients seen at hospitals with 
more than 50% minority patients have 37% higher adjusted odds of death compared to 
similarly injured patients treated at hospitals with less than 25% minority patients (Haider 
et al., 2012).  
During the 2020 COVID-19 pandemic, based on the Center for Disease Control’s data, 




persons were 2.8, 5.3, and 1.4 times higher compared to white, non-Hispanic persons, 
respectively. The numbers for Black or African American, Non-Hispanic persons were 
2.6,4.7, and 2.1 times higher for the same metrics and 2.8, 4.6, and 1.1 times higher for 
Hispanic or Latinx persons (COVID-19 Hospitalization and Death by Race/Ethnicity | 
CDC, no date). To better serve their community, health organizations need to address 
things such as engineered inequality, default discrimination, and the misconception that 
all technologies are always benevolent for everyone. Creating roadmaps for establishing 
the systems needed to support health organization’s path towards addressing health 
disparities can increase the patients’ trust in them which can include investigation of racial 
and ethnic disparities faced by their population, learning where to start with strategies in 
order to achieve a reliable collection of race and ethnicity data in electronic health systems 
and consequently taking the needs of the community population into account and 
stratifying quality measures based patient demographics. It should be noted that the path 
towards addressing disparities should include efforts by health organizations’ information 
technology groups to build systems that support those initiatives. These efforts can be in 
the forms of (but not limited to) mapping legacy data to CDC criteria, adopting standards, 
developing business intelligence data infrastructure, and stratifying artificial intelligence 
quality measures based on Racial Ethnicity and Language (REAL) and Sexual Orientation 
and Gender Identity (SOGI). Improvement of data governance, using analytical tools to 
identify data quality improvement opportunities, and addressing data anomalies can be 




2.2.1.4 Technological Changes 
With all the changes in population and demand, healthcare organizations are in necessary 
need of leveraging the value of technology advancements in order to be cost-effective, 
competitive, and responsive. Technological tools assisting decision-makers in Analyzing 
data, leveraging the power of big data, and information technology systems have become 
pillars of improving quality of care, identifying trends, anticipating changes, and 
controlling costs. Electronic Health Records (EHR) have shown to have great benefits in 
increasing outcomes for healthcare organizations in 92% of studies in the literature 
despite low patient engagement numbers (Buntin et al., 2011; Furukawa et al., 2014).  
Healthcare organizations should leverage the developments in technology and computing 
in order to increase patient engagement and satisfaction, reduce costs, anticipate changes, 
and learn to develop intangible assets in orders to integrate and intelligently use their 
resources. Based on a report published by the Institute of Medicine (IOM) of the National 
Academy of Sciences, the quality of health care in the United States is weaker compared 
to biomedical knowledge, and that this gap in quality due to organizational incompetency, 
rather than of individual physicians’(Beckles et al., 1998; Chassin, Galvin and Quality, 
1998; Corrigan, 2001). 
Every year new technologies are emerging focused on empowering patients and providers 
in order for organizations to better manage changes and costs. Furthermore, innovation 
in biotech and pharmaceutical industries has led to faster market entry and stronger 
research and development pipeline. As an example, a sudden change of speed in cost per 




next-generation genome sequencing technologies (Mardis, 2008). Besides, rare diseases 
have gained more attention from pharma companies due to significantly less time needed 
in terms of patient testing, government financial incentives, and higher approval rates 
from the US Food and Drug Administration (FDA) (Seoane-Vazquez et al., 2008). 
 It is healthcare managers' and organizations’ duty to leverage, coordinate, and manage 
emerging technology tools to bolster increased data transparency, patient involvement. 
This perspective can be affected by and affect other change perspectives such as 
legislative, social, competitive, and the economy in a great way as mentioned before. 
Innovations in computing and big data services are causing a transformation in the manner 
that health data is stored and transferred among patients and providers. Healthcare 
organizations are embracing technologies and innovations such as EHRs and EMRs, 
clinical documentation tools, big data, and telemedicine devices in order to improve the 
process of health information collection and consumption. Wearable technology, mobile 
health, and big data analytics are becoming progressively valuable in healthcare delivery 
systems. Although these innovations and technologies will significantly facilitate 
diagnosis, prevention, and treatment more efficiently, they dramatically increase the need 
for organizations to care about the security of their data (Shaygan, 2018). However, Lyon 
et al. (2014) suggest that as more patients adopt new information technologies, the 
importance of data analysis for organizations surpasses privacy and security concerns. 
As for big data analytics, the healthcare environment is one of the areas which is going to 




17.6% of the nation’s GDP increasing from 8.9% in 1980) (Nambiar et al., 2013; 
Christopher G. Worley and Mohrman, 2014). It is also estimated that one-third of that 
spending is due to waste caused by (as listed by the Institute of Medicine) unnecessary 
services, administrative waste including unproductive and duplicate documentation, 
inefficiently delivered services, high prices, fraud and missed prevention opportunities 
(Nambiar et al., 2013). In addition to that, the current reimbursement model favors the 
number of patients over treatment effectiveness: “physicians have been compensated 
under a fee-for-service system that only considers treatment volume, not outcomes” and 
patients have “little responsibility for the cost of the health care services they demand” 
(Kayyali, Van Kuiken and Knott, 2013). On top of the financial loss, other consequences 
of this problematic system include statistics such as: “one out of five elderly patients are 
readmitted within 30 days of discharge for no known reason” (Nambiar et al., 2013). Big 
Data analytics may hold the key to solving some of these issues. Barham (2017) conducts 
a literature review on how big data can create value for organizations and discusses the 
challenges hindering its adoption. Health organizations to leverage the power of big data 
in order to gain competitive advantage in terms of being more cost and time effective and 
improve their quality and experience of care for their patients. Barham (2017) 
recommends companies to acquire experienced data scientist, learn from successes and 
failures of other organizations, and embrace the benefits of data integration and sharing 
with partners, and finally working closely with software developers to develop more user-




 Like in other developed countries, the public sector of the U.S. has started to act 
concerning big data in order to leverage its potential in overcoming various complex 
challenges. In 2012, for instance, the Obama Administration invested $200 million in the 
“Big Data Research and Development Initiative”, with goals including the advancement 
of state-of-the-art core technologies of the big data era, acceleration of the pace of 
discovery in science and engineering, strengthen national security, and transform teaching 
and learning and to expanding the workforce needed to develop and use big data 
technologies (Jee and Kim, 2013). 
Social media is increasingly being used as a tool by governments, communities, and 
organizations for a range of purposes in disaster preparedness in areas such as disaster 
management.  In recent years, the government is bolstering the ease of data release and 
accessibility, which enables better access to and standardization of public data of patients, 
clinical trials, and health insurance (Christopher G. Worley and Mohrman, 2014). 
Moreover, ACA has also started the process of fundamentally re-shaping the industry and 
the interrelationships between healthcare entities. The private sector is also being 
affected. Hospitals, providers, clinics, insurance companies, pharmaceutical companies, 
researchers, physicians, nurses, and patients are all impacted by the changes that the use 
of big data is bringing into the industry. Meanwhile, traditional pharmaceutical retailers 
such as CVS Health are developing internal Digital Innovation Labs, that are rolling out 





All in all, new IT innovations can give health organizations insight and advantage. 
However, managers and organizations leveraging the fruits of these innovations should 
manage the ethical, security, and privacy risks that come along with them. The use of data 
and analytics in patient care opens up new opportunities for boosting care effectiveness 
and efficiency even though the full realization of the importance of data-driven insights 
has been clouded by some barriers. United States’ health information technology website 
lists some of these barriers as current data input and output limitations of medical record 
systems, scarcity of robust business models for interoperable data exchange across 
organizations, and wider organizational barriers that require coordinated solutions across 
stakeholders (HealthIT.gov, 2018). 
In the second decade of the 21st century, social media has become a significant part of 
many industries and organizations, and the healthcare environment is not an exception. 
Vance et al. (2009) hint at the increasing evidence showing that social media use among 
patients and health professionals is rising significantly. Personal social networks use 
between health professionals and physicians-in-training reflect the general trend in the 
environment and as for the Patient–doctor interactions, most of them are initiated by 
patients which demonstrates the level of awareness and interest from patients’ 
perspective.  
There is also a growth in online social media awareness in Western European hospitals, 
but different countries have applied social media to address different issues. Van der Belt 
et al.( 2012) mentions that other than the Netherlands and UK, there is a small proportion 




LinkedIn to hire professionals. Again, there is a need for further research to define metrics 
and connect the effects of social media in healthcare quality improvement. Chou et al. 
(2009) suggest that new technologies such as social media are reshaping the patterns in 
communication in the United States. 
A very important issue in leaning towards social media for health organizations is the 
consideration of the targeted group’s age, socioeconomic status, and racial ethnicity in 
order to assure enough awareness and interest among that specific target. In more rural 
structured areas, there may be less inclination, awareness, and confidence by patients to 
use social media. This inertia, however, can be mitigated by education and promotion of 
the benefits and conveniences of using social media. Clinicians also use online social 
networks, specifically the newer generation of clinicians for both personal and reference 
aims.  
However, a big portion of respondents have a cynical attitude towards online interactions 
and see them as being ethically problematic (Bosslet et al., 2011). Quantification of social 
media effects is a nascent area of research due to the lack of used terminology and 
research methods (von Muhlen and Ohno-Machado, 2012). Antheunis et al. (2013) argue 
that the literature has mostly focused on the benefits of social media on healthcare and 
suggests that their study has found dis-concordance in patients’ and professionals’ 
motives, barriers, and expectations regarding health-related social media use. Hawn 
(2009) discusses the impact of social media on health care and its benefits such as 




resulting in happier patients. The study also pinpoints the privacy, standard, and cost 
downsides of social media in healthcare. 
In sum, health organizations and managers should carefully monitor the potential effects 
and implications of social media in the environment and industry to be prepared for the 
challenges and clinch opportunities in order to reach or manage competitive advantage. 
2.2.1.5 Competitive Changes 
The last change perspective reviewed in this section is the competitive changes 
perspective. As the healthcare environment is becoming a harsher vying one for 
providers, there is significant pressure for providing a better quality of care at a lower 
cost. As mentioned before, these changes are causing a paradigm shift from the 
conventional fee-for-service models to value-based ones and focus on the quality of care 
as supposed to the number of services provided. This pressure is stronger in areas with 
more demand which there is buyer power. According to a report by Stanford Medicine, 
Physician practices in less vying areas cost more for office visits compared to more 
competitive areas of care (Baker, 2014). From another aspect, these pressures are leading 
to the consolidation of healthcare entities to increase efficiency, cost-effectiveness, and 
share risks. Although there is research evidence for the benefits of consolidation of 
healthcare entities in terms of information sharing and flow, there is not much supporting 
the same effect for cost-effectiveness. Dranove and Lindrooth (2003) Find robust, 
significant, and persistent results showing that consolidations into systems do not create 
savings whereas acquisitions and mergers generate savings from 3rd and 2nd consolidation 
years respectively (Dranove and Lindrooth, 2003).   
However, if these consolidations lead to prevention of medical errors, avoidable hospital 
admissions, and readmissions and/or improve hospital efficacy, an increase of shared-
decision making, and improvement of targeting costly services, achieving better quality 




criteria such as healthcare networks becoming narrower and health quality measures 




Accumulation of information is becoming more significant for health organizations 
(Sutcliffe and Weber, 2003).  With the methodical study of adaptive systems, healthcare 
organizations can provide managers with great insights and assistance in the preparation 
for emerging issues within the organization as well as healthcare delivery management 
(Shaygan, 2018). In this sense, being familiar with the external environment can be the 
key to leading a successful and competitive health system (Ginter, Duncan and Swayne, 
2013). 
Due to the involvement of several volatile change perspectives, the healthcare 
environment is currently a very erratic one making the extrinsic environmental analysis a 
daunting task for health organizations and managers. This study aims at contemplating 
emerging extrinsic changes happening in the United States healthcare environment in 
different areas. A literature review is performed to define and identify the different current 
change perspectives and their subcategories. To better illustrate these issues, the Ishikawa 
diagram (Cause and effect diagram) is used in this study as shown in Figure 2. Five 
perspectives were identified (Political/Legislative, Economic, Social/ Demographic, 






Figure 2: Cause and effect diagram for extrinsic change in the healthcare environment (Shaygan, 2018) 
 
An interesting finding of this study is the inter-dependence of different change 
perspectives through literature and to better reflect that finding some modifications were 
applied to the cause-and-effect diagram with the aims of better showing the effectiveness 
of change perspectives on each other. 
The Healthcare industry, in general, is very complicated and dynamic as many nascent 
trends and potential political changes are emerging and happening nationally and 
globally. This is even a bigger issue in the United States which is facing waves of political, 
social, economic, competitive, and technological changes.  Healthcare organizations need 
to be better prepared in predicating, identifying, adapting, being proactive and taking 
advantage of these changes, and cope with the potential harms coming their way. They 




them, and finally be flexible enough as an organization to transform and mold these 
resources to their advantage (Teece, 2007).  
In the same sense, healthcare organizations should sense the changes, seize the 
opportunities, or dodge the threats, and develop organizational flexibility to reconfigure 
themselves and gain a competitive advantage in the industry through learning 
mechanisms, alliances, innovation, and being cognizant of surrounding changes on 
national and global levels. As Eisendhardt (2000) suggests, in the highly dynamic 
environments (such as healthcare) no matter how valuable, rare, inimitable, and non-
substitutable the resources (such as tacit and explicit knowledge), they are going to give 
companies a fleeting and finite competitive advantage as opposed to a sustained one and 
the important thing is how firms reconfigure their “best practices” in unique ways 
(Eisenhardt and Martin, 2000). Health managers need to sense new opportunities and 
threats, seize them for the advantage of the company and reconfigure them in order to 





Figure 3: Modified Cause and Effect Diagram for Extrinsic Change in US Healthcare (Shaygan, 2018) 
 
Shi and Singh (2019) discuss the external forces on the United States healthcare delivery 
system as being national political climate, economic development, technological 
progress, social and cultural values, physical environment, population characteristics (i.e., 
demographic and health trends), and global influences which can be a great complement 





Figure 4:External forces affecting health care delivery (Shi and Singh, 2019) 
 
 
2.3 Learning Health Systems (Continuous Learning) 
The term Learning Health Systems (LHS) was first used in a 2007 report by the National 
Academies of Medicine (formerly known as the Institute of Medicine) as a system with 
some distinguishable characteristics (Institute of Medicine (IOM), 2007). The patient 
information, experience, and characteristics of every patient (consenting ones) is an 
opportunity for the health system to learn from. Moreover, evidence and science-based 
knowledge regarding best practices are instantly available to bolster the decision-making 




way of thinking becomes a piece of the employees’ and stakeholder’s culture through 
appropriate leadership as a part of a socio-technical infrastructure (Friedman et al., 2017). 
Milstein (2013) emphasizes that adopting LHS is one of the three things that the US 
should pursue in order to cut down care costs as a percentage of its GDP (Milstein, 2013). 
 However, there is an imperative for infrastructure for continuous improvement which 
will result in cost decrease through learning and economies of scale. In a perpetual cycle, 
the ongoing accumulation and analysis of data lead to result interpretations which assist 
decision-makers in taking actions and deciding what to study next. The continuous quality 
improvement has the potential to not only bolster the clinical evidence and research-based 
data and update the best practice in real-time but also will be able to address a lot of 
administrative and practice wastes which their elimination can cut care costs without the 
need for layoffs as the lean and continuous improvement philosophy is parallel with 
respect for people (Graban, 2016). Concurrent to this waste reduction, the accumulation 
of research and practice-based knowledge can take a substantially shorter time in terms 





Figure 5: Learning Health System Platform (Friedman et al., 2017) 
As much as health systems need to assimilate and gain knowledge, they must jettison the 
knowledge and resources that are impeding quality progress or have become obsolete due 
to innovation. Coicera (2017) stresses the importance of forgetting in LHSs as a procedure 
of programmatically decommissioning obsolete data and practices which their existence 





Taking all these different benefits and challenges into account points out that there are 
many players and impacting the continuous learning and consequently the maturity of 
health organizations. These factors can be government legislations, funds, and initiatives 
concurrent to the acceptance of its culture in terms of organizational and personal levels. 
The role of community and socio-technical infrastructure among many other aspects 
cannot be underestimated either.  
 
Figure 6:Five pillars of a learning health system (Institute of Medicine (IOM), 2007; Milstein, 2013) 
 
It should be noted that in the second characteristic of continuous learning maturity, the 
data is referring to the internal data generated by the health organization. However, it can 
be argued that health organizations can and should use the data generated externally (by 
other organizations) concurrent to the ones they generate themselves. This may lead to a 




may not have enough data regarding themselves and eventually more mature health 
organizations. 
 




The road for aligning care with individual patient needs has been paved in recent years 
more than ever with goals of population and patient outcome betterment (Epstein et al., 
2010).  One of the areas that can benefit from the patient input and proliferation of clinical 
data is the federal and state organizations in terms of regulatory decision-making. 
Historically, the actions of the regulatory departments such as the FDA have been more 
reactive than overactive (The increased speed of approvals for specific drugs in times of 
crisis and rare disease-related and orphan drugs). The new paradigm means that 
regulatory decision-makers such as FDA can reflect patient needs better and more 
proactive in their actions. There have been studies regarding topics such as the 
incorporation of the needs of patients into the risk-benefit evaluation of the medical 
device and the effects of patient-generated data in systems such as LHS on regulatory 
decision making (Levitan, Phillips and Walker, 2014; Irony et al., 2016; Tegenege et al., 
2017). In addition to the patient preferences and needs, the continuous improvement 
mindset will help demonstrate the benefits and challenges of LHS implementation and 
adoption in a clearer way and as a result, enables the more efficient allocation of federal 
and state funds into the needed areas. As Travis et al. (2004) discuss, in many countries, 
despite the decrease in prices and increase in funds, the move towards healthcare goals 




Some of the other challenges based on the mentioned study lie in the delay in knowledge 
and practice and the weak evidence-based information (Travis et al., 2004). Continuous 
learning can mitigate the weak data and significantly shorten the delay times between 
clinical research and practice. All in all, although there have been studies on the political 
and regulatory aspects of the adoption and assessment of learning health systems, more 
research can paint a clearer picture on how this health paradigm shift can impact the 
regulatory players with goals of increasing the quality of public health. 
2.3.1.2 Economic 
One of the main drivers behind the endeavors for new healthcare systems and 
management is the current high costs of US healthcare. Although the Affordable Care Act 
(ACA) has positively impacted the way healthcare is provided in the US through actions 
such as shifting from transaction-based rewards to outcome-based ones, it is not a panacea 
for driving down the healthcare costs. Although ACA has toned down the increasing 
percentage of healthcare costs in United States GDP (0.124% increase from 2010 to 2014 
compared to 1.863% from 2005 to 2010), about 18% of the GDP is still a staggering 
figure (compared to 8.9% in 1980) (McKinsey&Comapny, 2014.; The World Bank, 
2014.; Worley & Mohrman, 2014). The desire to drive down the costs of care merged 
with the surfacing of translational research’s importance and the adoption of EHRs has 
proliferated the calls for the development of systems that can drive down the costs and 
increase the quality of care (Lowes et al., 2017). 
As LHSs follow the continuous quality improvement philosophy they are aligned with 




know that employee lay-offs are not the solution and hospitals focus on eliminating the 
different types of waste that are going on in their organization. This is especially 
important since up to a third of care spending in the US is considered as avoidable waste 
(unnecessary services, administrative waste including unproductive and duplicate 
documentation, inefficiently delivered services, high prices, fraud, and missed prevention 
opportunities) (Institute of Medicine (IOM), 2007). Lowes et al. (2016), study the impact 
of the learning health systems implementation called “Learning From Every Patient 
(LFEP)” on 131 children with cerebral palsy which resulted in a 43% decrease in inpatient 
days, 27% fall in inpatient admission, 30% decrease in emergency room admissions, and 
210% and 176% cost reduction compared to time control group and program activities 
control group respectively (Lowes et al., 2017). Even if the costs aspect of the care would 
play second fiddle to the important topic of quality of care and its betterment, cost cuts 
would happen as a result of improved quality and decreased waste. There is an 
opportunity for research on how the LHS would affect the costs in hospitals in order to 
generate more evidence-based data on the challenges, benefits, and cost-cutting 
capabilities of continuous learning. 
2.3.1.3 Social 
One of the main drivers behind the emergence of LHSs is the need to deliver safe and 
efficient care to patients (Kelley et al., 2015). The need for clinical care to be both 
evidence and science-based concurrent to the increased pressure on quality improvement 
in care systems, the data and knowledge accumulation in practice and research can 




al., 2013). In researching to improve the quality of care, however, some social and patient-
related points should be considered. Firstly, although some patients welcome the 
increased convergence in research and practice, many others would not want themselves 
or their loved ones to take part in randomized clinical trials for comparative-effectiveness 
research. One of the concerns is about the proliferation of paper works, consent forms 
needed due to the increase in connected clinical research and practice adding to the 
organizational wastes. However, conditioned on robust practices and transparent 
mechanisms, many low-risk randomized clinical trials would not need any patient consent 
while the higher-risk procedures would get their needed concentration resulting in a safer 
system (Faden et al., 2014).  
Faden et al. (2014) also stress the importance of the thorough participation of patients and 
other stakeholders for mining the suitable specification of the institutional implications 
of the LHS decision making frameworks Faden et al. (2014) proposes an ethics 
framework for an LHS which is iconoclastic to traditional held thought about the 
separation in research and clinical ethics. This framework includes seven pillars for the 
ethical implementation of LHSs which are: 1-Respect the right and dignity of patients, 2- 
Respect clinician judgments, 3- provide optimal clinical care to patients, 4- Avoid 
imposing non-clinical risks and burdens on patients, 5- Address health inequalities, 6- 
Conduct continuous learning in order to improve the quality of clinical care and health 
care systems, and 7-Contribute to the common purpose of improving the quality and value 
of clinical care and health care systems (Faden et al., 2013). The mentioned paper also 




of the healthcare system. Although protecting patients is a very important subject, several 
hundred thousand people die needlessly each year from medical mistakes which can be 
avoided through quality improvement (Kohn, Corrigan and Donaldson, 2002). One of the 
important factors in the adoption of LHSs from the patient perspective is the clinician. As 
patients have more trust in their doctors compared to the researchers, there should be 
collaboration and teamwork between the clinicians and researchers in order to bolster the 
acceptance of LHSs and increase patients’ participation through shared decision making 
(Barry and Edgman-Levitan, 2012). Patients, for their good, should feel the need to 
contribute to and participate in the learning process just as health professionals and 
systems are obligated to learn. Kelley et al. (2015) points out that patients’ interest in 
individualized care correlated with the value they put on the relationship they have with 
their physician. So, the adoption of LHSs not only does not undermine the role of 
physicians but also highlights their role as an influential part of the system (Kelley et al., 
2015). This element turns clinicians’ attitude towards LHSs, quality improvement, and 
comparative efficiency research into an important factor. Health systems should involve 
clinicians more effectively in quality improvement in order to boost their attitudes and 
the diffusion of LHSs (Butler et al., 2017). Wolf et al. (2009) emphasize the importance 
of patients’ “health learning capacity” that should be considered. This capacity includes 
a wide spectrum of cognitive and psychosocial skills assisting patients or family members 
in effectively promoting, protecting, and managing their own or a loved ones’ health 
(Wolf et al., 2009). The need for this capacity shows that the education and structure of 
LHS culture should not be limited to the health system employees and educating patients 




al. (2016) hint at the reciprocal benefits that LHS and human factors can have on each 
other through gaining access to new research fields and adoption of a range of tools to 
pinpoint and address the implementation challenges respectively (Roth et al., 2016). To 
conclude, the social and patient side of LHSs is a very crucial one which includes many 
other aspects that should be looked into in terms of patient privacy, inclusiveness, 
transparency, accessibility, adaptability, governance among others (Rubin, 2017). 
One of the other areas that have been the focus of some research papers for LHS, is the 
area of public health and equity. Many are concerned that the improved quality and 
outcomes in healthcare would be limited to premium health services and people who can 
pay for them by themselves or through their insurances. Faden et al (2013) focus on the 
societal goal of a just healthcare system with the objective of high-quality care and 
economic welfare through LHSs (Faden et al., 2013). With the continuation of care 
quality disparities for racial and ethnic minorities, LHS can potentially bolster the care 
quality through applications such as data analysis, continuous quality improvement, and 
patient-centered care (Brooks et al., 2017). Brooks et al. (2017) posit a framework for 
integrating health equity into LHSs. This method includes prioritizing health equities, 
engaging the community, targeting health disparities, acting on data, learning, and 
improving. Some of the other factors that are important in the implementation of LHSs 
are the type of city and community that they are going to be structured in. As Khurshid 
(2016) puts it, working with champions and backbone organizations in the community, 
not being limited with the legacy systems, and looking at data sharing (among different 




solution (Khurshid, 2017). Through literature, there are also examples of data‐fueled 
learning health community constantly powered by the people and for the people (Okun 
and Goodwin, 2017). With the rise of new technologies such as genomics, the opportunity 
of gaining so much data from a wide range of different people is within reach. However, 
there are still barriers that hinder this access. Blizinsky and Bonham (2017) identify three 
barriers that face the LHS data that are provided by genomics. The challenges are 
inequality in the use of genomic medicine, lack of pharmacogenomics access in clinical 
care, and insufficient integration of social and environmental data into EHRs (Blizinsky 
and Bonham, 2017). Integration of technologies such as genomics and wearables as 
feeding factors for the data in LHS can play a vital role in LHSs’ adoption and their impact 
on public health through gaining more data about racial and ethnic, socio-economic, 
economic backgrounds, and age of people and the health issues they deal with. As the 
racial diversity is increasing in the US and by 2050 it is estimated that about one-fifth of 
the US population is going to be over 65, it is imperative to use opportunities like LHS to 
promote and improve public health and equity and deal with these extrinsic changes 
(Shaygan, 2018). 
2.3.1.4 Technical 
As the implementation of LHS needs a socio-technical infrastructure, the technical side 
of its adoption of assessment has significant importance. The adoption of EHRs in the US 
from one side and the development in fields such as genomics and wearable devices from 
the other side are paving the path for the collection of great amounts of data for health 




organizations are forced to leverage the value of technology advancements to be cost-
effective, competitive, and responsive. Concurrent to the mentioned advances, acquiring 
experienced data scientists and leveraging the benefits of data integration, sharing with 
different stakeholders, and acquisition and curation of data are some of the areas that can 
help healthcare organizations with their goals of increasing quality care, patient 
satisfaction, and public health while driving down the costs (Krumholz, Terry and 
Waldstreicher, 2016; Barham, 2017). The ongoing adoption of smart wearable devices is 
an important part of contributing to the body of patient-data in general and specific fields 
(such as diabetes, surgeries, and user empowerment and health promotion) (Lukowicz, 
Kirstein and Tröster, 2004; Kolodzey et al., 2017; Shaygan, Ozdemir-Gungor, D. Kutgun 
and Daneshi, 2017). The shift to LHS can provide the needed infrastructure for the 
development of new generation learning decision support tools in order to mitigate the 
diagnostic errors (Corrigan et al., 2017). As mentioned before, the adoption of EHRs can 
play a vital role in clinical research and consequently smoother implementation of LHSs 
and there are already new studies trying to build upon what has been done it terms of 
EHRs showing further interest in LHSs. A study by Daniel et al. (2016) tries to build on 
a platform called EHR4CR which is developed in order to provide communication, 
security, and semantic interoperability services between twenty-one European hospitals 
and pharmaceutical companies in five countries by proposing the need for cross border 
semantic interoperability for LHSs (De Moor et al., 2015; Daniel et al., 2017). There are 
also studies, seminars, and conference talks on the connections of LHSs, precision 
medicine, and implementation sciences. Chambers et al. (2016) stresses the importance 




quality and efficient healthcare system on pillars of precision medicine (Chambers, Feero 
and Khoury, 2016). This study goes on to talk about the synergy areas between LHS and 
implementation science in terms of improving the implementation of effective practices. 
Machine learning is one of the main enabling technologies behind LHS in terms of 
enabling and improving pattern recognition. Translation of the textual knowledge into 
machine-learned knowledge will enable the integration of the knowledge with a specific 
patient. Cahan and Cimino (2017) propose a self-growing and self-maintaining patient 
knowledge base that can be in reach of health professionals worldwide which can benefit 
low resource health systems, practitioners, and researchers concurrently (Cahan and 
Cimino, 2017). A 2017 report by the Office of National Coordinator for Health IT (ONC) 
and Agency for Healthcare Research and Quality (AHRQ) discusses the convergence of 
factors such as being fed up with the legacy systems, widespread adoption of networked 
devices, and increased public acceptance and exposure to systems like Amazon is paving 
the way for the increased integration of artificial intelligence in Healthcare (Derrington, 
2017). 
More evidence and research studies into the outcomes of the implemented LHS can 
provide insights into technical and infrastructural needs aligned with bolstering the 
systems and mitigating their shortcomings. There are studies in the literature which 
discuss the implementation of LHS cluster for specific diseases and areas (Hobbs, 2012; 
Kwon et al., 2012; Mandl et al., 2014; Shah et al., 2016; Turley, 2016; Johnson et al., 




2.4  Maturity Models  
Maturity models are instruments to facilitate organizational management (Vidal 
Carvalho, Rocha and Abreu, 2017). These models have been used with different goals 
and purposes for benchmarking system development or organizational management for 
years. They are built on entities such as people, organizations, functional areas, processes 
among many others (Rocha, 2011). Maturity models normally are used to evaluate these 
entities in terms of predicted patterns in the form of stages or levels. 
 Maturity models have been proven to be useful in a myriad of different fields such as 
software, system engineering, project, and program management, energy management, 
technology road mapping, healthcare technology management, and other areas with goals 
of facilitating process improvement (Kappel, 2001; Kerzner, 2001; Paulk, 2002, 2009; 
Garets and Mike, 2006; Dunbrack and Hand, 2013; Introna et al., 2014; Sanders and 
Burton, 2016).  
In the field of software, Paulk et al. (1993) came up with the Capability Maturity Model 
(CMM) which could be used as a maturity framework for bolstering organizational 
processes with goals of development and management of software and it encompasses 
five levels of maturity including initial, repeatable, defined, managed, and finally, 
optimizing (Paulk, 2002). The Software CMM has been replaced by CMM Integration 
(CMMI) since 1997, which integrates System Engineering with Software Engineering 
and Integrated Product Development in a single model (Paulk, 2009).  Also, on the project 
management side, there are maturity models such as OPM3, P3M3, and the project 




CMM model with the exception that the first step in P3M3 is awareness instead of initial. 
The project management maturity model (PMMM) includes a common language, 
common processes, singular methodology, benchmarking, and continuous improvement 
as its maturity levels (Kerzner, 2001; AXELOS, 2018). Demir and Kocabas applied the 
PMMM in education with the same maturity levels (Demir and Kocabas, 2010). In 2002, 
Knowledge Process Quality Model (KPQM), was introduced to aid companies to evaluate 
their knowledge management structures and finding ways for future improvements 
(Paulzen et al., 2002). Many current maturity models have different levels of maturity in 
order to describe the current state of the measured entity. Most of these models include 5 
levels and are based on CMM or CMMI which were discussed earlier with the level labels 
including but not limited to: 
Level 1 -getting started/awareness/initial/ common language. 
Level 2 -developing/focusing/repeatable/knowledge/ common process/ basic 
knowledge. 
Level 3 -complying/practicing/competence/defined /singular methodology/process 
definition. 
Level 4 -sustaining/exploiting/managed/excellence /benchmarking/ process control. 
Level 5 -advocating/transforming/optimized/ optimizing/mature/continuous 
improvement/process improvement. 
There are studies that have revised the CMM model and added some stages to the 




model for information system management and strategy (Galliers and Sutherland, 1991). 
These levels include Ad hocacy, foundations, centralized, cooperation, entrepreneurial, 
and harmonious. This research evaluates maturity for strategy, structure, systems, staff, 
style, skills, and superordinate goals. 
As it can be seen, maturity models have been proposed to address different issues, in 
different aspects of different areas and industries. The Healthcare industry has been no 
exception in using maturity models as models have been created to address specific parts 
and dimensions of the healthcare industry. The healthcare maturity models will be 
discussed next. Table 1 presents a myriad of maturity models in areas such as software, 
energy, systems engineering, project management, road-mapping, safety, knowledge and 
change management, risk and capability management, social media, manufacturing 
engineering, organizational design, quality engineering, education, and their number of 
stages in terms of maturity. 
Table 1: Maturity Models in Different Fields 
Model Area Stages Reference 
Capability Maturity Model 
(CMM/CMMI/QMMG) 
System Engineering Capability, 
Software Engineering, and 
Integrated Product Development 
5 (Paulk, 2002, 2009) 
Complex Product Systems (CoPS) 
Maturity Model 
Project Risk Management 5 (Yeo and Ren, 2008) 
Knowledge Process Quality Model 
(KPQM) 
Knowledge Management, Quality 
Improvement 
5 
(Paulzen et al., 
2002) 





Project Management Maturity Model 
(PMMM) in Education 








Model Area Stages Reference 
P3M3 Portfolio, Program, and Project 5 (AXELOS, 2018) 
Project Management Maturity Model Project Management 5 (Kerzner, 2001) 
Energy Management Maturity Model Energy Management 5 (Introna et al., 2014) 
Roadmapping Maturity Model Roadmapping 6 (Petrick, 2008) 
Roadmapping Influence model Roadmapping 4 (Kappel, 2001) 
Social Media Maturity Model Social Media 5 
(Thomas and 
Woodside, 2016) 
Service Systems Maturity Model 
 
Manufacturing Enterprises 5 (Neff et al., 2014) 
Maturity Models and safety culture Safety Culture Lit Rev 
(Goncalves Filho 
and Waterson, 2018) 
Organizational Design Maturity 
Model 









Management Maturity Model (IQM3) 
Quality Management 5 
(Caballero et al., 
2008) 
Organizational Change Readiness 
MM 
Change Management 6 
(Zephir, Minel and 
Chapotot, 2011) 
Capability Maturity Model for 
Business Intelligence 
Business Intelligence 5 
(Raber, Winter and 
Wortmann, 2012) 
Business Process Maturity Model 
(BPMM) 
Business Processes 5 
(Lee, Lee and Kang, 
2007) 
 
2.4.1  Technology Management Maturity in Healthcare 
Maturity models have also been used in the healthcare domain specifically in the 
information system technology sector (Vidal Carvalho, Rocha and Abreu, 2017). Tarhan 
et al (2015) argue that only a scarce number of maturity models have been proposed with 




Turetken and van den Biggelaar, 2015). However, there has been a myriad of studies in 
the field of maturity models in healthcare in recent years. 
There are models such as IDC’s mobility maturity model for mhealth and models such as 
HIMSS maturity model for electronic medical records (EMRAM), patient record/content 
management maturity model (Forrester model), and maturity model for electronic patient 
record (EPRMM) for the field of electronic medical records (Garets and Mike, 2006; 
Priestman, 2007; Clair, Brown and Moore, 2010; Dunbrack and Hand, 2013). There have 
been other maturity models designed for different fields in healthcare such as 
interoperability, infrastructure IT, data warehousing, analysis networking, telemedicine, 
networkability, and usability among other (Nehta, 2007; Sharma, 2008; Fitterer and 
Rohner, 2010; NHS, 2011; Zephir, Minel and Chapotot, 2011; Brooks, El-Gayar and 
Sarnikar, 2013, 2015; Van Dyk and Schutte, 2013; Sanders and Burton, 2016; HIMSS 
Analytics, 2018). As for organizations with goals of continuous learning, a mature system 
is defined as a system that generates timely actions to the information that it derives (or 
it can be derived) from data in order to create meaningful measurement regarding system 
learning (Ainsworth and Buchan, 2015). In this research, a mature health organization 
(system) in terms of technology management is defined as:  
“A system that generates timely actions to the information that it derives from data in order to 
create meaningful measurement regarding systematic learning and increased efficacy and 
effectiveness in health outcomes.” 
As an initial part of this research, Shaygan & Daim (2019) proposed an exploratory model to 




Decision Model (HDM). The model can help health organizations with pinpointing their 
strengths and weaknesses in the adoption and implementation of new technologies and 
socio-technological approaches such as Learning Health Systems (LHS) and their 
infrastructure while giving them organizational and competitive self-awareness and guide 
them in setting their strategies and resource allocation. The mentioned study was done to 
create an exploratory model to serve as a much-needed technology management tool for 
health organizations to assess their technology management maturity for both public and 
organization’s advantage in a more effective way.  
A list of maturity models proposed in healthcare is shown in Table 2. 
Table 2: Maturity Models in Healthcare 
Model Area Stages Reference 
Governance, Risk, and Compliance 
MM (GRC) 





Hospital Cooperation Maturity 
Model (HCMM) 
Hospital Corporation Quality 4 
(Mettler and 
Blondiau, 2012) 
Quintegra Maturity Model for 
Electronic Healthcare (eHMM) 
Healthcare Information 
System Technology 
7 (Sharma, 2008) 
Healthcare Data Quality Maturity 
Model (HDQM2) 
Healthcare Data Quality 5 
(Pinto-valverde 
et al., 2013) 







IDC’s mobility maturity model Healthcare, mHealth 5 
(Dunbrack and 
Hand, 2013) 
PACS Maturity Model 
Picture Archiving and 










Model Area Stages Reference 













NHS Maturity Model Healthcare 5 (NHS, 2011) 
Process Management in Hospitals 
Diagnosis- 
Related Groups (DRG) 
5 
(Cleven et al., 
2014) 
HIMSS Maturity Model for 
Electronic Medical Record 
(EMRAM) 















Patient records/content management 
maturity model (Forrester Model) 




Maturity Model for Electronic 
Patient Record (EPRMM) 
Healthcare, EMR 6 
(Priestman, 
2007) 
NEHTA Interoperability Maturity 
Model (IMM) 
Healthcare, Interoperability 5 (Nehta, 2007) 
NHS Infrastructure Maturity Model 
(NIMM) 
Healthcare, Infrastructure IT 5 (NHS, 2011) 
Healthcare Analysis Adoption 
Model (HAAM) 












PACS Maturity Model (PMM) Healthcare 5  
Telemedicine Service Maturity 
Model 
Healthcare, Telemedicine 5 
(Van Dyk and 
Schutte, 2013) 
Healthcare Usability Maturity 
Model 




Model Area Stages Reference 









Healthcare Information System 








2.5 Quadruple Aim of Care  
In 2008, Donald Berwick et al. provided a framework for the delivery of high-value care 
in the United States, revolving around three main goals: improving the individual 
experience of care; improving the health of populations; and reducing the per capita cost 
of healthcare also known as the triple aim of care (Berwick, Nolan and Whittington, 
2008). This framework discusses that and healthcare organizations that deliver individual 
care and population-based interventions that are evidence-based and highly reliable can 
achieve these three qualities. The enablers of this achievement in a care system are access 
to up-to-date medical knowledge, standardized definitions of quality and cost, and 
evidence and measurement collected and distributed by a thoroughly trustworthy body as 
indicators of the “state of the system” by its stakeholders. This state is assessed through 
its reliability, adherence to evidence, cost, and progress in improvement. These goals 
would ideally result in care that produces the best outcomes at the lowest cost over time 
(Porter and Teisberg, 2006). 
The important enablers for the positioning of the health organization for a successful 
pursuit of these aims are recognition of a population as the unit of concern, externally 




subgroups be treated equitably), and the existence of an “integrator” with the duty of 
focusing and coordinating services to assist the population on all three dimensions at once. 
Donald Berwick et al. (2008) define the roles of the integrators or health organizations 
pushing for the achievement of the triple aim of care are partnership with individuals and 
families, redesign of primary care, population health management, financial management, 
and macro system integration. 
As, in recent years, Physician well-being has become an increasing concern, due to 
increasing evidence of an epidemic of burnout and stress among medical 
professionals,  the goal of improving the work-life of health care providers was proposed 
to be added to the triple aim of care by Bodenheimer and Sinsky in 2014 (Shanafelt et al., 
2012; Bodenheimer and Sinsky, 2014; West, 2016). In other words, as the Triple Aim of 
care focuses on improving the patient experience of care, improving the health of 
populations, and reducing the per capita cost of healthcare will benefit from the 
expansion, the Quadruple Aim of care also includes the goal of improving the well-being 
of health professionals. The fourth aim can be addressed through different channels such 
as the implementation of a documentation team (to lessen the burden from physicians, 
Use of pre-visit/lab/follow up planning, expanding the role of nurses and medical 
assistants, standardization and coordination of workflows, and more effective training 
among others (Bodenheimer and Sinsky, 2014). 
 
2.6 Importance to Healthcare Management 
 
As the healthcare landscape and environment in the United States remains a volatile and 




organizations need to have an understanding of the healthcare system and its landscape 
as they need to comprehend the bigger picture of the environment which they try to plan 
and manage decision and strategies. This knowledge (or lack thereof) can significantly 
affect the viability, success, quality, and efficiency of the delivered care in results of 
impacting the timeliness of decision-making actions. Shi and Singh (2019) discuss this 
significance for care manages from different aspects such as positioning and 
understanding, handling threats and opportunities, evaluating implications, complying 
with regulations, planning, capturing new markets, and following the organizational 
mission. Moreover, pursuing goals of continuous improvement and learning in the 
dynamic healthcare environment can change the roles of managers from managing 
processes to people (leadership, motivation,…) (Poksinska, Swartling and Drotz, 2013). 
This necessitates a continuous effort from the managers’ side to balance the new 
organizational, technological, social, financial, and regulatory changes with the 
organization's culture, goals, and resources.  
In their book, Hegarty, Amoore, Blackett, McCarthy, & Scott (2017) divide healthcare 
technology management into two groups; Supporting and Advancing Care and 
Equipment Management. The former includes topics such as clinical supporting, teaching 
and training, clinical information, regulatory and standards issues, quality and risk 
management, adverse event investigation, and support and innovation in care processes. 
The second group, however, focuses on data management, scheduled maintenance, 
medical equipment, and systems support, technology assessment, performance 




referring to and the assessment of technology management maturity it is trying to evaluate 
includes many elements from both remits of technology management in healthcare. 
 Knowledge of the health care system and its development is critical for the effective 
management of healthcare organizations. Therefore, health organizations should pay 
attention to community needs, technological progress, consumer demand, and economic 
prospects, to be better positioned to achieve and maintain their organizational missions 
and technology management maturity as an organization. This maturity can bolster 
access, service quality, and efficiency in the delivery of services. Health organizations 
should address the need to take into account which technological, social, organizational, 
regulatory, and financial might affect their organization’s long-term stability. This 
knowledge should enable healthcare organization's decision-makers and managers to 
identify strengths, weaknesses, opportunities, and threats in a more effective and timely 
manner. The same thing goes for effectively allocating resources to manage changes (both 
taking advantage of them or mitigating their unwanted results). The action taken can 
address certain learning and improvement areas as well in terms of what should be 
learned, added, modified, jettisoned, and what sort of organizations training, 
technological infrastructure, public trust, or financial/regulatory need should be 
conformed with aligned with organizations goals and mission. In conclusion, knowledge 
of the health care system and its development is significantly important for the effective 
management of healthcare organizations. Factors such as requirements, technological 
advancements, stakeholder needs, and financial prospects, the decision-makers in 




missions and the goals of healthcare (quadruple aims of care (Bodenheimer and Sinsky, 
2014)). 
2.7 Research Centers in University Hospitals 
Healthcare organizations and hospitals (including university hospitals) are large 
institutions and consist of a very complex structure of management. Usually, different 
organizations within a hospital may have different management styles and smaller 
governance silos with certain guidelines being the same across these organizations. For 
this reason, this research will focus on a smaller entity inside university hospitals which 
are University Hospital Research Centers (UHRC) as the unit of study for this research. 
These centers focus on specific areas within a bigger health organization and have their 
directors, managers, and staff with different budget sources such as grants and donations, 
among others. Although they operate under the guidelines and goals of the university 
hospital, they have their own goals and missions which are aligned with their parent 
organization but more specific. These units also have a certain amount of autonomy that 
allows them to operate aligned with their mission and goals. 
A university hospital is an institution that combines the services of a hospital with 
the education of medical students and with medical research. Van der Meulen, 1994 
describes support from the federal government and the introduction of faculty practice 
plans in medical schools as major growth factors for these academic health centers (Van 
Der Meulen, 1994). The mentioned research goes on to discuss the high cost of healthcare 
as an external force in the growth of university hospitals and increasing concern about the 




significant cost to develop the ability to treat serious illnesses at the high end and in doing 
so they need to cope with a larger population with needs around different disorders as 
more and more types of patients are now being treated in more specialized care centers 
(Christensen, Bohmer and Kenagy, 2000).  
University hospitals are typically affiliated with a medical school or university. Most of 
these university hospitals have research and innovation centers as compartmentalized 
units within them that may focus on one or several specific topics. These units have 
different ways of financing their budgets and have certain amounts of autonomy in the 
way they are managed. These units can lead to breakthrough research for new cures, new 
standards of care, and better understanding of different issues in specified areas of care. 
In the United States, most of the funding for the research institutes and centers comes 
from publicly funded grants (such as NIH grants), private grants, industry partnerships, 
foundations (benefactor), endowments, state and federal customers, and donations. These 
centers focus on topics such as imaging, cancer, vaccine and gene therapy, medicine, 
public health, system effectiveness, Alzheimer’s, cardiovascular, occupational health, 
evidence-based practice, neuroscience, aging, immunology, orphan diseases, and 
innovation, among others. Each of these centers may focus on one or several topics within 
their field. One factor that may be decisive in the direction of the research in the center 
can be publicly or privately funded grants. In general, funding for science has changed 
throughout time and moved from largely being supported through private patronage (the 
backing of a prominent person or family), church sponsorship, or simply paid by research 




foundations (Understanding Science at Berkeley, 2020). As an example, Oregon Health 
and Science University (OHSU), located in Portland, Oregon, is a university hospital 
established in 1887. OHSU has around 33 research centers and institutes focusing on 
topics such as oncology, public health, imaging, aging, neuroscience, and systems 
effectiveness among many others. Some of these centers are created aligned with federal 
or state-level initiatives for specific needs. 
The U.S. Department of Health and Human Services (HHS) has a mission of enhancing 
the health and well-being of Americans by providing for effective health and human 
services and by fostering sound, sustained advances in the sciences underlying medicine, 
public health, and social services (U.S. Department of Health and Human Services 
(HHS), 2020). This department has different grants under programs like Administration 
for Children & Families, Agency for Healthcare Research and Quality, Centers for 
Disease Control and Prevention, Food and Drug Administration, and National Institutes 
of Health.  The National Institutes of Health (NIH) is the primary federal agency for 
medical, health, and behavioral research. It is the largest of the eight health-related 
agencies within the Public Health Service (PHS) within the HHS consisting of the Office 
of the Director and 27 Institutes and Centers (ICs) that focus on aspects of health, human 
development, and biomedical science (Sekar, 2020). NIH activities span from basic, 
clinical, and translational research, focused on particular diseases, areas of human health 
and development, to more fundamental parts of biology and behavior. Research training 
and health information collection and the spread of knowledge are among the mission of 




and other awards (HHS.gov, 2018). This allocated amount can fund more than 300,000 
researchers working at over 2,500 hospitals, medical schools, universities, and other 
research institutions in the United States (Sekar, 2020). Table 3 shows the NIH funding 
and the change for each year while demonstrating the change in funding compared to the 
peak year which was 2003. Figure 7 and Figure 8 demonstrate the change in NIH funding 
throughout the years in current and projected constant FY2020 values respectively (Sekar, 
2020). Research funded by the NIH has led to saving lives while increasing longevity and 
quality of life for people in the United States and around the world. Glass et al., 2020 
points at success stories such as The Framingham Heart Study, development of childhood 
vaccines, and the rapid decrease in morbidity and mortality from human 
immunodeficiency virus as some success stories among the countless success stories of 
the results of grants fund by the NIH in different areas such as disease-specific initiatives 
and various specialties (Jacob and Lefgren, 2011; Colaco et al., 2013; Blume-Kohout and 
Adhikari, 2016; Glass et al., 2020; National Institutes of Health (NIH), 2020). 
Carline (2014) explores grants on the medical education and educational innovation, as 
an example, discussing grants such as the Edward J. Stemmler, MD Medical Education 
Research Fund Awards from the National Board of Medical Examiners or awards from 
the Fund for Improvement of Post-Secondary Education for the smaller research while 
discussing the Undergraduate Medical Education for the 21st Century project with goals 
of medical education reform and training (innovation and research) grants from the 




Table 3: NIH funding and the Change Throughout the Years (Sekar, 2020) 
Fiscal Year Funding (B) Change Funding in 2020 values % Below 2003 Funding 
1994 $         10.90  $                        23.80  
1995 $         11.30 3.1% $                        23.74  
1996 $         11.90 5.6% $                        24.40  
1997 $         12.70 6.8% $                        25.30  
1998 $         13.60 7.3% $                        26.30  
1999 $         15.60 14.3% $                        29.20  
2000 $         17.80 14.1% $                        32.10  
2001 $         20.40 14.7% $                        35.60  
2002 $         23.30 14.0% $                        39.30  
2003 $         27.10 16.5% $                        44.20  
2004 $         28.00 3.2% $                        44.00 -0.5% 
2005 $         28.50 2.0% $                        43.20 -2.3% 
2006 $         28.50 -0.1% $                        41.20 -6.8% 
2007 $         29.10 2.2% $                        40.60 -8.2% 
2008 $         29.60 1.5% $                        39.40 -11.0% 
2009 $         30.50 3.2% $                        39.40 -10.8% 
2010 $         31.20 2.3% $                        39.10 -11.5% 
2011 $         30.90 -1.0% $                        37.70 -14.8% 
2012 $         30.80 -0.2% $                        37.10 -16.1% 
2013 $         29.30 -5.0% $                        34.60 -21.7% 
2014 $         30.10 2.8% $                        34.80 -21.2% 
2015 $         30.30 0.6% $                        34.30 -22.4% 
2016 $         32.30 6.6% $                        35.80 -19.0% 
2017 $         34.30 6.2% $                        37.10 -16.2% 
2018 $         37.30 8.8% $                        39.30 -11.2% 
2019 $         39.30 5.4% $                        40.30 -8.8% 
2020 $         41.90 6.6% $                        41.90 -5.4% 
 
 






Figure 8: NIH Funding Throughout the Years (Program Level Projected Constant FY 2020) (Sekar, 2020) 
 
Consoli and Mina, 2009 present a sketch for health innovation systems and the building 
blocks, interactions, and feedback between them (Consoli and Ramlogan, 2008; Consoli 
and Mina, 2009). This sketch consists of different elements around a problem and the 
factors it affects in the individual sphere (patient and practitioner), service provision 
(training, experience, therapy, and diagnosis), technology market (drugs and devices), 
regulations, and scientific community (publications). 
One of the reasons behind the realization of the need for health centers within university 
hospitals can be traced to the rise of evidence-based care and the opportunity for different 
centers with different focuses to collect data and perform research in the respective area 
of research. The paradigm shift in evidence-based healthcare was multi-perspective. The 
research strategy was shifting from lack of national leadership with scattered funding 
without effective communication and coordination to improve strategic nationwide 
leadership with improved communications between funders and researchers which led to 




research direction shifted from being research-led to needs-led while better research 
programs paved the way for higher research quality. This shift also led to improved 
research methods (more appropriate use of research methods), research outputs 
(improvement of clinical practice being set as the primary goal rather than publications), 
dissemination, mode of access to research findings (from innovation pull to innovation 
push to clinicians in a proactive manner), and practitioner understanding of research 
findings (more focus on metal analyses and systematic reviews as opposed to reports of 
individual research (Walshe and Rundall, 2001). 
In the United States, health systems are trying to shift from decades of operational systems 
designed to deliver health care as a reimbursable service and morph into systems that 
deliver health as a population goal (Goldman, Kumanyika and Shah, 2016). Parallel to 
these changes is the constant quality improvement efforts in areas such as reducing 
hospital-acquired infections and readmissions for heart failure. In this direction, both 
transformation and incremental improvement are called for the learning health system, 
which can constantly improve itself in different areas using the data generated internally 
and externally meaning clinicians use each patient encounter as an opportunity to make 
the next one better (Krumholz, Terry and Waldstreicher, 2016). This is especially 
important in the research centers within health organizations as their goal and mission are 
to learn and improve in a specific area of healthcare to be able to serve the population in 
need of that specific service or treatment better. 
As entities within university hospitals, health centers need to manage their technology, 
knowledge, and resources to ensure continuous improvement and efficient learning and 




(such as devices, data, access), social (patients, stakeholders, workforce), regulations 
(keeping tabs on the changes in regulations and healthcare structure), organizational 






















3. Research Gaps, Objectives, and Questions 
As the result of the literature review provided in the previous section, this part focuses 
on clarifying the research gaps, research questions, and research goals. 
3.1.Research Gaps 
As the result of the literature review, several gaps were identified which this research will 
attempt to bridge. The themes of the gaps range from the lack of a structured assessment 
tool for the technology management to the need for organized and classified categories 
of dimensions and criteria and emphasis on the much-needed focus on the technology 
management side of maturity in health organizations (Grossmann, Goolsby, Olsen and 
Michael, 2011; Hobbs, 2012; Grant et al., 2016; Brooks et al., 2017; Foley and Vale, 
2017). Some of the existing research in the literature also calls for the need for a model 
to include the main influence factors and their importance levels regarding maturity 
models in healthcare technologies and information systems (Carvalho, Rocha and Abreu, 
2016; Vidal Carvalho, Rocha and Abreu, 2017).  
As for continuous learning, its adoption, and implementation, there is a need for a multi-
criteria approach in studying this topic in the context of technology management maturity 
of health organizations. Most of the existing research in the literature focuses on 
healthcare maturity and continuous learning in healthcare organizations only through the 
specific lens based on the respective research field (Shaygan, Lavoie and Daim, 2018). 
Therefore, these studies may not address the complexity of health care organizations’ 




This section will go through each of these gaps by summarizing the existing literature 
around these talking points and clarifying the underlying gaps within those areas. 
Furthermore, in the research goal’s section, the ways in which the model will help 
mitigate and bridge these gaps will be explained. 
3.2.1. Gap I 
According to the literature and as discussed in the literature review in this research, the 
adoption and implementation of technology management maturity models in healthcare 
and continuous learning have not been studied in a multi-perspective way. In other words, 
through literature, each domain of research only talks about these topics from their lens. 
Research in public health has been focusing on the equity and social aspects (There’s a 
further need to strategically align maturity and learning with health equity in terms of 
addressing health disparities) (Bauer et al., 2015; Brooks et al., 2017) while technical and 
technological research focuses on the EHR, EMR, and machine learning aspects and 
technological infrastructure (Shah, 2016; Kraft et al., 2017; Malenfant et al., 2019; Nordo 
et al., 2019; Takenouchi et al., 2019). Furthermore, on the maturity models side, studies 
focus on healthcare information technology and systems or business intelligence 
exclusively (Brooks, El-Gayar and Sarnikar, 2013, 2015; Carvalho, Rocha and Abreu, 
2016; Carvalho et al., 2019). As an example (Brooks et al., 2017) proposes a practical 
framework to incorporate health equity into a developing continuous learning system and 
make sure that health disparities are considered in the development of such healthcare 
systems. Bauer et al. (2015) discuss the importance of learning and implementation 




concerns (Bauer et al., 2015). Brooks et al (2013) and (2015) proposes a review of 
existing business intelligence maturity models to determine their adequacy for use in 
healthcare while Carvalho et al. (2016,2018,2019) develop a maturity model for 
healthcare information systems (Carvalho et al., 2018).  Zephir et al. in 2011 propose a 
methodology that revolves around coping with organizational readiness to achieve 
business goals through technological and structural improvements bringing technical and 
human capabilities together with goals of measuring organizational development maturity 
(Zephir, Minel and Chapotot, 2011). Again, in this research, only two general dimensions 
of maturity in healthcare are integrated to determine maturity with a focus only on change 
management. Batenburg et al. propose a preliminary maturity model to evaluate and 
monitor factors including Governance, risk and compliance (GRC) and GRC maturity in 
Dutch hospitals (Batenburg, Neppelenbroek and Shahim, 2014). 
In general  Most of the existing literature focuses on one aspect of maturity in healthcare 
(machine learning, public health, leadership, political, regulatory, organizational, 
economic, technical) (Olsen, Saunders and Mcginnis, no date; Ren, Pazzi and Boukerche, 
2010; Lambin et al., 2013; Morain and Kass, 2016; Butler et al., 2017; Finkelstein and 
Jeong, 2017; Malenfant et al., 2019; Takenouchi et al., 2019). According to some authors 
the drivers of healthcare maturity and continuous learning adoption and maturity are 
multifaceted and need to be studied that way) (Hobbs, 2012; Schmittdiel et al., 2017; 
Shellum et al., 2017). Furthermore,  there are no systematic attempts to investigate the 
potential impacts of different aspects of maturity and continuous learning on the quality 




for a validated maturity model by defining healthcare processes, maturity levels, and 
functionality or capability at each perspective at each maturity level. Carvalho et al. 
(2016) reviews a wide variety of different healthcare maturity models through a literature 
review and concludes that none of the identified models has a sufficiently broad scope 
covering all areas and subsystems of health care organizations (Carvalho, Rocha and 
Abreu, 2016). One of the other challenges that the existing models face is regarding 
important factors for maturity. Carvalho et al. (2016) points out the existence of entries 
with the same name in different maturity models and entries with different names but with 
the same meaning or interpretation due to selected terminologies. This can also be due to 
the fact that as criteria are not grouped and organized in different categories and 
perspectives, lack of context would potentially cause confusion, duplication, and 
inconsistency. 
 All in all, the criteria for assessing technology management maturity models in 
healthcare in general and adoption and implementation of areas such as continuous 





Figure 9: Gap 1 
 
Gap 1: The criteria for assessing technology maturity models in healthcare in terms of 
management of technology and continuous learning are not organized and classified into 
perspectives. 
 
3.2.2. Gap II 
There’s a need for a framework to better assess the technology management maturity in 
terms of implemented and adopted technologies across all aspects of care (Grossmann, 
Goolsby, Olsen and Michael, 2011; Foley and Vale, 2017). In other words, there is no 
structured way of assessing the current state of the organization in terms of adoption and 
implementation of different aspects of technology maturity. There is a need for analysis 
to be conducted, evidence to be gathered, arguments to be constructed maintained over 
time around development, design, and implementation of continuous learning across all 
levels of care (Friedman et al., 2014). Moreover, there’s a need for tools for addressing 




for a tool to assist health organizations in decision-making and assessment of the adoption 
and implementation of systematic learning and its socio-technological infrastructure. 
Budrionis and Bellika (2016) argue that there is a lack of focus on the evaluation of the 
impact of learning health systems on service quality and patient outcomes (Budrionis and 
Bellika, 2016). 
Carvalho et al.(2016; 2015) discuss the need for a model including the main ingredient 
factors of healthcare technology maturity and the potential benefits of assigning weights 
to them to understand their relative importance: 
“A maturity model with a holistic approach including a comprehensive set of influencing 
factors is missing. In this perspective, a new model to fill the gap should be designed. 
This new model should include the main influence factors with different weights 
depending on their relative importance and its development should be supported by 
rigorous scientific methods of conceptualization and validation.” [106, Page 131] 
Budrionis and Bellika (2016) also stress the increased pressure for the need for impact 
evaluation of continuous learning in healthcare organizations due to becoming more 
mature as a novel care delivery paradigm and point out that this is not a major focus for 
researchers yet. In other words, although research exists around these ideas, there is a lack 
of assessment tools and research in this area and more focus is being put towards the study 
of the feasibility of continuous learning rather than their assessment and their impact. The 
creation of learning-related methodologies may also encourage further studies about this 
topic and boost its adoption speed on different scales. Furthermore, many of the existing 




scales and levels and do not provide a score or quantification of important factors 
regarding maturity in the organization. Lin et al. (2011) explore the status of e-healthcare 
maturity in Taiwan in light of a nationwide investigation using  Nolan’s stage model 
(Nolan, 1973) among others. The mentioned study offers a multi-perspective model to 
better understanding the current status of e-healthcare maturity in hospitals with goals of 
better formulating e-healthcare policies to encourage the adoption of electronic medical 
records (Liu, Hwang and Chang, 2011). However, this model only uses surveys and 
interviews and does not include any quantification of this perspective and their respective 
criteria for topics such as application portfolio, integration, IT infrastructure, user 
awareness, information system staff, and planning. Brooks et al. (2013) conduct a 
literature review of existing business intelligence maturity models to determine if they 
will be useful in healthcare organizations (Brooks, El-Gayar and Sarnikar, 2013). A 
maturity model can provide a readiness assessment and plan for a business intelligence 
strategy by providing insight into the important checklists and processes necessary to 
achieve the desired level in business intelligence maturity. Again none of the studied 
models include quantification of important factors for maturity in healthcare 
organizations (Watson, Ariyachandra and Matyska, 2001; Fisher, 2005; Min-Hooi Chuah 
and Wong, 2012; Raber, Winter and Wortmann, 2012; Halper and Stodder, 2014). Brooks 
et al. (2013) stress the need for a validated maturity model by defining healthcare 
processes, maturity levels, and functionality or capability at each perspective at each 
maturity level. The validation factor is critical to confirm the accuracy and completeness 
of the proposed model in the healthcare environment. Brooks et al. continued their 




a business intelligence maturity model assessment tool (Brooks, El-Gayar and Sarnikar, 
2015). This potential model needs to serve as a guidance tool for business intelligence 
deployment initiatives and assess hospitals’ readiness to go to the next maturity level and 
eventually bolster information management’s control and comprehension across the 
organization. Raber, Winter, and Wortmann proposed a business intelligence maturity 
model built based on fifty-eight capabilities across five levels ranging from initiate to 
perpetuate with goals of identifying business intelligence weaknesses and strengths  
(Raber, Winter and Wortmann, 2012). 
Pak and Song proposed a capability maturity model (HCMM) in 2016 with the goals of 
improving an individual’s capability to manage their health by using personal health 
records (Pak and Song, 2016). This model was created based on Capability Maturity 
Model Integration (CMMI) (Paulk, 2002; Caballero et al., 2008), which helps developers 
in selecting software improvement strategies by determining their current maturity and 
pinpointing the issues needed for improvement which did not include any 
quantification. Pak and Song identified a lack of statistically and empirically validation 
test in their study as a limitation despite the fact that it was grounded on the theoretical 
and empirical models and called for the need for a validated framework which takes 
different dimensions into account (Mettler and Blondiau, 2012). 
Similarly, Zephir et al. (2011) build on CMM to assess the organizational maturity with 
goals of integrating new practices in times of structural or technological change (Zephir, 
Minel and Chapotot, 2011). This methodology revolves around coping with 




improvements. This research integrated technical and human capabilities with the goals 
of measuring organizational development maturity. Batenburg et al. propose a 
preliminary maturity model to evaluate and monitor Governance, risk, and compliance 
(GRC) and GRC maturity in Dutch hospitals (Batenburg, Neppelenbroek, and Shahim, 
2014). This model contains five maturity levels ranging from forming to optimized and 
contains definitions or characteristics for four different criteria in each of the governance, 
compliance, and risk areas across all five maturity levels. This model, however, is not 
quantitatively addressing the maturity assessment and does not have validation as a part 
of its procedure and discusses a need for a statistical method, such as factor analysis, or 
path analysis (using Structural Equation Modelling, SEM) to be used to find unknown 
factors that may have influenced the results. Knowledge Process Quality Model (KPQM) 
used to evaluate their knowledge management structures in companies pinpoints the 
needs for further test into their model including analysis of suitable measures for model 
validation (Paulzen et al., 2002). Fitterer and Rohner (2010) identify a future step for their 
research as a longitudinal model involving before/after evaluation of organizations 
regarding networkability advancing projects with analysis of reliability and validity of the 
prospective maturity model (Fitterer and Rohner, 2010). 
Carvalho et al. (2016) reviews a wide variety of different healthcare maturity models 
through a literature review and concludes that none of the identified models has a 
sufficiently broad scope covering all areas and subsystems of health care organizations 
and therefore, stresses the need for a new model to encompass main maturity factors with 




and subsequent validation (Carvalho, Rocha and Abreu, 2016). One of the other gaps 
mentioned in the discussed study is that maturity models in the healthcare setting are 
either highly specialized or too general in sense of healthcare information systems such 
as eHMM, IDC HIT, and CCMM. Moreover, most of these models do not discuss the 
design or validation for these models (Mettler and Blondiau, 2012). As for the other gaps 
identified in similar research, not of the studied research included any weights assignment 
or factors quantifications. Lastly, this paper points out that many of these models do not 
necessarily provide organizations with an improvement roadmap of the desired maturity 
through a systematized process serving as a maturity ladder.  In 2018, the next level of 
Carvalho et al. research was published and identified the need for involve the 
development of an automatic tool for assessing hospital information system maturity 
based on the important influencing factors as a future research (Carvalho et al., 2018). As 
a continuation of their study Carvalho et al. proposed their model in 2019 named the 
hospital information system maturity model or HISMM for short (Carvalho et al., 2019).  
This model is a classic maturity model including a matrix made of different maturity 
stages and six important typified factors affecting maturity in hospital information 
systems. This model defines the current maturity stage, the next maturity stage and 
identifies the attributes that must be met to reach a new maturity stage. These six factors 
include people, data analysis, strategy, information security, infrastructure, and electronic 
medical records. Each of the six stages have certain characteristics that need to be 
achieved to in order for the hospital to reach that level of maturity in a certain factor. The 
literature review in this study was followed by surveys, creation of the initial maturity 




improvement roadmap cannot be specifically pinpointed, and the maturity model 
measurements is not related to hospital performance within the hospital and does not 
address the optimal diffusion of this kind of maturity within the organization (van de 
Wetering, 2016). Moreover, similar to prior models, there is still no room for 
quantification of the model and subsequently creation of a quantified, validated, 
assessment tool for maturity in healthcare organizations. Finally, without quantification 
or a resulting maturity score, comparing hospitals’ performances against their competitors 
which was identified as a gap was not addressed. 
Furthermore, based on the literature many maturity models are created by health national 
and corporations, which advocate technological developments (IDC Health Insights and 
HIMSS or even by national health organizations as the National Health Service or 
National Electronic Health Transition Authority). This poses a challenge to look deeper 
into the methodology, validation, and development of these models. Besides, many of the 
existing healthcare maturity models are not published in academic journals and only a 
small number have gone through a peer-reviewed process (van de Wetering and 
Batenburg, 2009; Mettler and Blondiau, 2012). Most healthcare maturity models are in 
the form of white papers, websites, or presentations which hinders researchers from 
validating their validity and procedure. 
Another important weakness of the current maturity models as discussed by Goncalves 
and Waterson in their 2018 maturity model in safety is that results obtained during one 
point in time may not prove to be repeatable during another (Goncalves Filho and 




and overall robustness of using maturity models have been argued. Although in some 
areas such as safety, industry and related literature can be used to mitigate validation 
problems (as in (Flin et al., 2000)), there’s a lack of methodologies that systematically 
include validation for their criteria and results. 
In sum, in the studied literature around maturity models and specifically maturity models 
in the healthcare-related topics there are certain types of gaps that can be merged into one 
gap group. Initially, most maturity models are built based on models such as CMM which 
merely categorizes performances or initiatives into different levels of maturity stages. In 
other words, no amount of quantification goes into these models which increases the 
amount of subjectivity which can be counted as a limitation of these models. Furthermore, 
many of these maturity models are products of companies, reports, and/or whitepapers 
which means they have not been through a peer-reviewed process and more importantly 
validation. Lastly, on top of the need for a quantified and validated model, there is a need 
for the proposed model to be repeatable for both being implemented on the same health 
organization more than once and to serve as a tool for evaluation of inter-organizational 
performances among different health organizations. 






Figure 10: Gap 2 
Gap 2: There is a lack of a quantified, validated, and repeatable model for assessing 
maturity in health organizations in terms of technology management from different 
perspectives. 
3.2.3. Gap III 
Recent progress in healthcare-related fields such as information technology has led to the 
proliferation of volumes of both clinical and financial healthcare data. Despite the fact 
that healthcare is increasingly dependent upon these fields such as IT, the accumulation 
of data has outpaced our ability to utilize it to improve operational efficiency, clinical 
quality, and financial effectiveness (Mettler and Vimarlund, 2009; Ferranti et al., 2010). 
Moreover, the technological innovations have brought upon some new 
issues/opportunities that healthcare organizations need to leverage or mitigate. About half 
of the cost growth in health care over the past 40 years has been caused by technology 
innovation (Congressional Budget Office (CBO), 2008). Moreover, studies have found 
causal relationships between technology and management of decisions and performance 




and innovations has become an important issue in healthcare organizations’ day-to-day 
items.  Technology management is needed to be developed in health organizations 
alongside important practices such as patient-centered care, interdisciplinary teams, 
evidence-based practice, continuous quality improvement, use of new informatics, and 
integration of public health to enable and bolster policies, management, and leadership 
(Frenk et al., 2010). At the same time, if healthcare organizations are considered as 
complex adaptive systems due to the dynamic environment that they exist in, the task of 
managing them becomes a challenge due to the constant system redesign as an adaption 
mechanism stressing the importance of specific technology management further (Rouse, 
2008). A technology manager, as a leader, in organizations going towards continuous and 
systematic learning and maturity, needs to act as a designer of the learning process and a 
steward of the vision and as a teacher assisting the whole health organization in fostering 
continuous desire to increase maturity (Argyris, 1991; Mohr, 2005). At the same time, 
managers should advocate local learning and standardized practices while balancing it 
out with attitudes and structures that encourage exploration and discovery (Carroll, 2002). 
Some of these issues and items have been explained in detail by Stephen J. Swensen, and 
James Dilling of Mayo Clinic in the Institute of Medicine report “Engineering a Learning 
Healthcare” in 2011 (Grossmann, Goolsby, Olsen and McGinnis, 2011). In this part, the 
main issues around technology management in healthcare and continuous learning will 
be briefly reviewed. Moreover, the usefulness of maturity models in assisting with some 
of these issues will be highlighted. One of the important aspects of technology 




drivers of technology management. Decisions regarding what is incentivized and paid for 
dictates a critical role in deciding what is done and prescribed for the patients. Public 
policy and health insurance programs are culprits of high expenditures related to 
technology. The fact that the fee for service to fee for value in healthcare systems in the 
United States has not been completely adopted yet causes the healthcare system that has 
not transitioned yet to pay for more exams, which in turn drive technology use and 
subsequently cost. Appropriate technology management can expedite and finalize this 
adoption and diffusion of value for service. In the current system, instead of paying for 
outcomes, safety, or service which is provided through time, the service fee is considered. 
When merely service fee is paid, things such as safety, accuracy, reliability are not 
considered. In other words, patients/payors are charged a certain amount of dollars for 
procedures with different accuracy or complication rates as use is being paid for not the 
value of care. Inefficient technology management in healthcare organizations may cause 
some providers to charge more as in the case of Hillman et al.’s research. According to 
Hillman et al.’s research, physicians/providers that own their equipment may incline to 
order more exams and charging more for less quality (Hillman et al., 1990, 1992, 1995). 
These are only some of the reasons why policy and programs play such an important role 
in technology purchase and management in the United States. 
Another issue that is important from the technology management aspect of continuous 
learning and maturity in healthcare organizations is the appropriateness of the technology 
use. Health organizations must make sure that a patient receives no more and no less than 




the United States are estimated to be unnecessary while it is estimated that poor quality 
costs a company like General Electric $127 million per year, which about $60 million 
that amount is caused at by overuse of technology in the radiology department (de 
Brantes, 2003; Thrall, 2004; Tosczak, 2004). There are many other examples of 
technology misuse across many departments in health organizations which can be 
mitigated by standard evidence-based work rooted in best-practice order sets and decision 
support. In the case of imaging and pharmaceuticals specifically, due to patient’s 
conceived value due to commercials and advertisements, more is desired which leads to 
higher cost while not necessarily being more effective in diagnoses and treatments in 
health organizations (Wennberg, Fisher, et al., 2007; Wennberg, O’Connor, et al., 2007).  
Also, technology management encapsulates managing technology in terms of not only 
volume but also reliability in terms of accuracy and safety (Grossmann et al., 2010). In 
other words, healthcare providers, including residents and fellows, should be placed in 
environments their rate of medical errors will decrease with training and management. 
Training providers to work in teams is critical to ensure an increase in reliability and 
safety to make sure optimal technology management is flowing in the organization.  
Another important issue is the effective diffusion of best practices as well as safety nets 
to support high-reliability patient care through Effective and efficient technology 
management which has been slow and inconsistent in the healthcare industry (Wennberg, 
Fisher, et al., 2007; Wennberg, O’Connor, et al., 2007; Ting et al., 2008). Some of the 
enablers of effective diffusion is for health organizations to know what their people know 




importantly transparency. Swensen and Cortese (2008) argue that enterprise-quality 
dashboards showcasing outcomes, safety, and service using common definitions and 
processes as effective transparency efforts (Swensen and Cortese, 2008).  
Technology itself can have a critical place in technology management. Information 
technology may take important roles in the optimization of technology appropriateness. 
It can also aid organizations to bridge expected knowledge gaps in healthcare delivery for 
points that providers may not know some information about the care they need to provide 
(not knowing what they don’t know) through knowledge repositories (Grossmann, 
Goolsby, Olsen and McGinnis, 2011). Technologies such as “Ask Mayo Expert” that 
demonstrate the agreed-upon standard best practice, salient risks, and references, and 
frequently asked questions, and appropriate medical specialty contact information to 
providers for assisting them in providing care.  
Finally, Stephen J. Swensen, and James Dilling of Mayo Clinic pinpoint the importance 
of sentient investment in social capital as an important part of effective technology 
management strategy with goals of high-reliability patient care. Social capital investment 
encapsulates the goals of transforming an organization from a collection of individuals 
into an agile, coherent, and collective mind (Lynch et al., 2000; Gopee, 2002; Grossmann, 
Goolsby, Olsen and McGinnis, 2011). This can be done by utilizing research engagement, 
administrations, and education. Swensen and Dilling emphasize on areas like 
transparency, teamwork training, horizontal infrastructure, and cross-functional, team-
based simulation training as important social engineering topics. An example of this can 




students and residents, together in cross-functional teams to enforce a more effective 
transformation culture. 
 In the past couple of decades, maturity models have been introduced as reference 
frameworks for fields like Information System management in organizations across a 
myriad of industries (Carvalho et al., 2018). As maturity models are instruments to assess 
and continually improve organizational processes, they can play an important role in 
managing these new technologies or technologically enabled changes that have been 
happening and significantly affecting the healthcare landscape. In the healthcare domain, 
maturity models have also been used to pinpoint a wide spectrum of challenges and the 
areas such as business intelligence, information system, safety, calibration, and capability 
assessment (Harigopal and Satyadas, 2001; Liu, Hwang and Chang, 2011; Zephir, Minel 
and Chapotot, 2011; Batenburg, Neppelenbroek and Shahim, 2014; Brooks, El-Gayar and 
Sarnikar, 2015; Tarhan, Turetken and van den Biggelaar, 2015; Goncalves Filho and 
Waterson, 2018; Carvalho et al., 2019). Maturity models in healthcare have been 
generally used to pinpoint strengths and opportunities of maturity in different aspects of 
health and subsequently, paving the path for future improvement and evolution. However, 
there has been minimal focus on the management and technology management side of 
maturity models in healthcare as how a health organization as a system would be assessed 
in terms of maturity from different perspectives and dimensions to give management 
better insight into health organization’s opportunities and strengths. Maturity models can 
give technology managers a clearer picture and a sense of self-awareness on where their 




resources to get to their desired maturity level from different aspects. Technology 
management maturity goals can be reached and reliable patient care can be provided on 
the condition that the healthcare industry fosters systems changes to drive continuous 
learning (Grossmann, Goolsby, Olsen and McGinnis, 2011). 
 There is a definite need to study the maturity of health organizations in terms of adoption 
and implementation of continuous learning and technology maturity from technology 
management aspect as this field is significantly important in the healthcare system in the 
United States due to the importance of: 
• Policies, especially those which create incentives such as payment can be central 
motivators of activities and performance. 
• Managing the appropriate use of technology and ensuring the high reliability of the 
technologies applied 
• Effective diffusion of best practices and safety nets is crucial for efficient and 
effective technology management as it allows for the optimization of technology 
use. 
• Social engineering strategies such as transparency, teamwork training, horizontal 
infrastructure, and cross-functional team-based simulations, can contribute to 
moving an organization toward integrated care coordination in which the decision 





The initial action in the improvement of the business processes in terms of effectiveness 
and efficiency is to be on the same page and understand the current state of the 
organization or business by assessing that organization’s processes from a different 
dimension. Maturity models have successfully assisted in this matter in different areas. 
One of the areas that there has been a lack of such models is in the healthcare domain 
(Tarhan, Turetken and van den Biggelaar, 2015). Although there are some hints at the 
importance of leadership in healthcare systems maturity and implementation and adoption 
of continuous and systematic learning, there is no literature focusing mainly or solely on 
the management side of the healthcare organizations’ technology management maturity 
and its socio-technological infrastructure (Morain, Kass and Grossmann, 2017; Pronovost 
et al., 2017). There’s a gap that needs to be filled in studying technology management 
maturity in healthcare organizations due to the importance of policies, managing the 
appropriate use of technology, effective diffusion of best practices and safety nets, and 
social engineering strategies  (Yong, Saunders and Olsen, 2010; Grossmann, Goolsby, 
Olsen and Michael, 2011). All in all, although technology management is a growing issue 
that continues to require significant attention in healthcare, there is a lack of studies on 





Figure 11: Gap 3 
 
Gap 3: Despite the fact that technology management is a growing issue that continues to 
require significant attention in healthcare organizations, there is a lack of studies on the 
assessment of technology management maturity in healthcare organizations. 
3.2.4. Gap IV 
 
The fourth and final gap identified in this research is the lack of literature on research 
centers and institutes within university hospitals. This need came after the identification 
of the study unit of this research. The unit of study in this research is research centers and 
institutes within university hospitals in the United States as focusing on healthcare 
organizations as the “unit” would be too broad and complex to tackle. The results and 
methodology in this research, however, may apply to broader cases and organizational 
structures. Usually, different organizations within a hospital may have different 
management styles and smaller governance silos with certain guidelines being the same 
across these organizations. These centers focus on specific areas within a bigger health 
organization and have their directors, managers, and staff with different budget sources 




and goals of the university hospital, they have their own goals and missions which are 
aligned with their parent organization but more specific. These units also have a certain 
amount of autonomy that allows them to operate aligned with their mission and goals. 
During researching and studying about 100 health research centers in around 15 
university hospitals in around 12 states in the United States, the lack of literature 
especially peer-reviewed articles and conference proceedings was identified. Almost all 
the information from these research centers had to be obtained using either their parent 
hospital’s website or their website. Some of these websites outline detailed information 
about research areas, history, and funding while others did not offer the same number of 
details. 
In addition to the lack of literature around the funding channels, level of autonomy, and 
structural details, there is almost no literature on how these health research centers are 
managed and how these entities manage innovation (specifically continuous improvement 
and organizational learning). 
As mentioned before, in the United States, health systems are shifting from decades of 
operational systems designed to deliver health care as a reimbursable service into systems 
that deliver health as a population goal (Goldman, Kumanyika and Shah, 2016). In this 
direction, both transformation and incremental improvement are called for continuously 
improving and learning, as in systems that can improve themselves in different areas using 
the data generated internally and externally meaning clinicians use each patient encounter 
as an opportunity to make the next one better. This is especially important in the research 
centers within health organizations as their goal and mission are to learn and improve in 




service or treatment better. There needs to study on how these research centers manage 
the technology, knowledge, and resources to facilitate and maintain continuous 
improvement and efficient learning and innovations while dealing with and/or taking 
advantage of multiple multi-perspective factors. 
 
 
Figure 12: Gap 4 
 
Gap 4: There is very little to no information around the structure and management of 
research centers within university hospitals. 
3.2.Research Goal 
The objective of this research is to develop a framework for assessing technology 
management maturity in healthcare organizations in the United States in an area such as 
continuous learning. The model can help health organizations pinpointing their strengths 
and weaknesses in the adoption and implementation of continuous and systematic 
learning and its socio-technical infrastructure while giving them organizational and 




management tool for health organizations to assess their technology management 
maturity for human advantage in a more effective way. 
3.3.Research Questions 
RQ1: What are the main perspectives and criteria in the assessment of technology 
management maturity in healthcare organizations? 
RQ2: What are the weights of criteria and sub-criteria related to the assessment of 
maturity in healthcare organizations? 
RQ3: Does the proposed framework offer a validated, quantified, repeatable, and 
practical way to assess technology management maturity in healthcare organizations? 
 
 











This section includes the methodological discussion of this study. 
 
4.1  Hierarchical Decision Model (HDM) Model 
To better understand the pros and cons of using the Hierarchical Decision Modeling 
(HDM), there is a need to better understand what it is. 
The Hierarchical Decision Model (HDM) was initially proposed by Kocaoglu in 1983. 
HDM is a methodology to analyze strategic decisions in a hierarchical structure by 
formulating consensus among participants who are mostly experts in specific areas related 
to decisions.  
HDM represents the problem hierarchically, enabling the decision-makers to visualize the 
criteria and their sub-criteria affecting the objective/mission. It is mostly applied for 
evaluating alternatives or selecting best-fitting options to accomplish an objective 
previously specified (Turan et al., 2009). HDM calculates the relative 
contribution/weights of perspectives/criteria through a systematic process of eliciting and 
evaluating subjective judgments of relevant experts in order to assist decision-makers in 
the decision-making process. HDM may be similar to the Analytic Hierarchy Process 
(AHP) introduced by Saaty (Saaty, 1977). However, HDM utilizes a different 
computational approach (Constant Sum calculations as opposed to Eigenvectors). 
Munkongsujarit et al. (2009), argues that HDM aids the decision-maker by presenting the 
decision problem as a hierarchy of problems that are more facilitated in terms of handling 




down to simpler sub-problems in a way that the decision problem morphs into a hierarchy 
(Taha et al., 2007). HDM is a tool used in decision-making to rank and evaluate the 
available alternative that is available followed by determining the most suitable choice 
among them (Munkongsujarit et al., 2009). It is a tool that assists decision-makers in 
quantifying and incorporating quantitative and qualitative judgments into a complex 
problem (Taha et al., 2007). 
In the general form, HDM has five levels named as Mission-Objective-Goal-Strategy-
Action (MOGSA) (shown in figure 27), yet there is no restriction on the numbers of 
levels, but elements at the same level have to be “preferentially independent” (Kocaoglu, 
1983). As the HDM structure is set, pair-wise comparisons among sub-elements for each 
branching node are made (figures 28 -29). The weights of each criterion are derived from 
pair-wise comparisons. Thus, in the generalized form of HDM researchers need to make 
pair-wise comparisons among objectives, goals under each objective, and strategies under 
each goal separately (Daim and Kocaoglu, 2015). 
 






Figure 15: Mission /Perspective/ Criteria Model (Shaygan, Ozdemir-Gungor, D. Kutgun and Daneshi, 2017; 




Figure 16: Depiction of the HDM Model (Gibson, 2016; Estep, 2017) 
 
When implementing the HDM model, structured expert panels are asked to 
validate/quantify the model. The quantification will result in weights for each 




items in the same level, and a “local” weight within its accommodating category. Then, 
the alternatives are evaluated against the lowest level of the hierarchy, which is the 
decision criteria, to find the best decision possible. The comparison is implemented by 
the distribution of 100 points between the two elements (pairwise comparison). The 
element with higher priority/importance assigned to it (by the allocation of more points 
reflecting its degree of priority/importance). In models such as AHP, 1-5 or 1-9 scales are 
used in the pairwise comparison process. In HDM, the Constant Sum method is used for 
the aggregation of expert judgments. 
To evaluate alternatives, performance scores of alternatives for each criterion are required 
as well. Performance scores can be determined by using scoring for scalar scores or 
desirability functions for discrete scores. A desirability function is a transformation 
function that converts actual performance value to a score ranging from 0 to 100 based 
on market desirability or expert opinion (Daim et al., 2015).  
Simply, HDM breaks down contributing factors to an objective into perspectives and 
criteria on different hierarchical levels and enables the analysis of the contribution of each 
factor or criterion to the objective. Then each option is evaluated in terms of the criteria 
to have a final point of achieving the objective, between 0 and 100  (Kocaoglu, 1983). 
The final score for each alternative is calculated by using Equation 1. 











Wk: Weight of criterion (k) 
Fjk, k: Relative importance of factor (jk) with respect to criterion (k) 
Tn,jk,k: Performance and physical characteristics of technology (n) along with factor (jk) 
for criterion (k) 
V(tn,jk,k): Desirability value of the performance and physical characteristics of technology 
(n) along factor (jk) for criterion (k) (Shaygan, Ozdemir-Gungor, D. Kutgun and Daneshi, 
2017). 
 
In the case of this research, some minor changes have been applied to the model which 
are as follows: 
 







M: Maturity Score  
K=Number of Perspectives 
J= Number of Criteria 
Pk: Weight of Perspective (k), k=1...k 




D(jk): Desirability value (Maturity Assessment Value) of Criterion (jth) for Perspective 
(kth) 
Each item in the hierarchy is given weights. Each item will have a “global” weight against 
all other items, and a “local” weight within the category it belongs to. Then, the 
alternatives are evaluated against the lowest level of the hierarchy, which is the decision 
criteria, to find the best decision possible. 
The experts evaluate criteria hierarchy and alternatives by conducting pairwise 
comparisons, with a constant-sum measurement scale (1–100 scale) for comparing every 
two elements. For example, each expert can evaluate the perspectives through pairwise 
comparison similar to the following example: (P1 40:60 P2), which means, in terms of 
importance, Perspective 1 is less important than Perspective 2 with the ratio of 40 to 60. 
All experts will do the same for perspectives and criteria under each perspective. Then, 
based on HDM mathematical formulas, the experts’ evaluation will be aggregated in order 
to calculate the weights of perspectives and criteria, with the total sum of 1, for each level 
within the hierarchy and on the whole hierarchy. As well as weights for the alternatives 
against each other for each criterion. And a final score for each alternative in comparison 
with the other alternatives based on the aggregated evaluations of all experts, to find out 
the best decision possible (Kocaoglu, 1983; Daim and Kocaoglu, 2016). 
Additionally, in instances in which there is a need in having a reusable model, or in 
instances of having many alternatives, desirability curves can be used. The combination 
of desirability curves with HDM is used to identify levels/ metrics for each criterion. Each 




the desirability curves approach, the experts need to evaluate related levels/metrics for 
each criterion (desirability matrix) while giving each metric a scaled quantitative value. 
This enables the normalization of the evaluation results by experts across all the criteria 
(Phan, 2013; Estep and Daim, 2016; Gibson and Daim, 2016). 
HDM also includes the calculations for disagreement, inconsistency, and sensitivity 
analysis (explained in details in question 3) to validate the reliability and robustness of 
the final model (Kocaoglu, 1983; Chen and Kocaoglu, 2008; Daim and Kocaoglu, 2015; 
Estep and Daim, 2016; Gibson and Daim, 2016; Estep, 2017; Shaygan, Ozdemir-Gungor, 
D. Kutgun and Daneshi, 2017; Shaygan et al., 2018a). 
4.1.1 Merits of the HDM model 
As mentioned in the previous section, the HDM model helps the decision-makers to 
visualize the criteria and their sub-criteria affecting the objective/mission. This is 
specifically helpful in understanding more complex problems, and consequently better 
decision-making under uncertainty. It offers a quantified, validated, and repeatable 
analysis of the decision elements by considering the expert judgments. By aggregation of 
diverse yet relevant expert judgments, the decision-makers are able to propose more 
meaningful and robust solutions. Furthermore, sending the survey/software links to 
experts individually avoids the risk of a physical meeting being monopolized by more 
vocal individuals. At the same time by hearing out each expert separately, mitigates the 
risk of not hearing and considering fewer vocal experts (as the case of focus groups may 
be). Furthermore, with the analysis of inconsistencies, disagreements, and model 




much-needed validation for creating the multi-criteria decision model (in this case, 
maturity model). The use of desirability curves allows the reusability of the model in a 
different case (such as different health organizations, departments, etc.). Finally, the 
HDM model has been used in a vast variety of technology management areas such as 
technology adoption, strategic planning, technology planning, technology transfer, and 
technology assessment in a wide variety of industries such as healthcare, energy, 
semiconductors, transportation, internet of things, wearable devices among others 
(Munkongsujarit et al., 2009; Fenwick and Daim, 2011; Abotah, 2014; Iskin, 2014; 
Kocaoglu et al., 2016; Estep, 2017; Shaygan, Ozdemir-Gungor, D. Kutgun and Daneshi, 
2017; C. G. Pereira et al., 2018; Shaygan et al., 2018a). 
In the case of maturity models in healthcare organizations, the HDM model can bridge 
several gaps identified in the gaps analyses section.  Specifically, the second gap reads 
as: “There is a lack of a quantified, validated and repeatable model for assessing maturity 
in health organizations”. The validation part is addressed through the validation of 
perspectives, criteria, and desirability curve metrics by the experts. Moreover, the 
quantification part is addressed through quantifying the perspectives, criteria, and 
desirability curve metrics. Finally, through utilizing the desirability curves, the model can 
be used for different cases without the need to quantify the perspectives and criteria again. 
4.1.2 Limitations of the HDM Model 
When using the HDM model, the decision-makers may face several 
challenges/limitations that need to be addressed. Some of these limitations are imputed to 




However, some limitations are related to the nature of the model itself. These limitations 
are discussed in this section. 
4.1.2.1  Expert related limitations 
HDM model uses experts for validation and quantification of the decision elements. The 
expert judgment is however subject to potential bias. In cases like healthcare, the experts 
may have been selected from a wide variety of areas/departments and they may bring 
some subjectivity and that is not always on purpose. In other words, inherent human bias 
may be present and may represent a threat to achieving solid results if not treated and 
mitigated properly. Some ways of coping with this limitation are to be meticulous in 
selecting the experts and ensuring that different (yet relevant) backgrounds in the research 
are represented. Other ways to mitigate the risk of bias have been discussed in question 
3. 
Another group of export-related challenges is the risk of inconsistent, inaccurate 
judgments by the experts. Furthermore, expert disagreements pose a limitation to the 
HDM model. Although these challenges are some of the characteristics of human 
judgment, there is a way to mitigate each of these challenges. As a part of validating the 
results of the model, the HDM methodology measures the inconsistency and 
disagreement indexes for the collected judgments. In cases where the obtained index is 
higher than the acceptable threshold (both for inconsistency and disagreement), remedies 
can be applied which are explained in question 3 in detail (such as clarification of research 




The last category of the limitations for the export-related category is related to the amount 
of work/time needed from the experts in order to validate/quantify the model. In many 
cases, the experts may be busy people and may not have substantial time to allocate to 
pairwise comparisons or perspective/criteria validations. For each level of the model with 
“n” elements, there is a need to pairwise compare elements “
𝑛(𝑛−1)
2
” times. This can 
deem very time-consuming for a level that has 8 elements (meaning 28 pairwise 
comparisons). This may lead to experts getting tired and putting less attention into 
comparing the decision elements and consequently deteriorate the model’s reliability.  
4.1.2.2  Model Sensitivity 
In instances where the HDM model includes alternative (actions), the addition and/or 
removal of new alternatives may substantially change the final weights (results). 
However, in cases that use desirability curves instead of alternatives, this limitation is 
avoided. 
Another issue is the lack of adaptability to changes/time. In the dynamic world that we 
are living in, rarely will the problems stay the same through time. The dynamic 
environment may subject the model to changes in the importance of decision elements 
and even the decision elements themselves. In other words, with time, some elements 
(criteria) may become less important or even obsolete whereas there may be an increase 
in the priority of some criteria or even emerging criteria in the model. These dynamics 
can happen gradually or abruptly and based on HDM’s nature; these changes will result 




on the importance and pace of changes) updates for the models, their components, and 
weights. Sensitivity Analysis (SA) is one of the ways to bolster decision makers’ 
awareness by learning about how robust the model is and how resistant it is to changes in 
cases where the model should be modified (Tran, 2000; Abotah, 2014; Iskin, 2014; 
Gibson, 2016; Estep, 2017). 
4.1.2.3  Criteria Balance among Perspectives/Criteria 
Finally, it is important to point out that when using HDM, it is preferred to have a close 
number of criteria under each criterion. The reason for this is that when there is a 
difference (more than 1) between the number of criteria under different perspectives it 
may lead to smaller weights for the criteria under the perspectives with a higher number 
of criteria (although it may be the perspective with the highest weight.). The only known 
remedy for this limitation is trying to keep the criteria under each perspective close to the 
others. 
 
4.1.3 HDM Justification 
Earlier, in the research gaps section the need for a multi-perspective, validated, and 
quantified model was stressed. Carvalho et al.(2016; 2015) discuss the need for a model 
including the main ingredient factors of healthcare technology maturity and the potential 
benefits of assigning weights to them in order to understand their relative importance by 
specifying that there should be a model that includes the main influence factors with 
different weights depending on their relative importance and its development should be 




Furthermore, technology management maturity models are complex, and specifically in 
the case of healthcare organizations, there is a need for a method/model that can simplify 
some of that complexity. Significant time-gaps in the practical transformation of clinical 
knowledge into clinical practices, ever-increasing healthcare costs, high rates of medical 
errors, healthcare institutions’ obligations towards improving safety, clinical outcomes, 
and efficacy of care from one side, and the rise of disruptive innovations such as 
genomics, wearables, machine learning, and artificial intelligence in health systems, the 
adoption of EHRs and novel diagnostic tools, and the plethora of data from the other side 
has made the need for a new approach in managing the U.S healthcare systems an 
imperative. These issues are multi-perspective and there is a need to take a multi-
perspective approach when dealing with decision-making problems in this area. 
With the gaps identified in the pre-comprehensive exam proposal and more specifically 
in the research gaps section, there is a need for a model which: 
• Considers the criteria for assessing technology management maturity and 
continuous learning in healthcare organizations in classified categories. 
• Takes a quantified, validated, and reusable approach in assessing maturity in 
healthcare organizations (weights for factors in each level of the hierarchy) 






Figure 17: Research Gaps, Goal, and Questions (Reprise) 
 
After reviewing several other models which are used in multi-criteria decision-making, it 
is found that the HDM methodology can adequately tackle the gaps mentioned above. 
HDM is indeed a multi-criteria decision-making method with a hierarchical structure that 
enables a more complex analysis through pairwise comparing the important factors 
(perspectives/criteria) in a certain problem/decision. Furthermore, HDM captures 
experts’ judgments and turns them into the weights for important factors regarding the 
problem. This data collection can be done anonymously and individually bolstering the 
quality of data that can be used towards helping the decision-maker. When using HDM, 
different kinds of analysis such as Inconsistency analysis and Disagreement analysis can 
be done to validate expert judgments. Moreover, at each level of the hierarchy, 
surveys/questionnaires/interviews can be used to validate the selected 
perspectives/criteria (initially found using literature review). In addition, Sensitivity 




of flexibility while giving them a better idea of when the model will require an update. 
Finally, although a heavy load of quantification may go into the quantification, validation, 
and calculation of the results, HDM results are intuitive and not difficult to use/understand 
by people who have a less academic background. 
HDM, as result, will provide weights for each of the decision elements in the model as a 
prioritization/ resource allocation tool. By learning about the importance of each decision 
element in each level of the hierarchy, decision-makers can have a better idea and 
understanding of the situation at hand. 
The use of desirability curves in this study will bolster the model through the 
identification of the desired outcome for each criterion. In the case of this study, the 
desirability curves will allow each health organization to be measured in terms of pre-
defined metrics for each criterion. Moreover, the desirability curves pave the way for the 
model to become a reusable one. The reusability of the model is specifically important as 
health organizations may need to measure their maturity regularly to make sure if they 
are on the right path or not. The reusability factor will also allow the model to be applied 
to several healthcare organizations (partners/competitors) to gain a better understanding 
of their performance. 
The HDM model can be used by health organizations to identify their strengths and 
opportunities. This will give health organizations a sense of self-awareness as “where 
they are?”, “where they need to be?”, and “how can they better reach the point they want 
to be?”. The model can serve decision-making assisting tool where health organizations 




reach the goals of continuous improvement and learning in the delivery of care. Although 
cutting costs may not be an initial goal of this, it can certainly be a result of maturity in 
healthcare organizations. 
The HDM model has been used to tackle many multi-criteria problems in different areas 
and industries. It has been used to determine the innovativeness of companies (Phan, 
2013), evaluation of energy policies (Abotah, 2014), assigning technology transfer scores 
to research proposals (Estep, 2017), measuring research center performances (Gibson, 
2016), measuring readiness for smart city projects (Barham and Daim, 2018), forecasting 
of emerging therapeutic antibodies patents (Pereira et al., 2018) , and development of 
technology transfer score (Lavoie, Kim and Daim, 2017; Lavoie and Daim, 2020) among 
others and is, therefore, selected as the methodology for measuring maturity in healthcare 
organizations with goals of improvement in the quadruple aim of care. 
4.2.Critical Issues in Forming an Expert Panel and Selecting the Experts 
As a part of the methodology in this research, expert panels in the field of the study will 
help with the validation and quantification of the model. This validation and 
quantification are in terms of the pairwise comparisons in the model (perspective/criteria) 
as well as the desirability curves for each criterion’s metrics. In order to be able to discuss 
the critical issues around forming an expert panel and the selection of these experts, there 
should be some clarification and definitions around what an expert is and what is not. A 
short literature review has been conducted to shed some light on this issue. 
The roots of the word “Expert” comes from Middle English, borrowed from Anglo-




of experīrī "to put to the test, attempt, have experience of, undergo"(Merriam-Webster, 
2019a). As for the meaning, based on Merriam Webster’s definition, Expert means 
having, involving, or displaying special skill or knowledge derived from training 
or experience. As for the panel, it is defined as a group of persons selected for some 
service (such as investigation or arbitration) (Merriam-Webster, 2019b). Martin et al. 
(2012) define expert knowledge as important information on a specific topic that is not 
widely known by others (Martin et al., 2012). Some technical papers refer to expert 
opinion as informed opinion on a technical problem based on experience and training 
(Meyer and Booker, 2001). From these definitions, we can conclude that expert panels 
can be defined as: “A group of people having, involving, or displaying special skill or 
knowledge derived from training or experience in a field not widely known by others, 
selected for judgment and decision making of a topic in that specific field.”.   
Expert panels are frequently utilized in developing and accessing projects at model 
development, and interpretation of results (Fazey, Fazey and Fazey, 2005; Runge, 
Converse and Lyons, 2011; Sutherland et al., 2011; Martin et al., 2012). In the fields of 
technology and healthcare, expert panels have been used in the quantification and 
validation of multi-criteria decision models (Daim and Kocaoglu, 2015; Shaygan and 
Testik, 2017; Shaygan, Ozdemir-Gungor, D. Kutgun and Daneshi, 2017; Testik et al., 
2017b; Shaygan et al., 2018b) 
Expert panels’ judgments, according to some studies,  as well be the only or the most, 
credible source of information available for making management decisions in cases where 




2000 discuss that expert panels are invaluable in terms of addressing the multi-perspective 
nature of complex problem while it is important to be wary of potential biases (Holman 
et al., 2000). Moreover, expert panels can play an important role in raising qualitative 
issues in the creation of conceptual models (Knol et al., 2010). 
Kuhnert et al. (2010) signify that expert judgment in ecology is increasing in importance 
as a tool for conservation decision-making in instances of insufficient data (Kuhnert, 
Martin and Griffiths, 2010). Expert knowledge assists researchers in the science and 
practice of conservation due to the complexity of problems, insufficient data, and the 
imminent nature of many decision-making processes (Martin et al., 2012). 
In a seminal study about expert judgments, Dreyfus and Dreyfus (2005) discuss a five-
stage phenomenological model of skill acquisition and thus different levels of expertise 
which will be briefly introduced here to bolster the clarification of the subject (Dreyfus 
and Dreyfus, 2005). 
The first level of skill acquisition is the “Novice” stage which means that although the 
person has no prior experience or knowledge in the field, he/she has a grasp of the basic 
rules, conditions, and the environment surrounding the subject at hand. The second stage, 
“Advanced Beginner”, is a novice who has now a wider understanding of the subject 
matter due to a little experience/exposure. The next level is “Competence” which refers 
to having more grasp of the subject in terms of elements and prioritization. In other words, 
the once novice now has a better understanding of the subject and can disintegrate the 
complex issue into simpler parts to make them less overwhelming and more feasible. The 




each of these simpler parts one at a time. As the fourth level, “Proficiency” hints at 
situational subjectivity in the reasoning. In other words, as the level of expertise grows, 
long and structured lines of reasoning are replaced by faster actions and decisions more 
intuitively. The final level, based on this study, is “Expertise”. The final level of skill 
acquisition means that the expert has a higher level of understanding and refinement to 
the previous levels enabling her/him to reach faster intuitive solutions/decisions for 
complex scenarios. This means that, at this stage, the expert can see what is needed to be 
done and how it can be done in an intuitive way (Dreyfus and Dreyfus, 2005). Day (2002) 
however, stresses that decisions based on intuitions do not necessarily turn a person into 
an expert (Day, 2002). Day continues to emphasize that, in order to become experts, there 
is a need to have different kinds of practice in terms of cognition and its context as 
opposed to being solely based on the accumulation of practice. 
As for critical issues around forming and selection of expert panels, there are a couple of 
areas to consider which are discussed below: 
4.2.1. Bias 
The first critical issue discussed in the forming and selection of expert panels for research 
is biased. Bias is indeed one of the most important challenges faces when expert panels 
are used in research (in this case, validation, and quantification of the model). At times, 
the bias from the experts' side can be caused to the overconfidence in the subjects known 
well by the experts (Nemet, Anadon and Verdolini, 2017). In order to better understand 
bias, there’s a need for a definition for it in the relevant literature. Bias happens when an 




challenge that judgment (Mahoney, 1977). Also, experts, as humans, are unable to get rid 
of cognitive bias and overconfidence (Morgan, 2014). In addition to overconfidence, the 
bias from the experts’ side can be due to the expert’s tendency to influence the outcome 
of the study. Research assessment performed by expert panels may be biased because of 
the factors on the organizational, the panel, or individual evaluator’s level (Langfeldt, 
2004). Langfeldt also categorizes the bias in research assessment based on cognitive 
constraints, and interests from one side and scholarly/professional and non-professional 
side. When in professional and based on cognitive constraints, experts may only view the 
decision/problem through the own scholarly view (Mullen and Goethals, 1987).  At the 
same time when the scholarly bias happens due to interest, there is a risk of Nepotism. In 
terms of non-professional bias with cognitive constraints, there is the risk of disregarding 
data/information because of the sub-optimal information seeking. As for the non-






Figure 18: Categories of Bias in Research Evaluation (Langfeldt, 2004) 
These issues make the identification and recruitment of proper and reliable experts for the 
problem a challenging and arduous process (Tran, 2000; Abotah, 2014). Being impartial 
is important as impartiality in judgment ensures both the consistency and meritocracy of 
expert judgment/decisions (Lee et al., 2013). 
To mitigate some of the problems caused by the potential bias from the experts’ side, 
models like Hierarchical Decision Models, Analytical Hierarchical Processes, and Delphi 
elicit anonymous judgments from experts. However, these methods are still prone to bias 
from personal judgment due to personal judgments and/or interests (gains) which may 
conceal the reality of the subject as a result. 
Considering the mentioned issues regarding bias, researchers need to pay extra attention 
in selecting the expert panel to ensure that there are no reasons for the experts (in terms 




4.4.1.  Size 
 The other critical issue around forming expert panels is the size of the panel. In terms of 
the size of the panel for the research/studies/dissertations using the HDM methodology, 
a different number of experts have been used. Phan (2013) argues that the ideal size for 
an expert panel should be around 10-15 experts while Okoli and Pawlowski suggest the 
panel of between 10 and 18 (Okoli and Pawlowski, 2004; Phan, 2013). However, the size 
of expert panels has varied for different studies. Tran (2013) and Chan (2013) used a 
smaller expert panel of 5 and 3 members respectively (Tran, 2000; Chan, 2013). Many 
research in technology management utilizing expert panels for judgment in terms of 
validation of quantification of models has used between 6-12 experts as panel members 
as a manageable range time-wise yet reliable result-wise (Abotah, 2014; Gibson, 2016; 
Estep, 2017). 
4.4.2. Balance 
Other than the risk of bias and the size of the panel other important factors should be 
considered when forming an expert panel. As this research revolves around maturity 
models in healthcare and organizational learning, it is important to have a wide variety of 
experts covering different perspectives and dimensions of the healthcare environment. 
There is a definite need to have healthcare experts from the technological, social, 
organizational, regulatory, and financial sides as one of the gaps of this research is that 
technology management maturity in healthcare should be studied in a multi-perspective 




significant representation of the information and knowledge in the field of the 
problem/decision (Abotah, 2014). 
4.2.2. Quality 
Another important issue is the quality and value of the judgment provided by the experts. 
The expert judgment should reflect the reality of what is happening regarding the 
problem/decision which is being studied. Factors such as bias can affect this aspect of the 
expert panels. Looking at this aspect from a different lens, it should be considered that 
how much of an expert the selected individual is which will directly affect the potential 
contribution and value of the judgment provided by the expert. This judgment will 
eventually determine the value and the merit of the study itself. Another side of the expert 
quality can be imputed to how much time and contribution the expert is willing to allocate 
to the research. Before selecting the experts, matters such as the time, knowledge, and 
meticulousness needed for taking part in the expert panel should be discussed (Chan, 
2013; Abotah, 2014). Another important aspect that should be ensured beforehand is the 
expert’s willingness to participate in the study. 
4.2.3. Researcher’s Burden 
While most of the topics discussed in this section are the issues around experts, there are 
some points that the person in charge of constructing the expert panel should do. The 
researcher must communicate the research goals to the experts. In instances where there 
is poor communication of the goals to experts, judgments will be prone to inaccuracy. A 




goals to the experts in order to make sure he/she is neither misleading/influencing the 
experts nor providing insufficient information to experts. 
Furthermore, the researcher should leverage the right communication tools to assure they 
are clear, fair, and user-friendly for the experts while making sure that the output is usable 
for the research. Software, survey websites, phone conversations, emails can be used to 
collect the expert judgment. In the case of study groups, sometimes an expert may 
monopolize the conversation or influence the other experts that are attending that study 
group.    
Issues such as inconsistency and disagreement and how their judgments can be validated 
in terms of these issues will be discussed in detail in the following sections. 
4.3.Inconsistency 
One of the ways in which the Hierarchical Decision Model (HDM) ensures the validation 
of the quantification done by the expert panel is the inconsistency test. The word 
“inconsistent” means “Acting at variance with one's principles or former behavior” 
(Oxford Dictionary, 2019b). Based on Estep (2017), inconsistency is the disagreement 
within an individual’s (in this case, expert) assessment (Estep, 2017). Moreover, Abbas 
(2016) defines inconsistency in the HDM context as: “Inconsistency is a slight or gross, 
deliberate or unintentional error in the elicited pairwise judgment related to the rank order 
and mutual preference proportionality of alternatives.” (Abbas, 2016). In addition, 
Abotah (2014), defines inconsistency as “a measure that explains how reliable and 
homogeneous in his or her answers each expert was through the whole questionnaire” 




quite common in multi-criteria decision models such as AHP, FAHP, and HDM (Leung 
and Cao, 2000; Aguarón and Moreno-Jiménez, 2003; Grošelj and Zadnik Stirn, 2012; 
Chan, 2013; Gibson, 2016). This probability is invigorated in cases where the decision 
models are complicated and have many criteria involved. 
 
Figure 19: Screenshot of the Financial Pairwise Comparisons 
 
As an example of the kind of inconsistency caused during the experts’ assessment and 
quantification of the model, consider the following hypothetical scenario: 
During the quantification of the “Financial” perspective’s criteria in this study, an expert 
has pairwise compared the three criteria within this perspective namely, resource 
allocation, funding, and cost reduction (shown in figure 26). Let us assume based on our 
hypothetical expert’s judgment, resource allocation is more important than funding while 
funding is more important compared to cost reduction. Based on this logic, resource 
allocation must be more important compared to cost reduction based on this expert’s 
judgment. In addition, if based on the expert’s judgment, resource allocation is 1.5 times 
more important than funding and funding is 2 times more important compared to cost 




than cost reduction based on our hypothetical expert’s judgment. This type of consistency 
is called cardinal consistency. 
Another example of expert inconsistency is shown in the following scenario: 
Let us assume our hypothetical expert has ranked resource allocation 2 times as important 
as cost-cutting and funding. Moreover, the expert has ranked funding 2 times as important 
as cost-cutting. Based on this ranking, resource allocation should be the most important 
criterion. However, in this case, the ordinal consistency has been violated as based on the 
expert’s judgment, resource allocation and funding should have the same importance. If 
the cardinal consistency is maintained in a judgment, the ordinal consistency will 
automatically be guaranteed. 
Experts, as humans, are subject to inconsistency in their judgment. This issue is even 
more frequent in more complex problems. This implies that inconsistencies are expected 
to occur in the quantification of the HDM model (Gibson, 2016). Therefore, the result of 
expert judgment in the HDM model will each contain a level of inconsistency which must 
be measured and controlled to ensure the soundness of the decision (Abbas, 2016). 
Here, a summary of the way inconsistency is measure in the HDM model is provided. 
Inconsistency measures have been calculated for many HDM related literature through 
the years (Kocaoglu, 1983; Chan, 2000; Phan, 2013; Abbas, 2016; Lingga, 2016; Estep, 
2017; Shaygan, Ozdemir-Gungor, D. Kutgun and Daneshi, 2017; Shaygan et al., 2018a). 
In the HDM model, the inconsistency is calculated using the sum of standard deviations. 
For n elements of comparison, n! vectors are created using the constant sum calculation 




are asked to allot a constant sum of units, to some items based on a specified criterion 
(Chayes, 1960). Each of the resulted vectors represents an element combination (Phan, 
2013). As an example, for the financial perspective, there are (3! =6) possible 
combinations for the criteria as follows: 
1- Resource allocation, Funding, Cost cutting 
2- Resource allocation, Cost cutting, Funding. 
3- Funding, Resource allocation, Cost-cutting. 
4- Funding, Cost cutting, Resource allocation. 
5- Cost-cutting, Funding, Resource allocation  
6- Cost-cutting, Resource allocation. Funding 
Consistency in providing the pairwise comparison will result in relative values for each 
of the mentioned criteria combinations whereas any inconsistency will result in 
inconsistent values for each combination. Therefore, the inconsistency in HDM is 
obtained through calculating the standard deviation between the values calculated in the 
n! combinations (Phan, 2013; Estep, 2017). In this section, the calculation of 
inconsistency in HDM is presented with referencing to the HDM-related literature 
(Kocaoglu, 1983; Phan, 2013). 
 
Let: 
𝐶𝑖𝑗= relative value of the i
th element in the jth orientation for an expert 
𝐶?̅?= mean relative value of the i



















Variance of the expert in providing relative values for the n elements is calculated using 












The acceptable threshold for the inconsistency measure in HDM models has been 
discussed in the literature. Kocaoglu in 1983 established a maximum of 10% as the 
acceptable threshold for the inconsistency in HDM models  (Kocaoglu, 1983). In cases 
where the inconsistency is higher than 10% or 0.1, several actions can be taken. It can be 
requested from the expert to do the pairwise comparisons again. Moreover, a conversation 
with the expert may clarify the evaluation procedure for the expert and thus, solve the 
inconsistency problem in the second attempt. In cases where a consensus cannot be 
reached with the expert or in cases of continued inconsistency, the expert’s judgment may 
be deleted from the results. Another action that can be taken was introduced by Abbas 




of the decision (Abbas, 2016). This method uses the root-sum of variances by considering 
the number of pairwise comparisons made by the expert. 





In the above equation, the Root sum of the variance is used as the inconsistency value. 𝛼𝑖
2 
represents the variance of the for the ith decision element and is calculated using the 








In the equation above, Vij is the normalized relative value for the j
th combination of 
variable i in “n!” orientations. The value ?̅?𝑖𝑗 is the mean of the normalized relative values 









Another important topic in the validation of the quantification of the HDM model is the 
analysis of the disagreement among experts. The word disagreement means lack of 
consensus or approval (Oxford Dictionary, 2019a). In the context of HDM, different 
experts may have different ideas in terms of the assessment of the factors and the most 




despite the fact the disagreement among experts is expected and natural, it is critical to 
measure and analyze the disagreement degree among the model experts as a part of 
validating the maturity model in healthcare before moving on to the data analysis 
procedure. As mentioned, disagreement among experts is an expected element of the 
model. However, it is critical to set a threshold for an acceptable disagreement value. 
agreement on problem/decision is necessary before an analysis based on quantification of 
the criteria/perspectives (Mumpower and Stewart, 1996). Disagreement among experts 
can be sourced to different factors such as different approaches and ways of 
thinking/ideology, lack of expertise, self-interest, lack of goal communications, 
insufficient or poor quality data/ feedback (Hammond, 2000). Therefore, although some 
of these disagreement risks may be mitigated through articulate and clearly defined 
research goals and user-friendly and intuitive tools, some sources of disagreement may 
still exist in the model. 
What does disagreement entail in the context of HDM? Disagreement is defined by Estep 
(2017) as “The extent to which an expert panel is in agreement with their judgment 
quantification is represented by a disagreement value.” (Estep, 2017). Moreover, Tran 
(2000) and Abotah (2013) define disagreement as “the agreement among the experts’ 
judgment is represented by a disagreement value of the expert group in a pairwise 
comparison procedure.” and “the disagreement of experts can be understood as the 
deviation of their judgments from each other.” respectively (Tran, 2000; Abotah, 2014). 




validation for literature using HDM (Tran, 2000; Abotah, 2014; Estep, 2017; Shaygan et 
al., 2017, 2018a; Cowan and Daim, 2018). 
Similar to the inconsistency threshold, the acceptable disagreement level should not 
exceed 10% (0.1) (Chan, 2013; Estep, 2017; Shaygan et al., 2017). In instances where the 
disagreement value exceeds the threshold, several remedy methods can be performed to 
alleviate the disagreement among experts. In cases where a small number of experts are 
contributing to the disagreement value, can be eliminated as outlier after identification 
through standard deviation analysis. Moreover, in cases where the views provided by the 
experts which are causing the disagreement are deemed valid and concerning, their ideas 
should be shared with other experts through methods such as the Delphi method followed 
which can potentially decrease the disagreement value in the next quantification 
iterations. Furthermore, the Hierarchical Clustering Method (HCM) can be utilized to 
categorize similar data points in a cluster (Iskin, 2014). The goal of HCM is to discover 
natural groupings. Iskin defines this model as “HCM obtains homogeneous clusters of 
cases based on measured characteristics. The process starts where each case is considered 
as a separate cluster; and for each iteration, a new cluster is determined by combining one 
case with a cluster identified earlier in a fashion that the arithmetic distance between new 
and old clusters remains the shortest among all possible alternatives. The process 
continues until one cluster is left.” (Iskin, 2014).  
4.4.1. Hierarchical Agglomerative Clustering (HAC) 
The disagreement index was proposed in Kocaoglu’s 1983 publication (Kocaoglu, 1983). 




used in this research uses Hierarchical Agglomerative Clustering (HAC) method to 
calculate the disagreement value for the experts’ judgment. The following formulas show 
the HAC method to calculate the disagreement index. 
Let vij be j
th expert’s relative value for the ith decision variable. Thus, group relative value 
for the ith decision variable for all “m” experts can be calculated as (for i= 1, 2… n): 
















Consequently, the disagreement index for the m experts can be obtained by calculating 








4.4.2. Intraclass Correlation Coefficient (ICC) 
Another method for calculating the disagreement index (the measurement of the 
reliability of quantitative scales) is to use Intraclass Correlation Coefficient (ICC) (Fleiss 
and Cohen, 1973; Sheskin, 2007; Estep, 2017) intra-class correlation coefficients can be 
used as statistics for measuring homogeneity in cases where there is a need to study the 




McGraw and P. Wong, 1996). McGraw et al. continue to discuss ICC as a measure of the 
proportion of a variance that is imputed to objects of measurement, often called targets 
(Shrout and Fleiss, 1979). In the context of this research and for the HDM methodology, 
ICC calculates the disagreement among experts for a relative number of elements. In this 
case, ICC determines the agreement measure among experts based on “n” elements’ 
relative importance which is obtained through the pairwise comparisons. 
ICC can be calculated as follows (Bartko, 1966; LeBreton and Senter, 2008): 
 
𝐼𝑛𝑡𝑟𝑎𝑐𝑙𝑎𝑠𝑠 𝐶𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 (𝐼𝐶𝐶) =
𝑀𝑆𝐷 − 𝑀𝑆𝐸
𝑀𝑆𝐷 + (𝑘 − 1)𝑀𝑆𝐸 +
𝑘
𝑛 (𝑀𝑆𝐼 − 𝑀𝑆𝐸)
 
n= Number of targets (decision elements) 
k= Number of experts 
MSD= Mean square for decision elements 
MSI= Intra-expert mean square 
MSE= Mean square error (residual) (calculated using two-way ANOVA) 
For this case, ICC can take values in the interval (
−1
(𝑘−1)
< 𝐼𝐶𝐶 < +1) with (+1) showing 
total intra-expert agreement while any values that are zero or negative would show total 
disagreement among experts (Bartko and Carpenter, 1976). There are different opinions 
about the acceptable threshold for disagreement in the ICC method. LeBreton and Senter 




agreement among experts whereas other studies stress the importance of research 
questions, objectives, and data in indicating the threshold (LeBreton and Senter, 2008; 
Trevethan, 2017). 
4.4.3. F-Test 
Another way to determine the significance of expert disagreement is to use the F-test 
through hypothesis testing (Shrout and Fleiss, 1979). The F-test can be used to justify the 
disagreement values above the 10% threshold to decide the significance of the model. In 
this context, the F-test will hypothesize whether the ICC value is equal to zero: 
ICC= Intraclass Correlation Coefficient   
MSD= Mean square for decision elements 
MSE= Mean square error (residual) 
Hypothesis: 
𝐻0: 𝐼𝐶𝐶 = 0 
𝐻𝛼: 𝐼𝐶𝐶 > 0 
H0 implies that there is no correlation among the judgment and therefore shows complete 
disagreement among experts. Hα however, implies that there is no statistically significant 





With one and two degrees of freedom for decision and error respectively, and with 95% 




calculated F is bigger than the critical value, H0 can be rejected concluding that there is 
no significant disagreement among experts.  
𝐼𝑓 𝐹 > 𝐹𝐶𝑟𝑖𝑡𝑖𝑐𝑎𝑙 𝑇ℎ𝑒𝑛 𝐻0 𝑖𝑠 𝑟𝑒𝑗𝑒𝑐𝑡𝑒𝑑 𝐸𝑙𝑠𝑒 𝐹𝑎𝑖𝑙 𝑡𝑜 𝑟𝑒𝑗𝑒𝑐𝑡 𝐻0 
 
4.5.Sensitivity Analysis 
In the HDM model, in order to analyze the impacts of potential changes in the values at 
levels of the model, Sensitivity Analysis (SA) is used. SA is a method that can be used to 
perform analysis on how different perspectives/criteria of the model will change in 
scenarios where there is a change in value/weight of model elements. In other words, SA 
helps decision-makers determine how much a given model depends on its input factors 
(Saltelli, Tarantola and Chan, 1999). It also facilitates the process of understanding model 
behavior and the extent to which its different factors interplay. Lilburne and Trantola 
(2008) define SA as “the study of how uncertainty in model predictions is determined by 
uncertainty in model inputs.” (Lilburne and Tarantola, 2009).  
Local SA focuses on the impact of change in value one at a time, while a global SA 
considers the potential impacts of simultaneous variation of model inputs over their finite 
range of uncertainty. In other words, in the case of local SA, the value other than the one 
changed is assumed as fixed. In the global SA however, several values would 
concurrently change and the average of the changing output over the variation of all inputs 
is simulated (Tian, 2013). The global SA can be performed using different methods such 
as regression (SRC, SRRC, t-value methods), screen (Morris method), or variance based-




derivative methods, multiple-start perturbation method, regional SA, and density-based 
method (Morris, 1991; Park and Ahn, 1994; Storlie et al., 2009; de Wilde and Tian, 2010; 
Mechri, Capozzoli and Corrado, 2010; Eisenhower et al., 2012; Tian and Choudhary, 
2012; Hygh et al., 2012; Spitz et al., 2012; Tian, 2013; Paton, Maier and Dandy, 2013; 
Pianosi et al., 2016).  
In the field of technology management, due to its dynamic and fast-paced nature, SA has 
been used to determine potential impacts of change in the importance/weights of the 
perspectives as a way to ensure the robustness of the model/results (Phan, 2013; Estep, 
2017). In the case of Multi-Criteria Decision Making (MCDM) models, the importance 
(weights) may change due to the pairwise comparison matrix’s adjustment or 
change/recalculation of the matrix after changing inputs (Chen, Yu and Khan, 2013). 
Moreover, SA helps decision-makers in verifying the stability of the optimal solution and 
validating the used methodology (Muñoz, Romana and Ordóñez, 2016). 
Estep (2017) performed SA on her model on technology transfer score for research 
proposal evaluation with test several analysis scenarios. The SA in Estep’s dissertation 
was performed to better understand the impact of future-based scenarios (rank of 
proposals in her case), with changes in the importance of difference model perspectives. 
Moreover, SA determined how sensitive the model was to changes in expert judgment 
and showed the path the organization can take to improve its technology transfer potential 
(Estep, 2017). 
In the context of the technology management maturity model in healthcare (HDM model), 




on health organization’s final maturity score. In this context, sensitivity analysis can be 
very helpful in comparing different health organizations, comparing different 
departments within a health organization, and justification of changes in prioritization due 
to changes in the importance of different perspectives (technological, social, 
organizational, regulative, and financial). Furthermore, SA, in the context of this research 
will demonstrate the changes in the prioritization of factors in different extreme cases 
(scenarios). In other words, the model’s results will be tested in 5 different scenarios 
where one perspective is utterly dominant compared to the other 4 in terms of relative 
importance/weight. In summary, SA in the case of HDM, help decision-makers with the 
following (Chen and Kocaoglu, 2008): 
• Assist decision-makers with clarifying the impact of changes at policy, strategy, 
and operation levels. 
• Validating and testing the robustness of results/decisions. 
• Providing a wider understanding of possible outcomes based on the generation of 
different rankings (for perspective/criteria) in different scenarios. 
• Facilitation of expert consensus. 
• Provide decision-makers with “what if” scenarios and questions. 
This approach has been utilized by studies in the field of technology management and 
multi-criteria decision-making (Abotah, 2014; Estep, 2017). The SA will need to (in this 
case) determine the extent to which the model can withhold the changes before resulting 




Chen and Kocaoglu proposed a method in 2008 to determine the allowed range of values 
changes which would not result in changing the final prioritization of the results (Chen 
and Kocaoglu, 2008). This method has also been used in the technology management 
literature (HDM methodology) (Tran, 2000; Phan, 2013; Iskin, 2014; Estep, 2017). 
 
Based on this method, the initial prioritization of the model’s output will not be subject 
to change under the following circumstance: 
For the perturbation 𝑃𝑙∗




𝑂 ≤ 1 − 𝐶𝑙∗
𝑂 
The original maturity score (ranking) (Ar, Ar+n) for healthcare organization will not be 
subject to change if:  
𝜆 ≥ 𝑃𝑖
































The top choice will remain at the top rank if the above condition is satisfied for all r=1 
and n=1, 2… I-1. The rank order of all Ai’s will not change if the above condition stands 
of all r=1, 2… I-1, and n=1. 
The allowance range of perturbations (𝐶𝑙














This research will use the “Boost” approach to test the HDM model’s reliability and 
sensitivity. The boosting approach is a scenario-driven method in which the analysis is 
done around boosting one factor (at a time) to the maximum and observe the impact of 
that on the final result and other perspectives/criteria’s relative importance. In the case of 
this research, the Boost approach is performed for all of the 5 perspectives in the model. 
In each scenario, one of the perspectives is given the maximum importance (without 
removing any perspectives). These scenarios are performed to learn how the overall index 
score of each alternative is changed, and whether that would result in re-prioritization of 






In instances in which there is a need in having a reusable model, or in instances of having 
many alternatives, desirability curves can be used. The combination of desirability curves 
with HDM is used to identify levels/ metrics for each criterion. Each level/metric 
connected to a criterion acts as a useful value to assist decision-makers. Using the 
desirability curves approach, the experts need to evaluate related levels/metrics for each 
criterion (desirability matrix) while giving each metric a scaled quantitative value. This 
enables the normalization of the evaluation results by experts across all the criteria (Phan, 
2013; Estep and Daim, 2016; Gibson and Daim, 2016). 
HDM also includes the calculations for disagreement, inconsistency, and sensitivity 
analysis (already explained in the methodology section) to validate the reliability and 
robustness of the final model (Kocaoglu, 1983; Chen and Kocaoglu, 2008; Daim and 
Kocaoglu, 2015; Estep and Daim, 2016; Gibson and Daim, 2016; Estep, 2017; Shaygan, 
Ozdemir-Gungor, D. Kutgun and Daneshi, 2017; Shaygan et al., 2018a; Estep, Daim and 
Shaygan, 2021). 
When using the HDM model, each criterion that is being evaluated by an entity (health 
research centers/institutes in this case), can be assigned a level that best fits it for each 
criterion in that research center. For example, the research center’s current status for each 
factor affecting technology maturity and continuous learning will be identified by the 
decision-makers after investigating the research center’s capabilities. Taking the 




within the research center will use the value curves of each criterion to determine which 
level in that value curve represents the research center the closest. 
 













5. Research Design  
The research phases in this study will include thorough literature that delves into the 
background information regarding the healthcare landscape in the US, continuous 
learning in healthcare, and Maturity Models in healthcare. The knowledge and data 
gathered in this section will be the basis of gap analysis and bricks of the HDM model in 
terms of perspectives and criteria. 
After the literature review, based on the findings of the literature review, the initial HDM 
model and desirability curves will be developed. This step will, in parts, will be done 
simultaneously with the next step which includes experts giving feedback in terms of 
validating the model to finalize the HDM model. 
In the next phase, several panels of experts will be formed with the goals of validating 
and quantifying the model. Each panel will provide certain expertise that will be used to 
evaluate respective parts of the model. The experts are initially asked to evaluate the 
criteria and desirability curve values. Then, they will be asked to perform a pairwise 
comparison based on the HDM approach to quantify the perspective and criteria.  
Next, the pairwise comparisons done by experts will be initially validated by using 
inconsistency and disagreement analyses. Finally, the business impact of the results and 
their meaning and implication will be discussed. Leading to the conclusions of the 
research. The general phases which are going to be implemented in this research are 





Figure 21: Research Framework (Basic) 
A more detailed breakdown of the proposed and implemented steps in this study are 
demonstrated in the diagram below (Figure 22). As it can be seen the actions fall under 
three categories which are “model development and validation”, “Model quantification 
and analysis”, and “Case study and results”. 
 
Figure 22: Research Framework (Detailed) 
Each step and phase will require a different set of data and data collection sources which 
are summarized below: 
• Literature Review: In the literature review part of this research, academic 
publications will be the main source of information. These publications can be in 












books related to the research interest areas, and peer-reviewed conference 
proceedings. In some cases, information available from reputable websites will be 
used. The knowledge extraction from websites happens mainly in order to provide 
recent statistics and regulations cited that are hard to get from academic 
publications. Government websites (such as CMS.gov, NIH.gov), credible 
business websites (Forbes.com, PWC.com), and healthcare organizations 
(OHSU.edu, mayoclinic.org). Research gaps, goals, and questions are the results 
of this step. 
• Determination of Critical Factors:  Following the clarification of research gaps, 
questions, and goals, the critical decision elements revolving around the proposed 
decision should be identified. Since the HDM model is being used, in this step, 
following the information collected in the literature review section, initial 
perspectives and their sub-criteria should be identified. 
• Model Definition and Build: For this part of the research, the initial model should 
be designed. The figure below shows the initial proposed model for this research. 
As it can be seen, the initial model has a hierarchical structure including 





Figure 23: Initial Model Depiction 
 
• Expert panel formation: with the goals of validating and quantifying the model, 5 
expert panels were created. This section has already been discussed in detail in 
the previous section. 
• Design of Validation Instruments: This section included creating the Qualtrics 
surveys for perspectives, criteria, and desirability metrics validation. This section 
also included creating the invitations, emails, and expert instructions for the 
validation of the mentioned elements. These emails, instructions, and surveys are 
completely shown in appendixes C and D. As for desirability curve metrics 
validations, the list of metrics was sent to the respective panel of experts, and their 




• Quantification Instrument Design: Following the model validation in terms of 
decision elements and metrics, this section included creating the HDM model 
using the ETM HDM software. This section also included creating the invitations, 
emails, and expert instructions for the quantification of decision elements. These 
emails, instructions, and surveys are completely shown in appendixes C and D. 
• Model Quantification by Experts: In this section, experts quantified the 
perspectives and criteria using the instructions provided in the previous step. Each 
expert conducts pairwise comparisons in both perspectives and criteria levels. In 
addition to the importance weights of decision elements, the inconsistency index, 
and disagreement index are products of this section. 
• Quantification of Desirability Curve Metrics: Using Qualtrics, the experts needed 
to assign a value (0-100) to each criterion’s metric. Sufficient instructions are 
provided to experts in this section. 
• Data Analysis: For this step, as mentioned before, the inconsistency index and the 
disagreement index are analyzed to check if they are acceptable or not based on 
the defined thresholds. If any of them are not within the acceptable range, actions 
should be taken to solve the issue.  In case the model has acceptable inconsistency 
and disagreement, the weights obtained from the expert quantification are 
finalized. 
• Case Study Metrics Assignment: In this step, expert(s) familiar with the research 
and project (health research center) are asked to assign the proper metrics for each 




steps. The experts will take the research goals into account. Furthermore, while 
assigning these numbers the performance of the research center against each 
criterion considering the goals of technology maturity and continuous learning. 
The product of this section is the technology maturity score for the healthcare 
organization. 
• Sensitivity Analysis: sensitivity analysis will demonstrate the impact of changes 
in the perspective relevance on the research center’s final maturity score. In this 
context, sensitivity analysis can be very helpful in comparing different health 
organizations, comparing different departments within a health organization, and 
justification of changes in prioritization due to changes in the importance of 
different perspectives (technological, social, organizational, regulative, and 
financial). Furthermore, scenario analysis, in the context of this research will 
demonstrate the changes in the prioritization of factors in different extreme cases 
(scenarios). In other words, the model’s results will be tested in 5 different 
scenarios where one perspective is utterly dominant compared to others in terms 
of relative importance/weight.  
• Results Analysis/ Conclusion: Following all the validation, quantification, and 
analysis, the technology maturity score results for healthcare organizations. 
Healthcare organizations can use this score to gain a sense of self-awareness of 
where they are, where they want to be, and how to get there. This model’s results 




model as a decision-making assistant will bolster healthcare organizations' 
efficiency and effectiveness in resource allocation and productive initiatives. 
5.1. Perspectives and Criteria 
During the initial literature review, using the ATLAS.ti qualitative and research software, 
68 potential criteria were mined from the literature. This was done through coding the 
specific parts of the papers that were being read with the tag “potential criteria”. 
Following this, the criteria that were being repeated in different papers were deemed as 
more important. Public health and strategic management-related criteria, data security, 
standards, transparency, and cost-cutting were some of these recurring themes.  Through 
this procedure, as more papers’ codes were added, certain patterns and themes were 
identified which eventually lead to the merge/add/removal of some identified potential 
criteria. As an example, criteria such as “Public Trust”, “Physician Trust”, “Public 
Acceptance”, “Respecting Clinical Judgement”, “Respecting the rights and dignities of 
physicians”, and “Physician Trust” was later merged into “Stakeholder Trust”. Although 
some criteria did not qualify to the initial model, they were later added to the model 
through the expert validation of the criteria (such as training). The experts suggested 
removing/adding some criteria. To verify that these items were aligned with the literature, 
a deeper literature review which is provided in this exam was implemented for 3 of the 
added or moved criteria (training, governance, privacy). Following the literature review 
and then expert validation, the model was finalized before being quantified. Based on this 




each stage. This research has 5 perspectives, and each perspective holds between 4 to 5 
items as its criteria.  
Some of the reasons for this numerical range have been discussed in the HDM literature. 
When the number of criteria under a perspective increases it may turn the pairwise 
comparison procedure into an arduous one. This may be a big advantage as many of the 
experts may be busy professionals that may not be able to allocate a significant amount 
of time to quantifying and validating the model. The number of pairwise comparisons at 
each perspective is (n*(n-1)/2) with n being the number of sub-criteria. If there are 3 sub-
criteria there will be 3 pairwise comparisons while if there are 6 sub-criteria there will be 
15 pairwise comparisons. However, if the number of criteria exceeds 6 it will need a 
minimum of 21 pairwise comparisons at that perspective which may be too time-
consuming and lead to significant deterioration in terms of reliability. Looking at the 
number of criteria from the other side, if the number of criteria is less than 3, basically 
there would be no pairwise comparisons and it would merely be “a” comparison. Hence 
the numerical range of 4-5 has been used in the HDM related dissertations and research 
for each perspective node (Munkongsujarit et al., 2009; Phan, 2013; Iskin, 2014; Gibson, 





Figure 24: Snapshot of the Initial Selected Criteria 
 
5.1.1. Technology Perspective 
Systematic assessment of technology management maturity needs a socio-technical 
infrastructure and therefore, the technological side of the adoption of assessment of goals 
such as systematic and continuous learning has significant importance. The adoption of 
EHRs in the US from one side and the development in fields such as genomics and 
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wearable devices from the other side are paving the path for the collection of great 
amounts of data for health systems. Especially with all the demographic and demand 
changes, healthcare organizations are forced to leverage the value of technology 
advancements to be cost-effective, competitive, and responsive. Concurrent to the 
mentioned advances, acquiring experienced data scientists and leveraging the benefits of 
data integration, sharing with different stakeholders, and acquisition and curation of data 
are some of the areas that can help healthcare organizations with their goals of increasing 
quality care, patient satisfaction, and public health while driving down the costs 
(Krumholz, Terry and Waldstreicher, 2016; Barham, 2017). 
Information technology (IT) which is the transformation of data into useful information 
involves identifying data needs, collecting the right data, storing and analyzing it, and 
turn it into a useful and ideally automatic reporting system in a format desired by its end 
users. Several types of information exist for specialized uses by health care professionals, 
managers, payers, patients, researchers, and the government. IT departments in health 
care organizations play a significant part in decisions to adopt new information 
technologies to improve health care delivery, increase organizational efficiency, and 
comply with various laws and regulations (In terms of clinical information systems, 
administrative information systems, and decision support systems) (Shi and Singh, 2019). 
IT departments in healthcare organizations use medical records systems to collect, 
transcribe, and store clinical data; radiology and clinical laboratory reporting systems; 
pharmacy data systems to track medication use and mitigate the risks of errors, 
medical/drug reactions/interactions; scheduling systems for patients (both in terms of 




materials management, among others. Moreover, Health informatics (application of 
information science to improve the efficiency, accuracy, and reliability of health care 
services) necessitates the use of IT but transcends it by stressing the improvement of 
health care delivery (such as design and assessment of the effectiveness of clinical 
decision support systems). As mentioned among the goals of learning healthcare systems 
and continuous learning in those organizations, using health data beyond their primary 
use can play a pivotal part in turning health organizations into learning ones. Some of the 
topics covered in this perspective are: 
• Management of big data resources in terms of security, privacy, governance, and ethics. 
• The socio-technical infrastructure needed to improve and provide the capacity to capture, 
compile, and protect clinical and financial data, which enables the evaluation, adjustment, 
analysis, and dissemination, and integration of learned knowledge into clinical care 
processes to secure the promised improvements. 
• Data systems and tools are used to capture, share, and integrate data, information, 
visualizations, and knowledge gained from research into the organization in real-time. 
• Ensuring that technologies and IT products are user-friendly (e.g., considering health 
literacy and technology competence) to all users (stakeholders). 
This perspective covers topics such as data management and handling of technology in 
terms of infrastructure, security, privacy, and knowledge flow and sharing in healthcare 
organizations. 
 
5.1.2. Social Perspective 
This perspective encapsulates topics such as public acceptance, trust, accessibility, equity, 




The mission of public health has been defined as fulfilling “society’s interest in assuring 
conditions in which people can be healthy.” by the institute of medicine in 1988 dealing 
with a spectrum of concerns to make sure that optimal health is disseminated for society 
(Institute of Medicine (US) Committee for the Study of the Future of Public Health, 
1988). Enabling this mission and goal requires support and engagement from the involved 
stakeholders. The stakeholders can take the shape of patients, providers, policymakers, 
payers, and physicians.  
These social and public health-related issues may involve the application of scientific and 
technological know-how to avoid, mitigate, or cope with any public health and safety 
threats. The wide scope of topics in terms of the social aspect of technology in healthcare 
can have effects on topics varying from nutrition issues to health policy. Shi and Singh 
(2019) discuss public health’s activities that of which include dissemination, both to the 
public and to health professionals, of timely information about important health issues, 
particularly when communicable diseases pose potential threats too large segments of a 
population. 
 Some of the topics covered in this perspective are: 
• Key components of establishing stakeholder (patients, providers, payors, policymaker, 
purchasers, families) trust include: 
o Garnering buy-in and trust from stakeholders so they contribute to a culture of 
continuous improvement and learning. 
o Transparency with stakeholders regarding current limitations and plans to 
address and mitigate them through a system that supports clinical and 




o Maintaining trustworthiness as a research center by following through on 
promised commitments and ensuring new knowledge is used to improve the care 
of those who contributed to its generation via an enhanced use of their data. 
• The degree to which the stakeholders are benefiting from the clinical and research 
advantages of continuous learning. Health research centers must carry out consistent and 
innovative outreach efforts to ensure that services are accessible to diverse populations to 
reduce racial, ethnic, sexual orientation/gender, and other disparities. 
• The degree to which a health research center can engage stakeholders (patients, providers, 
payors, policymaker, purchasers, families) to participate in continuous improvement and 
learning projects and initiatives. 
• Research centers’ ability to acquire and retain talented and diverse staff in different areas 
(physicians, nurses, researchers, data scientists, public health professionals, managers, 
epidemiologists, administrative staff, etc.) 
5.1.3. Organizational Perspective 
This perspective covers certain organizational aspects of technology management in 
healthcare such as leadership, change management, organizational culture and 
transparency, strategic management, and quality improvement. 
 
The topics covered in this perspective are: 
• Broad leadership can expand and guide stakeholders’ commitment to the goals of 
continuous learning and increased technology maturity. 
• Research centers’ ability to improve through strategic decisions, management of 
competing priorities, internal and external partnerships/collaborations, problem 




• The extent to which a research center’s employees have adopted and are committed to a 
culture of continuous learning and practice transparency to safeguard stakeholder trust to 
improve the health of individuals, communities, and diverse populations. 
• Training employees and stakeholders on the latest technologies and best practices within 
the health research center. 
• Having the necessary governance to support a sustainable operation, uphold required 
standards, build, and maintain trust with stakeholders, and continuously innovate. 
 
5.1.4. Regulatory Perspective 
Operating in a highly regulated environment, health care managers must comply with 
government regulations, such as standards of participation in government programs, 
licensing rules, and security and privacy laws regarding patient information, while 
operationalizing the organization within the constraints of reimbursement rates. From the 
public standpoint, the Medicare and Medicaid programs have made significant 
modifications to their reimbursement methodologies that have caused the need for 
operational changes in the way services are organized and delivered. On the other hand, 
Private agencies, such as the Joint Commission, also play an indirect regulatory role 
especially in the monitoring of the quality of services. Health organizations must obey 
the rules set by the various public and private agencies that regulate the health care 
marketplace. Therefore, it is critical for health organizations to constantly keep abreast of 
the rules and regulations governing at state and federal levels. 
The implications of health policy and new reform proposals are better reacted to when 
health organizations sense and comprehend the issues and their connection to the delivery 




organizations' ability to be flexible and dynamic in terms of being proactive or timely 
reactive to the regulatory changes in healthcare. Many of these regulations or policies 
may be affected by the political climate as government policy in the United States plays 
a significant role in deciding which drugs, devices, and biologics are made available to 
Americans. The U.S. government is also one of the largest sources of funding for 
biomedical research. By controlling the amount of funding, public policy indirectly 
influences medical innovation (Shi and Singh, 2019). 
 
This perspective includes regulatory and legal aspects needed to assess the maturity of 
technology management in healthcare organizations such as governance, regulative and 
legal influences, and standard compliance. 
 
The topics covered in this perspective are: 
• Research centers’ compliance with standards and regulations to ensure transparency with 
stakeholders, data interoperability, and commitment to meaningful use and joint 
commissions. 
• Research centers’ flexibility and agility in responding and adapting to changes (new 
regulations, legislations, and policies) in terms of anticipation and readiness (resources, 
policies, strategies, and management). 
• Research centers’ adherence to regulations and policies to ensure privacy in terms of 
information technology, medical data, patient access, third party interactions, and ethical 
use of information (IRBs), among others. 
• Research centers' ability to inform policies by participating in expert panels, providing 




with the state and the federal government to complete analyses regarding policy 
development, implementation, and impact. 
 
 
5.1.5. Financial Perspective 
In terms of technology management and organizations' maturity in this area. 
Technological innovations are argued as one of the most significant factors in healthcare 
cost inflation. This issue has been more highlighted in the past couple of decades, 
accounting for about half of the total increase in health care spending (Sorenson, 
Drummond and Khan, 2013). These technological costs can be due to the acquisition of 
new technology or equipment, training, setting, logistics, and maintaining it. Therefore, 
health organizations need to balance the tradeoffs using new technologies as (concurrent 
to increasing costs) it may benefit them greatly in terms of incentives, attracting patients, 
and competition. Hence, widespread adoption of technology has a multiplier effect. 
Moreover, changes in areas such as financing, insurance, payment, and delivery can 
present new threats or opportunities in the health care market. On top of the mentioned 
factors, the external factors discussed in the literature section can make this task of 
balancing even more difficult. Health organizations can be more effective when they 
proactively deal with any threats to their institution’s profitability and viability.  
This perspective encapsulates the financial side of assessing the maturity of technology 
management in healthcare organizations. Topics such as investment resource allocation, 
funding, and cost reduction fall under this category. 




• Research centers’ ability to prioritize and decide to invest its resources (financial, human, 
space...) in alignment with the goals of increased technology maturity and continuous 
learning.  
• The extent to which incentives and funding are aligned with the encouragement of 
technology maturity, continuous learning and improvement, waste elimination, and 
rewarding high care value. 
• Research centers’ ability to cut costs as a result of increased maturity, learning, 
continuous improvement, and waste eliminations without compromising quality. 
• Research centers’ success in meeting reimbursement programs’ goals (policy incentives, 
value-based purchasing, etc.) and  














5.2. Initial Identified Perspectives and Criteria 
In this section, the tables for the initially identified perspectives and criteria and their definitions 
are provided. All criteria were mined from the literature or discussion with healthcare experts 
validated by literature. 
 
Table 4:Model Perspectives 
Perspective Definition 
Technology 
This perspective covers topics such as data management and handling of 
technology in terms of infrastructure, security, privacy, knowledge flow, and 
sharing in healthcare organizations. 
Social 
This perspective encapsulates topics such as public acceptance, trust, broad 
accessibility, equity, and engagement. Stakeholders can take the shape of 
patients, providers, policymakers, payers, and clinicians. This perspective also 
includes the ability of healthcare organizations to attract and acquire a skilled 
and diverse workforce. 
Organizational 
This perspective covers certain organizational aspects of technology 
management in healthcare such as leadership, change management, 
organizational culture and transparency, strategic management, and governance. 
Regulatory 
This perspective includes regulatory and legal aspects needed to assess the 
maturity of technology management in health research centers, such as the 
ability to adapt to and comply with changing regulations and informing policies. 
Financial 
This perspective encapsulates the financial side of assessing the maturity of 
technology management in health research centers. Topics such as investment 
resource allocation, appropriate funding, and cost reduction without 












Table 5: Initial Technology Criteria 





Management of big data resources in terms 
of security, privacy, and ethics 
(Saunders and Smith, 
2013; Bernstein et al., 
2015; English et al., 
2016; Rumsfeld, Joynt 
and Maddox, 2016; 




The socio-technical infrastructure needed to 
improve and provide the capacity to capture, 
compile, and protect clinical and financial 
data, which enables the evaluation, 
adjustment, analysis, and dissemination of 
learned knowledge  
(Saunders and Smith, 
2013; Mandl et al., 
2014; English et al., 
2016; Johnson et al., 






Data systems and tools are used to capture, 
share, and integrate data, information, 
visualizations, and knowledge gained from 
research into the organization in real-time. 
(Saunders and Smith, 
2013; Bernstein et al., 
2015; Cahan and 
Cimino, 2017; Morain, 



















Table 6: Initial Social Criteria 




Key components of establishing stakeholder (patients, 
providers, payors, policymaker, purchasers, families) 
trust include: 
• Garnering buy-in and trust from stakeholders 
so they contribute to a culture of continuous 
improvement and learning. 
• Transparency with stakeholders regarding 
current limitations and plans to address and 
mitigate them through a system that supports 
clinical and translational research, public 




2010; Faden et 
al., 2013; Kelley 
et al., 2015; Kraft 
et al., 2017) 
Accessibility 
The degree to which the public is benefiting from the 
advantages of continuous learning. Health research 
centers must carry out consistent and innovative 
outreach efforts to ensure that services are accessible to 
diverse populations to reduce racial, ethnic, sexual 
orientation/gender, and other disparities. 
(Fiscella et al., 
2000; Faden et al., 
2013; Bernstein et 
al., 2015; Kraft et 




The degree to which a health research center can 
engage stakeholders (patients, providers, payors, 
policymaker, purchasers, families) to participate in 




Mandl et al., 
2014; Price-
Haywood, 2015; 
Kraft et al., 2017) 
Talent 
Acquisition 
Research centers’ ability to acquire talented and diverse 
staff in different areas (physicians, nurses, researchers, 
data scientists, public health professionals, managers, 
epidemiologists, administrative staff, etc.) 
(Grossmann, 
Powers, et al., 
2011; Faden et 
al., 2013; 
Pronovost et al., 
2017; Schmittdiel 





Table 7: Initial Organizational Criteria 
Perspective Criteria Definition References 
Organizational 
Leadership  
Broad leadership which can expand and guide 
stakeholders’ commitment to the goals of 
continuous learning and increased technology 
maturity. 
(Bernstein et al., 
2015; Graban, 
2016; Morain, Kass 
and Grossmann, 




Research centers’ ability to improve through 
strategic decisions, management of competing 
priorities, research partnerships, problem 
identification, and finding solutions. 
(English et al., 










The extent to which a research center’s 
employees have adopted and are committed to 
a culture of continuous learning and practice 
transparency to safeguard stakeholder trust in 
order to improve the health of individuals, 




2007; McClellan et 




and Olsen, 2010; 
Curcin, 2016) 
Training 
Training employees and stakeholders on the 
latest technologies and best practices within 
the health research center. 
(Lynch et al., 2000; 
Gopee, 2002; 
Grossmann et al., 
2010; Grossmann, 




Having the necessary governance to support a 
sustainable operation, uphold required 
standards, build and maintain trust with 












Table 8: Initial Regulatory Criteria 




Research centers’ compliance with 
standards and regulations to ensure 
transparency with stakeholders, data 
interoperability, and commitment to 
meaningful use and joint commissions. 
(Institute of Medicine 
(IOM), 2007; Blumenthal 
and Tavenner, 2010; 
Friedman, Wong and 
Blumenthal, 2010; 





Research centers’ flexibility in adapting 
to new regulations, legislations, and 
policies in terms of anticipation and 
adaption (resources, policies, strategies, 
and management). 
(Blumenthal and Tavenner, 
2010; Grossmann, Goolsby, 
Olsen and McGinnis, 2011; 
Morain and Kass, 2016; 
Shaygan, 2018) 
Privacy 
Research centers’ adherence to 
regulations and policies to ensure privacy 
in terms of information technology, 
medical data, patient access, third party 
interactions, and ethical use of 
information, among others. 
(Curran, Stearns and 
Kaplan, 1969; Gostin et al., 
1993; Prentnieks and Qual, 
1996; Melton III, 1997; 
National Research Council, 
1997; Rothstein and Talbott, 




Table 9: Initial Financial Criteria 




Research centers’ ability to prioritize and 
decide to invest its resources in alignment 
with the goals of increased technology 
maturity and continuous learning. 
(Rouse, 2001; Pronovost et 
al., 2017; Rouse, Johns and 
Pepe, 2017; Shaygan, 





The extent to which incentives and funding 
are aligned with encouragement of 
technology maturity, continuous learning 
and improvement, waste elimination, and 
rewarding high care value. 
(Institute of Medicine 
(IOM), 2007; Blizinsky and 
Bonham, 2017; Morain, 
Kass and Grossmann, 
2017; Pronovost et al., 
2017; Shaygan, 2018) 
Cost 
Reduction 
Research centers’ ability to cut costs 
through increased maturity, learning, 
continuous improvement, and waste 
eliminations without compromising quality. 
(McClellan et al., 2008; 
Yong, Olsen and Mcginnis, 
2010; IOM, 2011, 2013; 





5.2.Model Description for Data Collection 
The following actions were taken to help the experts with their judgment: 
In each expert panel email that was sent out to the relevant panel, a concise and clear 
summary of what is expected and what needs to be done at each level was provided. 
Furthermore, files containing a more detailed research summary and perspectives/criteria 
information was attached to each level’s emails and shown in detail in Appendix C. 
 
 








Figure 26: Qualtrics Snapshot (Continued) 
 
• Enough information was provided to experts in each of the 
validation/quantification steps in Qualtrics. In each survey, description summaries 
were provided to experts so they could use it as a quick reference while doing the 
survey. Appendix D shows the surveys along with the related descriptions. 
 
 
Figure 27: Qualtrics Snapshot (Continued II) 
 
• In the HDM software tool (also, in the invitation email for the perspectives/criteria 
quantification), Clear descriptions appear as tooltips for each item being 





Figure 28: ETM HDM Snapshot 
 
5.3. Justification of the Selected Elements 
As mentioned in the perspectives/criteria section, different levels of review and validation 
will go into finalizing the model. Relative papers were reviewed followed by coding them 
in ATLAS.ti and following pattern identification some criteria were merged or removed 
from the list. Next, the initial model will be sent to an expert panel. In my comprehensive 
exam run, there were 6 real experts in the field and after getting their feedback on the 
model, privacy and training (separating it from talent acquisition) were recommended. It 
was also recommended to while moving governance from the regulatory perspective to 
the organizational perspective. The summary of the steps taken to finalize the model for 





Figure 29: Criteria Selection Stages 
In this section the further literature review to verify/validate the added/moved criteria is 
provided. Privacy, training, and governance are reviewed in a deeper sense in the context 
of maturity models in healthcare and continuous improvement. These three criteria were 
added after the advice of the experts in my panel. A further literature review was 
conducted to make sure their recommendations were aligned with the existing literature. 
5.5.1. Privacy 
One of the results of the criteria validation stage in this research was Privacy. Although 
privacy was considered as a part of the “Data Management” criterion, some of the experts 
pointed out the importance of a “Privacy” criterion in the regulatory perspective of the 
model. Privacy is important in the data management sense but due to its sensitive nature 
needs to be evaluated in regulatory terms as well. This can be due to fact that many health 
organizations have growing concerns about patient privacy for their clinical and 
epidemiological research data (Gostin et al., 1993; Prentnieks and Qual, 1996; Melton 
III, 1997; National Research Council, 1997). Clinical and medical data has been stored 
and used for research in health organizations repositories (paper or electronic-based) since 
the early 1900s starting with Mayo Clinic in Rochester Minnesota (Kurland and 




data to build upon has become trickier and as Vanderbroucke argues in 2011, a 
jeopardizing element in the use of patient data for research (Vandenbroucke, 2011). For 
that reason, The Mayo Clinic Foundation started to obtain broad informed consent from 
patients to use their data for future research as one way to ensure the continuation of 
research while making sure that all the data being used in by consented patients. At the 
same time, health organizations should be able to use personal health information to teach, 
train, conduct research, deliver care, and ensure quality while making sure their 
employers who get health information to pay claims would not use it for any non-health 
purposes, like hiring, firing, and promotions (Sharyl J. Nass et al., 2009). Health 
organizations should also make sure that there are proper safeguards to protect the real 
interests of patients and increased perceived understanding and benefit of learning from 
the historical data by society through positive promotion (Vandenbroucke, 2011). 
Because of the “disruptive” transformation of health records from papers to electronic 
records health organizations have the arduous task of managing both paper-based and 
electronic data. This task becomes even more difficult due to the fragmentation of paper-
based records especially for the older records (Rothstein and Talbott, 2006). Although 
Rothstein and Talbott (2006) argue that most individuals can be confident that old, 
sensitive health information that may have no current clinical usefulness is unlikely to be 
disclosed when they authorize release of their medical records for employment or 
insurance purposes, health organizations should still make sure that they are aligned and 
compliant with privacy regulations. In past couple of years, with the adoption of 
electronic health records, patient data from different health organizatoins, providers, and 




privacy and confidentiality protections as a  part of the architecture of the nationwide or 
geographical health Information repositories. As more health organizations are sharing 
patient data among them for the goals of contninuous learning and improvement, privacy 
and confidentialty of patient information can be threteaned. For that reason in the United 
States, laws to protect health information privacy and confidentiality are largely designed 
to protect against unauthorized access to, use of, and disclosure of personal health 
information. Myriad of state and federal laws attempt to make health information secure 
from hackers or misuse or abuse of health data by health care employees (Dwyer III, 
Weaver and Hughes, 2004). Some of these laws specify the form in which health records 
may be stored or transmitted; others are focused on the penalties of unauthorized access 
through civil or criminal sanctions. As the protection of privacy and confidentiality of 
clinical and medical data is a major issue, state laws focus on health data disclosure are 
concentrated on specific information while federal laws focus only on the data gathered 
by federal agencies (Curran, Stearns and Kaplan, 1969). These concerns make health 
organizations obligated to adopt a code of ethics in addition to clarifying and defining 
rules and regulation which govern information protection. In other words, when a group 
of health organizations is sharing their data towards the goals of maturity and continuous 
improvement, proper standards of ethics and law should be ensured in the collection, 
storage, disclosure, and use of sensitive data. One way of mitigating the risks revolving 
around patient privacy due to centralized and shared healthcare information is to include 
the participating organizations and agencies in the development of the privacy systems 




Hence, this criterion was added to the regulatory perspective and is defined as: 
Organization’s adherence to privacy regulations and policies to ensure the privacy of 
information technology, medical data, patient access, information disclosure, third party 
interactions, and ethical use of information among others in terms of collection, storage, 
disclosure, and use of information. 
5.5.2. Governance 
Another change in the criteria was “Governance” which was moved from a regulatory 
perspective to an organizational. Additional literature review in the context of healthcare 
was performed for the governance criterion. Corporate governance emerged as a solution 
to unbalanced relations between companys’ main stakeholders (Verdeyen and 
Buggenhout, 2003). In 1932, Brele Jr and Daniels argued that United State’s corporate 
structure was inefficient as shareholders owned insignificant shares to have the power to 
monitor and audit companies effectively(Berle Jr and Means Daniel James, 1932). This 
meant that stakeholders were only investors as opposed to being owners of firms. The 
creation of boards and governance would allow share or stakeholders to get a return on 
their investment on top of controlling and influencing the management in effective ways. 
In the stakeholder type organization such as hospitals, governance structures need to be 
desgined in such manner that there would be clear ideas about power, responsibilites, and 
checks and balances and this accountability and control can protect health organizations 
when there is sufficient amount of disclosure and transparency (Berle Jr and Means 




Van som (2014) defines clinical governance as: “A governance system for healthcare 
organizations that promotes an integrated approach towards management of inputs, 
structures and process to improve the outcome of health-care service delivery where 
health staff work in an environment of greater accountability for clinical quality” (Vanu 
Som, 2004). In the United States, hospitals are overseen by at least one board of directors 
(trustees). While non-profit hospitals normally have a single overseeing board, for-profit 
hospitals may have different boards and governance systems overseeing their matters 
such as corporate, regional, and local ones (Jha and Epstein, 2010). The mentioned study 
argues that the big gap in board activities between high-performing and low-performing 
hospitals highlights the importance of board policymakers hoping to improve care in U.S. 
hospitals. There is an emerging argument that boards, including in healthcare, need to 
incorporate a culture of high trust across the executive and non-executive divide. This 
should be implemented along with a robust challenge, and a tight grasp on the business 
of delivering high-quality care for customers (patients in healthcare context) in a 
financially viable manner (high trust – high challenge – high engagement) (Chambers, 
2012). 
There have been works in the literature focusing on the impacts of governance in 
healthcare organizations. One important aspect that governance facilitates is 
multidisciplinary teamwork, partnerships, and cooperation practices which can have great 
implications for healthcare delivery and organizational culture organizations (Vanu Som, 




an electronic format using an agent-based method in order to facilitate modularization of 
clinical governance concerns from the aspect of a system (Taleb-Bendiab et al., 2006).   
Bevan (2008) proposes the CHI model which takes into account learning, innovation, and 
improvement for clinical governance (Bevan, 2008). This model takes into account 
strategic capacities such as patient focus, leadership, direction, and planning which feeds 
into resources and processes while utilizing the use of information for patient experience 
and outcomes. The resources and processes in the CHI model are quality improvement 
processes, focus on staff, and use of information (Bevan and Cornwell, 2006). 
Hastings et al. (2014) look into the interrelations of health system governance and 
workforce outcomes (Hastings et al., 2014). In other words, this paper looked into how 
governance bolsters change in the workforce to guarantee effective use by healthcare 
providers. Although the results in this study do not show a significant correlation between 
workforce and improvement in patient outcomes, it emphasizes on key strategies to 
support change management in healthcare organizations. These key strategies are built 
trust through the articulation of organizational goals, taking the workforce into account 
in terms of planning, implementation, and evaluation, and finally making sure of the 
existence of strong leadership. The governance mechanisms may include shared clinical 
governance, funding schemes, and professional development with enablers such as 
engagement, communication, change management, leadership, and vision. These 
mechanisms while being focused on patient, financial, or clinical systems, should also 
encompass workforce and human resources to guarantee that employees can and are 




responsibility to ensure the quality of care is provided by their hospital through 
determining strategy (direction), evaluation of performance (control), and forming 
organizational culture (values, rules, and tone) (Chambers, 2012). Chmabers (2012) 
Stresses the importance of avoiding faith-based and exhortative approaches and move 
towards guidance, training, and development and calls for more research and effort into 
the composition, structure, processes, and dynamics of healthcare boards for the sake of 
patient safety (Chambers, 2012). Garratt (2010) stresses on short-term focus on 
conformance and a more long-term concentration on performance (Garratt, 2010). In 
other words, although accountability and supervision are really important conformance 
issues, there should be a long-term focus on policy formation and strategic thinking in 
terms of external and internal focuses respectively. For this purpose (literature and expert 
validation), it was concluded that governance is more of an organizational issue than a 
regulatory matter.  
Health organizations may have different governance systems across different and some 
may work better than others. Regulatory governance is a part of the whole organizational 
governance that focuses on compliance and accountability of the health organization 
when it comes to regulations and policy.  
As an example, one kind of governance may be data governance within health 
organizations’ information technology groups. Data governance can be a program that 
creates clear and functioning Standards, Policies, Procedures, Roles, Responsibilities, and 
Accountabilities, in order to create an environment of trusted and high-quality data that 




Data governance is important to health organizations as it deals with topics such as data 
stewardship, data quality management, data access, and privacy among others. This type 
of governance is critical in healthcare organizations as data can be treated a strategic asset 
by these organizations since: 
• There is clear ownership within the health organizations’ business community, 
and Data Stewards are accountable and responsible for the management of data 
assets.  
• Data is secure and protected, and there are clear pathways to who grants access 
to data. 
• Clear documentation exists to help provide users additional context and meaning 
to the data they use for decision-making. 
• The quality of critical data is constantly monitored and measured, and defects 
are corrected in the source system. 
• There is a clear understanding of the critical data flow of elements throughout 
the organization.  
• Data is easily accessible to reach a potential audience, and data users can easily 
identify data assets within the environment that can be leveraged. 
To sum up, in terms of data governance, health organizations need to pay attention to 
stewardship (to ensure ownership), processes (to ensure consistency), and governed tools 
(to deliver access and reports. These three items will provide trusted data and reports for 




(accountability and responsibility), topics such as metadata management (business 
glossaries, report catalogs, application banks,…), data quality (completeness, conformity, 
consistency, accuracy, timeliness,…), and data access/protection are the key functional 
area in data governance for a healthcare organization. 
The other important aspects of governance in a health organization include but are not 
limited to, leadership, strategies, financial matters, decision making for resources and 
investments, policymaking, risk management, planning, training, and evaluation of 
quality across different departments of a healthcare organization. 
5.5.3. Training 
As for training, it was decided that it would be separated from talent acquisition from the 
social perspective to the organizational perspective. Technology management 
encapsulates managing technology in terms of not only volume but also reliability in 
terms of accuracy and safety (Grossmann et al., 2010). In other words, healthcare 
providers, including residents and fellows, should be placed in environments their rate of 
medical errors will decrease with training and management. Training providers to work 
in teams is critical to ensure an increase in reliability and safety to make sure optimal 
technology management is flowing in the organization. 
Stephen J. Swensen, and James Dilling of Mayo Clinic pinpoint the importance of sentient 
investment in social capital as an important part of effective technology management 
strategy with goals of high-reliability patient care. Social capital investment encapsulates 
the goals of transforming an organization from a collection of individuals into an agile, 




Olsen and McGinnis, 2011). This can be done by utilizing research engagement, 
administrations, and education. Swensen and Dilling emphasize areas like transparency, 
teamwork training, horizontal infrastructure, and cross-functional, team-based simulation 
training as important social engineering topics. An example of this can be utilized in 
health organizations' training teams to train health medical and nursing students and 
residents, together in cross-functional teams to enforce a more effective transformation 
culture. 
By the help of experts validating the criteria and further literature review, especially on 
the importance of technology management in continuous learning, the importance of 
training was stressed in technology maturity of healthcare organizations and the fact the 
continuous training is needed as an enabler of increased maturity and continuous learning 
from the organizations’ point of view, initiated the move from social to organizational 
perspective. Figure 14 shows the perspectives and criteria post validation. 
5.6. Initial Model 
After implementing the mentioned approach and justifying the added/moved elements, the model 
was finalized for the proposal and the initial model in the main dissertation study. The model has 
between 3 and 6 elements in each perspective with a total of 5 perspectives and 18 criteria. The 
next section shows an iteration of running the model and validating/quantifying the decision 





Figure 30: Initial Model 
 
5.7. Experts Identification and Selection 
Several methods are used to identify and select the potential experts for validation and 
quantification of the model. 
1- Researcher’s Connections: the researcher may have several connections related to 
learning health systems, the healthcare industry, and hospital management, based 
on previous work experience and current engagement with committees related to 
this research topic. 
2- Advisor and Committee Connections: Help provided by advisor and committee 
members in terms of the identification of local and national experts related to 




requested. This is because these people are highly probable to be engaged directly 
or indirectly in a related field of research and application. 
3- Social network analysis (SNA): This process can be used to investigate social 
structures by identifying networks and people in the centers of those networks 
(Daim and Kocaoglu, 2015; Kocaoglu et al., 2016).SNA will be used to identify 
experts related to healthcare technology management and learning health systems 
which can potentially lead them to be a part of the expert panels based on their 
expertise.  
 
It should be considered that all experts may not be in all panels. In other words, experts 
will be divided into panels and each expert will be matched and assigned to a certain area 
of the proposed model of this research in terms of validation and/or quantification. This 
means that each expert is able to join more than one panel based on relevant expertise. 
Here is a table summarizing the involvement of each panel in different steps of validation 
and quantification of the model. 
Table 10: Expert Panel Summary 
Panel Task # of Experts Tool 
P1 Perspective Validation 24 Qualtrics 
P2 Criteria Validation 26 Qualtrics 
P3 Perspectives/Criteria Quantification 30 ETM HDM 
P4 Desirability Metrics Validation 11 Qualtrics 











Table 11: Panel 1 Participants 
# Position 
4 Project Manager 
5 Chief Information Officer 
6 Project Manager 
7 Health Application Analyst 
8 Health Application Analyst 
11 Research Center Director 
12 Professor of Public Health 
15 Public Health Researcher 
16 Vice President of Nursing 
17 Assistant Professor in Medical Ethics & Health Policy 
19 Chair of Engineering Division in Hospital 
20 Professor of Health Informatics 
22 Research Center Director 
24 Industrial Engineering Professor (Healthcare) 
25 Quality Engineering Professor 
26 Professor at the Department of Healthcare Institutions Management  
29 Research Center Director 
30 Research Center Director 
34 Project Manager 
36 Health Management Researcher 
40 Department of Industrial Engineering (Chair) 
41 Health Informatics Analyst 
42 Health Data Scientist 























Table 12: Panel 2 Participants 
# Positions 
5 Chief Information Officer 
6 Project Manager 
8 Project Manager 
11 Research Center Director 
12 Professor of Public Health 
14 Project Manager 
15 Public Health Researcher 
16 VP of Nursing 
17 Assistant Professor in Medical Ethics & Health Policy 
19 Chair of Engineering Division 
20 Professor of Health Informatics 
22 Research Center Director 
24 IE Professor (Healthcare) 
25 Quality Engineering Professor 
26 Department of Healthcare Institutions Management. Professor 
29 Research Center Director 
30 Research Center Director 
32 Technology Faculty Research Coordinator 
34 Project Manager 
36 Industrial Engineering Researcher 
40 Department of Industrial Engineering (Department Chair) 
41 Health Informatics Analyst 
42 Health Data Scientist 



































Table 13: Panel 3 Participants 
# Position 
1 Data Scientist 
2 Senior Information Systems Project Leader 
3 Director of finance and Operations 
4 BI Project Manager 
6 Project Manager 
10 Research Center Director 
12 Professor at Department of Public Health 
13 Professor at Department of Public Health 
14 Project Manager 
15 Public Health Researcher 
16 Vice President of Nursing 
18 Assistant Professor of Learning Health Sciences 
19 Division of Engineering Chair 
20 Professor of Health Informatics 
21 Deputy Director for Public Health 
22 Research Center Director 
23 Learning Health Systems Researcher 
26 Professor at the Department of Healthcare Institutions Management 
30 Research Center Director 
32 Lecturer and Faculty Research Coordinator 
33 Professor  
37 Professor at the Department of Healthcare Institutions Management 
39 Performance Improvement Manager 
40 Department of Industrial Engineering (Department Chair) 
41 Health Data Analyst 
42 Data Scientist 
43 Associate Vice President for Information Systems 
44 Senior Project Manager 
45 Project Manager 










Table 14: Panel 4 Participants 
# Position 
2 Senior IS Project Leader (Regulatory) 
6 Healthcare Consultant 
14 Project Manager 
17 Assistant Professor in Medical Ethics & Health Policy 
22 Director of Research Center 
26 Faculty member at Department of Healthcare Institutions Management 
33 Professor of Internal Medicine 
35 Senior Policy Analyst 
38 Chief Technology Officer 
41 Health Data Analyst 
43 Associate Vice President for Information Systems 
46 Professor, Director, Center for Health Policy and Research 
 
 
Table 15: Panel 5 Participants 
Expert # Position 
13 Associate Professor and Program Director, MPH Health Management and Policy 
14 Project Manager 
15 Public Health Researcher 
16 Vice President of Nursing 
19 Chair, Division of Engineering 
20 Professor of Health Informatics 
22 Director of Research Center 
26 Faculty member at Department of Healthcare Institutions Management 
33 Professor of Internal Medicine 
35 Senior Policy Analyst 
41 Health Data Analyst 
43 Associate Vice President for Information Systems 

































6. Results of Model Validation and Quantification 
6.1 Model Validation 
In this section, to test the proposed model in theoretic and practical terms, the model was 
validated and quantified using a panel of experts. In order to test the practicality of this 
model, it has been applied to a department in a health organization in the United States. 
As result valuation tools, the inconsistency and disagreement values will be tested with 
regards to the acceptable threshold and sensitivity analysis will be performed to test the 
model in different situations based on different prioritizations. 
As the first of the model implementation, the perspectives of the model were validated. 
All 5 different perspectives were validated by 24 experts with 100% agreeing that the 
perspectives were sufficient, and no changes were needed to be made. The threshold of 
80% percent was considered for passing for each perspective and criteria. The summary 
of the prospective validation is shown in Table 16. 
Table 16: Perspective Validation 
Perspective # of Experts Yes No Validation 
Technology 24 24 0 100% 
Social 24 24 0 100% 
Organizational 24 24 0 100% 
Regulatory 24 24 0 100% 






Figure 32: Perspective Validation 
After validating the perspectives, each perspective’s criteria were validated by each of the 
26 experts in panel 2. In this section, I received great feedback from my experts leading 
to the addition of 2 criteria and reword two criteria. Although none of the criteria failed 
in terms of getting a validation percentage of under threshold, the changes made in 
wording and definitions were based on the comments and feedback provided by experts 
and validated and verified by further literature review. The summary of the criteria 
validation is shown in the Table 17-21. 
 
Table 17: Technology Criteria Validation 
Technology # of Experts Yes No Validation 
Data Management 26 26 0 100% 
Supporting Infrastructure 26 26 0 100% 



















Figure 33: Technology Criteria Validation 
 
Table 18: Social Criteria Validation 
Social # of Experts Yes No Validation 
Stakeholder Trust 26 23 3 88% 
Accessibility 26 26 0 100% 
Stakeholder Engagement 26 25 1 96% 




































Table 19: Organizational Criteria Validation 
Organizational # of Experts Yes No Validation 
Leadership 26 25 1 96% 
Strategic Management 26 25 1 96% 
Culture and Transparency 26 25 1 96% 
Training 26 26 0 100% 
Governance 26 25 1 96% 
 
 
Figure 35: Organizational Criteria Validation 
 
Table 20: Regulatory Criteria Validation 
Regulatory # of Experts Yes No Validation 
Standards Compliance 26 26 0 100% 
Policy Preparedness and 
Adaption 
26 25 1 96% 



































Table 21: Financial Criteria Validation 
Financial # of Experts Yes No Validation 
Resource Allocation 26 26 0 100% 
Funding and Mission Alignment 26 25 1 96% 
Cost Reduction 26 25 1 96% 
 
 
Figure 37: Financial Criteria Validation 
 
 
6.2 Validated Model 
After getting the feedback from expert panels 1 and 2, three new criteria were added 
which are user experience, informing policy, and financial synergy with policies and 
priorities under technology, regulatory, and financial perspectives, respectively. 
Furthermore, two criteria were edited in their wording. Organizational culture and 
transparency were shortened to “Culture and Transparency” and the word retention was 
added to talent acquisition as the importance of talent retention was realized during the 
validation process. Finally, based on the feedback, some criteria definitions were 
reworded or rephrased for clarity and accuracy. Here is an example of expert feedback on 













“I think "supporting infrastructure" and/or real-time knowledge access & sharing need 
to be conceived more broadly to include not only DISSEMINATION of learned 
knowledge, but systems to ensure said knowledge is subsequently integrated into 
clinical care processes to secure the promised improvements. It's not enough just to put 
it out in the world and hope someone will do something with it.” 
 
Another example of expert feedback on “Stakeholder Trust”: 
“It must also be ensured that the institution is TRUSTWORTHY. Part of this 
trustworthiness is following through on promised commitments and ensuring new 
knowledge is used to improve care of those who contributed to its generation via 
enhanced use of their data).” 
 
In this section each of the added criteria will be briefly explained. 
6.2.1. User Experience 
Defined as ”Ensuring that technologies and IT products are user-friendly (e.g., 
considering health literacy and technology competence) to all users (stakeholders) 
(Lehoux, 2004; Rudd, 2010; Vehko et al., 2019)”, this criterion was added to the model 
under the technology perspective based on the expert panel’s feedback. User Experience 
(UX) can enhance users’ motivation and engagement (Zaharias and Pappas, 2016). As 
Lehoux (2004) argues, it is enough to only transfer the technology to the user or 
stakeholders but to make sure the intended knowledge to be transferred as well. The same 
study looks into the importance of user-friendliness in this transfer. Moreover, Giansanti, 
Castrichella and Giovagnoli (2007) found that user-friendliness has the biggest effect on 




One of the comments that were received during the validation phase stressed the need for 
involving a criterion that touches on technological user-friendliness and literacy: 
“You can think of something around how easy is it for the patients or consumers of the 
service or research the center is providing can benefit from it in terms of technological 
user-friendliness and literacy.” 
To this end, User Experience was added to the technology perspective in the model. 
6.2.2. Informing Policy 
Defined as ”Research centers' ability to inform policies by participating in expert panels, 
providing evidence and comments regarding policies under consideration, and securing 
contracts with the state and the federal government to complete analyses regarding policy 
development, implementation, and impact (Douglas et al., 2009; Bendavid and Miller, 
2010; Behrns, 2015; McMahon et al., 2020)”, this criterion was added during discussions 
and feedback by the regulatory focused experts in the validation expert panels. It is 
important for healthcare organizations and research centers to keep abreast and improve 
policies by: 
• Participating in expert panels. 
• Providing evidence and comments regarding policies that are under 
consideration. 
• Securing federal and state contracts based on policy development, 




An example would be for a research center to define the questions that society, patients, 
and healthcare need and work towards providing evidence that will help inform policy. 
Health research centers should reach outside of their organization to connect with 
policymakers and the community and by engaging in meaningful conversations, gain a 
better understanding of the existing problems and how they can address them. Moreover, 
centers need to improve their ability to communicate their findings back to policymakers 
leading to a more effective policy generation (Pomeroy, no date). This criterion is very 
important as stakeholders collaborate to generate evidence that informs health policy, the 
results can be an effective way to push research.  
To sum up, academic health research centers can have a significant impact on research 
and evidence-informed health policy through taking part in new collaborative models of 
research. 
It should be noted that research centers should remain unbiased and keep the aims of 
healthcare as their moral compass and make sure their research is not misused in 
politically charged policy shaping. 
 
6.2.3. Financial Synergy with Policies and Priorities 
The third added criterion is defined as “Research centers’ success in meeting 
reimbursement programs’ goals (policy incentives, value-based purchasing, etc.) and 
accessing government, foundation, and other grants (NIH, DARPA, DOD, various private 
funds, etc.) (Weeks and Pardee, 2019)”. This criterion had been partially realized during 
the literature review phase for health research centers and this realization was invigorated 




been explained in section 2.7. Here are some of the comments that hinted at the inclusion 
of this criterion: 
“It is important to include the center’s success in accessing government and other 
grants. NIH, DARPA, DOD, various private funds, etc.” 
Another expert’s comment stressed the importance of policy incentives: 
“Greater environmental incentives: consider policy incentives, value-based purchasing, 
and other reimbursement programs; also, reputation and accreditations and the 
financial benefit of meeting those requirements.” 
As the result of the literature review on research centers and the feedback received from 
the experts at the validation phase, this item was added under the financial perspective. 
6.2.4. Finalized Model 
After the completion of the validation of model perspectives and criteria, the final 
model consists of 5 perspectives, each of them containing from 4 to 5 criteria. The total 
number of criteria in this model is 21. The final validated model is shown in Figure 38. 



















































Table 26: Validated Financial Criteria 
 
 
6.3. Desirability Curves 
The metrics provided for each criterion were validated. they were tweaked and slightly 
edited based on the great comments and feedback provided by the expert panel. For the 
validation of the metrics for each criterion, the initials metrics were sent to the relative 
panel. Each criterion’s metric validation is shown in the tables below (Tables 27-31). 
Furthermore, the experts quantified the desirability curve metrics. In other words, each 
metric for each criterion now has a different quantified amount associated with it. Each 
criterion’s metric/state values. These values are shown in Tables 32-52 while the curves 
are shown in Figures 39-59. The quantification data for the desirability curve values were 
collected using Qualtrics in the winter of 2020. 
The quantified metrics will be used in the case study section which will add the unique 
extra layer based on the context of the studied research centers on top of the weighted 
criteria and perspectives. This is especially helpful in instances in which there is a need 




curves can be used. The combination of desirability curves with HDM is used to identify 
levels/ metrics for each criterion. Each level/metric connected to a criterion acts as a 
useful value to assist decision-makers. Using the desirability curves approach, the experts 
need to evaluate related levels/metrics for each criterion (desirability matrix) while giving 
each metric a scaled quantitative value. This enables the normalization of the evaluation 
results by experts across all the criteria (Phan, 2013; Estep and Daim, 2016; Gibson and 






























What level of data management does this research center provide? 
No measures are taken to assure and maintain data security, privacy, governance, or ethics 
Initiatives and efforts are put into 1out of 4 (security, privacy, governance, ethics) 
Initiatives and efforts are put into 2 out of 4 (security, privacy, governance, ethics) 
Initiatives and efforts are put into 3 out of 4 (security, privacy, governance, ethics) 
Initiatives and efforts to assure and maintain data security, privacy, governance, and ethics exist 
Supporting Infrastructure 
What level of socio-technical infrastructure does the research center provide in managing and 
analysis of data and dissemination of knowledge? 
No socio-technical infrastructure to handle data management, analysis, dissemination, and 
integration of learned knowledge 
Socio-technical infrastructure for 1 out of 4 (data management, data analysis, knowledge 
dissemination, knowledge integration) 
Socio-technical infrastructure for 2 out of 4 (data management, data analysis, knowledge 
dissemination, knowledge integration) 
Socio-technical infrastructure for 3 out of 4 (data management, data analysis, knowledge 
dissemination, knowledge integration) 
Socio-technical infrastructure in place for management and analysis of data and dissemination and 
integration of learned knowledge 
Real-time Knowledge Access and Sharing 
Is the research center providing real-time data and knowledge access, sharing, and learning? 
No real-time data access and sharing capabilities in place 
Some real-time data capture, access, and sharing but no integration of learned knowledge 
Data capture, access, and sharing of real-time data but no integration of learned knowledge 
Real-time data and information capture, access, and sharing concurrent to the integration of learned 
knowledge 
User Experience 
What is the quality of user experience provided by the research center to its stakeholders 
(users)? 
Technologies and IT products are not user-friendly 
Technologies and IT products are somewhat user-friendly 
Technologies and IT products are designed with optimization of user experience in mind 
Technologies and IT products are designed and reviewed (periodically) with optimization of user 



















What is the level of stakeholder trust in the research center's initiatives and projects 
(continuous learning)? 
Not trusted by the overwhelming majority of stakeholders 
Trusted by the minority of stakeholders 
Trusted by half of the stakeholders 
Trusted by the majority of stakeholders 
Accessibility 
What is the level of benefit from and accessibility to new technologies? 
Stakeholders are not benefiting from the clinical and research advantages of the research center 
Only a minority of stakeholders are benefiting from the clinical and research advantages of the 
research center 
Half of the stakeholders are benefiting from the clinical and research advantages of the research 
center 
The majority of stakeholders are benefiting from the clinical and research advantages of the 
research center 
All stakeholders are benefiting from the clinical and research advantages of the research center 
Stakeholder Engagement 
What is the level of stakeholder engagement in research center’s projects and initiatives? 
Stakeholders are opposed to participating in the research center's continuous improvement and 
learning projects and initiatives 
Stakeholders are reluctant to participate in the research center's continuous improvement and 
learning projects and initiatives 
Some of the stakeholders are eager to participate in the research center's continuous improvement 
and learning projects and initiatives 
The majority of the stakeholders are eager to participate in the research center's continuous 
improvement and learning projects and initiatives 
All stakeholders are eager to participate in the research center's continuous improvement and 
learning projects and initiatives 
Talent Acquisition and Retention 
How is the research center performing in acquiring and retaining skilled and relevant 
talents? 
No acquisition and retention of skilled and diverse talent 
Acquisition of skilled and diverse talent only in some areas 
Acquisition and retention of skilled and diverse talent only in some areas 



























What level of leadership support is bolstering technology maturity and continuous learning in 
the research center? 
There is leadership opposition to technology maturity and organizational learning 
The leadership is indifferent to technology maturity and organizational learning 
The leadership provides some support to technology maturity and organizational learning 
The leadership provides good support and advocacy to technology maturity and organizational 
learning 
The leadership is enthusiastic about the support and advocacy of technology maturity and 
organizational learning 
Strategic Management 
What level of strategic management is being implemented in the research center? 
There is no strategic vision, plan, or management and implementation of technology maturity and 
organizational learning 
There are strategic vision and plan but no management and implementation of technology maturity 
and organizational learning 
There is some clear strategic vision/plan and management/implementation of technology maturity and 
organizational learning 
There is a clear and calculated strategic vision/plan and managed implementation of technology and 
organizational learning 
Culture and Transparency 
What level of organizational culture (in terms of maturity and learning) has been adopted by 
the employees of the research center? 
Organizational Inertia 
Support by the minority of employees 
Support by half of the employees 
Support by the majority of employees 
Governance 
What level of governance exists in the research center? 
No governance 
Simply documented governance with no communications among departments 
Documented and Updated governance in separate departments towards the management of inputs, 
structures, processes with goals of improving outcomes 
Documented and periodically updated governance with some communication among departments 
towards the management of inputs, structures, processes with goals of improving outcomes 
Central governance promoting an integrated approach/best practices towards the management of 
inputs, structures, processes to improve the outcome 
Training 
What level of training with goals of organizational maturity and continuous learning exists in 
the research center? 
There is no relevant or dedicated training in the research center 
There are some non-multidisciplinary informal trainings the research center 
There are some multidisciplinary informal trainings in the research center 
There are multidisciplinary formal trainings in the research center 

















What is the level of the research center's adherence to and compliance with 
standards and regulations? 
There is no compliance with existing regulations 
There is low compliance with existing regulations 
The health organization is somewhat compliant with existing relevant regulations 
The health organization is highly compliant with existing relevant regulations 
The health organization is completely compliant with existing relevant regulations 
Policy Preparedness and Adaption 
To what extent is the research center flexible and ready in responding and 
adapting to policy changes? 
The research center has no readiness plans in terms of response and adaptation to 
policy changes and only reacts post-change. 
The research center aspires to increase flexibility and preparedness for policy changes 
but has no plans for different scenarios yet. 
The research center has plans for different policy change scenarios in terms of 
readiness and adaptation. 
The research center is proactive in terms of readiness and adaptation to policy changes 
with a systematic plan which is periodically reviewed and modified. 
Privacy 
What level of privacy measures exists in the research center? 
No privacy measures, metrics, or procedures 
Privacy drove by regulatory framework including Ad-hoc vulnerability scanning, basic 
metrics and processes. 
Privacy protection is driven by the regulatory framework, risk management, IRBs, and 
processes 
Robust and continuous privacy protection driven by the regulatory framework, risk 
management, IRBs, and efficient metrics-based processes 
Informing Policy 
What level of policy informing power existing in the research center? 
Research center is not involved with informing policy 
Research center is involved with 1 out of 3 (participating in expert panels, providing 
evidence and comments regarding policies under consideration, securing contracts) 
Research center is involved with 2 out of 3 (participating in expert panels, providing 
evidence and comments regarding policies under consideration, securing contracts) 
Research center is involved by participating in expert panels, providing evidence and 













How well is the research center performing in terms of resource allocation and their alignment with 
technology maturity and continuous learning? 
Prioritization of resources are not aligned with technology maturity and continuous 
organizational learning 
Prioritization of resources are minimally aligned with technology maturity and continuous 
organizational learning 
Prioritization of resources are somewhat aligned with technology maturity and continuous 
organizational learning 
Prioritization of resources are highly aligned with technology maturity and continuous 
organizational learning 
Prioritization of resources are completely aligned with technology maturity and continuous 
organizational learning 
Funding and Mission Alignment 
What level of alignment exists between incentives and technology maturity and continuous 
organizational learning? 
Incentives and funding are not aligned with missions of technology maturity and continuous 
organizational learning 
Incentives and funding are minimally aligned with missions of technology maturity and 
continuous organizational learning 
Incentives and funding are somewhat aligned with missions of technology maturity and 
continuous organizational learning 
Incentives and funding are highly aligned with missions of technology maturity and 
continuous organizational learning 
Incentives and funding are completely aligned with missions of technology maturity and 
continuous organizational learning 
Cost Reduction 
What level of success has the research center had in cutting costs? 
The research center has had no success in cutting costs 
The research center has had success in cutting costs through layoffs and waste elimination  
The research center has had success in cutting costs as a result of waste eliminations with 
compromising quality 
The research center has had success in cutting costs as a result of waste eliminations 
without compromising quality 
The research center has had success in cutting costs as a result of increased maturity, 
learning, continuous improvement, and waste eliminations without compromising quality 
Financial Synergy with Policies and Priorities 
What level of financial synergy does the research center have with policies and priorities? 
The research center has had no success in meeting reimbursement programs’ goals or 
accessing government, foundation, and other grants 
The research center has had little success in meeting reimbursement programs’ goals or 
accessing government, foundation, and other grants 
The research center has had success in 1 out of 2 (meeting reimbursement programs’ goals, 
accessing government, foundation, and other grants) 
The research center is successful in meeting reimbursement programs’ goals and accessing 





Table 32:Data Management Metrics Value 
Data Management Desirability 
No measures are taken to assure and maintain data security, privacy, 
governance, or ethics 
0.00 
Initiatives and efforts are put into 1out of 4 (security, privacy, governance, 
ethics) 
11.36 
Initiatives and efforts are put into 2 out of 4 (security, privacy, governance, 
ethics) 
36.82 
Initiatives and efforts are put into 3 out of 4 (security, privacy, governance, 
ethics) 
73.91 
Initiatives and efforts to assure and maintain data security, privacy, governance, 




Figure 39: Data Management Metrics Value 
 
Table 33: Supporting Infrastructure Metrics Value 
Supporting Infrastructure Desirability 
No socio-technical infrastructure to handle data management, analysis, 
dissemination, and integration of learned knowledge 
0.00 
Socio-technical infrastructure for 1 out of 4 (data management, data analysis, 
knowledge dissemination, knowledge integration) 
15.55 
Socio-technical infrastructure for 2 out of 4 (data management, data analysis, 
knowledge dissemination, knowledge integration) 
37.55 
Socio-technical infrastructure for 3 out of 4 (data management, data analysis, 
knowledge dissemination, knowledge integration) 
70.91 
Socio-technical infrastructure in place for management and analysis of data and 








Figure 40: Supporting Infrastructure Metrics Value 
 
Table 34: Real-Time Knowledge Access and Sharing Metrics Value 
Real-Time Knowledge Access and Sharing Desirability 
No real-time data access and sharing capabilities in place 0.00 
Some real-time data capture, access, and sharing but no integration of learned 
knowledge 
25.55 
Data capture, access, and sharing of real-time data but no integration of learned 
knowledge 
59.18 
Real-time data and information capture, access, and sharing concurrent to 












Table 35: User Experience Metrics Value 
User Experience Desirability 
Technologies and IT products are not user-friendly 0.00 
Technologies and IT products are somewhat user-friendly 23.64 
Technologies and IT products are designed with optimization of user experience in 
mind 
72.82 
Technologies and IT products are designed and reviewed (periodically) with 




Figure 42:User Experience Metrics Value 
 
Table 36: Stakeholder Trust Metrics Value 
Stakeholder Trust Desirability 
Not trusted by the overwhelming majority of stakeholders 0.00 
Trusted by the minority of stakeholders 11.36 
Trusted by half of the stakeholders 45.73 






Figure 43: Stakeholder Trust Metrics Value 
 
Table 37: Accessibility Metrics Value 
Accessibility Desirability 
Stakeholders are not benefiting from the clinical and research advantages of the 
research center 
0.00 
Only a minority of stakeholders are benefiting from the clinical and research 
advantages of the research center 
14.45 
Half of the stakeholders are benefiting from the clinical and research advantages 
of the research center 
47.00 
The majority of stakeholders are benefiting from the clinical and research 
advantages of the research center 
81.27 















Table 38: Stakeholder Engagement Metrics Value 
Stakeholder Engagement Desirability 
Stakeholders are opposed to participate in research center's continuous 
improvement and learning projects and initiatives 
0.00 
Stakeholders are reluctant to participate in research center's continuous 
improvement and learning projects and initiatives 
6.09 
Half of the stakeholders are eager to participate in research center's continuous 
improvement and learning projects and initiatives 
49.18 
Majority of the stakeholders are eager to participate in research center's 
continuous improvement and learning projects and initiatives 
83.09 
All stakeholders are eager to participate in research center's continuous 




Figure 45: Stakeholder Engagement Metrics Value 
 
Table 39: Talent Acquisition and Retention Metrics Value 
Talent Acquisition and Retention Desirability 
No acquisition and retention of skilled and diverse talent 0.00 
Acquisition of skilled and diverse talent only in some areas 27.73 
Acquisition and retention of skilled and diverse talent only in some areas 55.73 





Figure 46: Talent Acquisition and Retention Metrics Value 
Table 40: Leadership Metrics Value 
Leadership Desirability 
There is leadership opposition to technology maturity and organizational learning 0.09 
The leadership is indifferent to technology maturity and organizational learning 5.91 
The leadership provides some support to technology maturity and organizational 
learning 
29.09 
The leadership provides good support and advocacy to technology maturity and 
organizational learning 
74.09 
The leadership is enthusiastic about the support and advocacy of technology maturity 











Table 41: Strategic Management Metrics Value 
Strategic Management Desirability 
There is no strategic vision, plan, or management and implementation of technology 
maturity and organizational learning 
0.00 
There are strategic vision and plan but no management and implementation of 
technology maturity and organizational learning 
15.91 
There is some clear strategic vision/plan and management/implementation of 
technology maturity and organizational learning 
59.00 
There is a clear and calculated strategic vision/plan and managed implementation of 




Figure 48: Strategic Management Metrics Value 
 
Table 42: Culture and Transparency Metrics Value 
Culture and Transparency Desirability 
Organizational Inertia 0.45 
Support by minority of employees 17.36 
Support by half of employees 51.45 






Figure 49: Culture and Transparency Metrics Value 
 
Table 43: Training Metrics Value 
Training Desirability 
There is no relevant or dedicated training in the research center 0.00 
There are some non-multidisciplinary informal trainings the research center 15.27 
There are some multidisciplinary informal trainings in the research center 40.36 
There is multidisciplinary formal training in the research center 76.36 


















Table 44: Governance Metrics Value 
Governance Desirability 
No governance 0.00 
Simply documented governance with no communications among departments 13.00 
Documented and Updated governance in separate departments towards the 
management of inputs, structures, processes with goals of improving outcomes 
44.00 
Documented and periodically updated governance with some communication 
among departments towards the management of inputs, structures, processes 
with goals of improving outcomes 
71.64 
Central governance promoting an integrated approach/best practices towards 




Figure 51: Governance Metrics Value 
Table 45: Standards Compliance Metrics Value 
Standards Compliance Desirability 
There is no compliance with existing regulations 0.00 
There is low compliance with existing regulations 10.27 
The research center is somewhat compliant with existing relevant regulations 32.09 
The research center is highly compliant with existing relevant regulations 83.64 





Figure 52: Standards Compliance Metrics Value 
Table 46: Policy Preparedness and Adaptation Metrics Value 
Policy Preparedness and Adaptation Desirability 
The research center has no readiness plans in terms of response and adaptation 
to policy changes and only reacts post-change. 
0.00 
The research center aspires to increase flexibility and preparedness for policy 
changes but has no plans for different scenarios yet. 
16.18 
The research center has plans for different policy change scenarios in terms of 
readiness and adaptation. 
63.27 
The research center is proactive in terms of readiness and adaptation to policy 













Table 47: Privacy Metrics Value 
Privacy Desirability 
No privacy measures, metrics, or procedures 0.00 
Privacy driven by regulatory framework including Ad-hoc vulnerability 
scanning, basic metrics and processes. 
27.91 
Privacy protection is driven by the regulatory framework, risk management, 
IRBs, and processes 
73.73 
Robust and continuous privacy protection driven by the regulatory framework, 




Figure 54: Privacy Metrics Value 
 
Table 48: Informing Policy Metrics Value 
Informing Policy Desirability 
The research center is not involved with informing policy 0.00 
The research center is involved with 1 out of 3 (participating in expert panels, 
providing evidence and comments regarding policies under consideration, 
securing contracts) 
35.00 
The research center is involved with 2 out of 3 (participating in expert panels, 
providing evidence and comments regarding policies under consideration, 
securing contracts) 
73.91 
The research center is involved by participating in expert panels, providing 








Figure 55: Informing Policy Metrics Value 
 
Table 49:Resource Allocation Metrics Value 
Resource Allocation Desirability 
Prioritization of resources are not aligned with technology maturity and 
continuous organizational learning 
0.00 
Prioritization of resources are minimally aligned with technology maturity 
and continuous organizational learning 
11.82 
Prioritization of resources are somewhat aligned with technology maturity 
and continuous organizational learning 
39.45 
Prioritization of resources are highly aligned with technology maturity and 
continuous organizational learning 
82.27 
Prioritization of resources are completely aligned with technology maturity 













Table 50: Funding and Mission Alignment Metrics Value 
Funding and Mission Alignment Desirability 
Incentives and funding are not aligned with missions of technology maturity and 
continuous organizational learning 
0.00 
Incentives and funding are minimally aligned with missions of technology 
maturity and continuous organizational learning 
10.73 
Incentives and funding are somewhat aligned with missions of technology 
maturity and continuous organizational learning 
44.55 
Incentives and funding are highly aligned with missions of technology maturity 
and continuous organizational learning 
81.91 
Incentives and funding are completely aligned with missions of technology maturity and 




Figure 57: Funding and Mission Alignment Metrics Value 
 
Table 51: Cost Reduction Metrics Value 
Cost Reduction Desirability 
Research center has had no success in cutting costs 0.00 
Research center has had success in cutting costs through layoffs and waste 
elimination 
14.64 
Research center has had success in cutting costs as a result of waste 
eliminations with compromising quality 
26.64 
Research center has had success in cutting costs as a result of waste 
eliminations without compromising quality 
77.73 
Research center has had success in cutting costs as a result of increased 







Figure 58: Cost Reduction Metrics Value 
Table 52: Financial Synergy with Policies and Priorities Metrics Value 
Financial Synergy with Policies and Priorities Desirability 
Research center has had no success in meeting reimbursement programs’ goals 
or accessing government, foundation, and other grants 
0.00 
Research center has had little success in meeting reimbursement programs’ goals 
or accessing government, foundation, and other grants 
11.00 
Research center has had success in 1 out of 2 (meeting reimbursement programs’ 
goals, accessing government, foundation, and other grants) 
70.82 
Research center is successful in meeting reimbursement programs’ goals and 















6.4. Model Quantification Results 
The next part is quantifying the criteria and perspectives based on the pairwise 
comparison done by the expert panel in the ETM HDM tool software. Each expert 
performed the pairwise comparisons between the perspective and then each of the 
underlying criteria for the respective perspective. The results were partly generated by 
ETM HDM software and partly by manual calculation in Microsoft Excel in order to 
obtain a better breakdown of the results and validation measurements. The perspective 





Table 53: Perspective Weights 
Perspectives Mean % Ranking 
Technology 0.200 20 3 
Social 0.217 22 2 
Organizational 0.226 23 1 
Regulatory 0.181 18 4 
Financial 0.175 17 5 






Figure 60: Perspective Weights 
 
Table 54: Technology Criteria Local Weights 









 Data Management 0.264 27 
Supporting Infrastructure 0.223 22 
Real-time Knowledge Access and Sharing 0.275 28 









































Stakeholder Trust 0.226 23 
Accessibility 0.196 20 
Stakeholder Engagement 0.295 30 
Talent Acquisition and Retention 0.281 28 
 
 
Figure 62: Social Criteria Local Weights 
 
 
Table 56: Organizational Criteria Local Weights 












Leadership 0.188 19 
Strategic Management 0.238 24 
Culture and Transparency 0.200 20 
Training 0.191 19 














Figure 63: Organizational Criteria Local Weights 
 
 
Table 57: Regulatory Criteria Local Weights 








Standards Compliance 0.240 24 
Policy Preparedness and Adaptation 0.289 29 
Privacy 0.232 23 
Informing Policy 0.237 24 
 




























Table 58: Financial Criteria Local Weights 








Resource Allocation 0.217 22 
Funding and Mission Alignment 0.302 30 
Cost Reduction 0.190 19 




Figure 65: Financial Criteria Local Weights 
 
Table 59: Inconsistency and Disagreement Results 
Validation Test Value Threshold 
Disagreement 0.020 <=0.1 
Inconsistency 0.017 <=0.1 
 
As it can be seen from the table above the inconsistency for both perspective and criteria 
are in the acceptable ratio being 0.013 and 0.017 respectively which are below 10% as 
Kocaoglu established in 1983 as the acceptable threshold for the inconsistency in HDM 







Financial Synergy with Policies and Priorities





Moreover, the disagreement measure is in the acceptable range (0.020) (below 10% (0.1) 
(Chan, 2013; Estep, 2017; Shaygan et al., 2017)).  The inconsistency and disagreement 
thresholds have been used as indicators for validating the HDM results according to the 
literature (Iskin, 2014; Abbas, 2016; Estep, 2017; Shaygan, Ozdemir-Gungor, D. Kutgun 
and Daneshi, 2017). 
By looking at the universal weights (each criterions’ weights in the context of the whole 
model), “Stakeholder Engagement” is the criteria with the highest weight as determined 
by the expert panel followed by “Talent Acquisition and Retention”, and “Strategic 
Management” with 0.064 (6.4%), 0.060 (6.0 %), and 0.057 (5.7%) respectively. The 
global weights for the criteria and the sorted global weights are shown in Figure 67-69. 
Based on the results of the experts’ pairwise comparisons, the Organizational perspective 
plays the most important role in technology management in research centers with 23% 
followed by the social aspect with 22%. By taking a deeper look into these two 
perspectives in the criteria weights (local weights), we can see that “Strategic 
Management” plays a very important role (24% of the organizational perspective) in the 
maturity of research centers. This is aligned with the literature as it stresses the importance 
of strategic management in healthcare systems maturity and implementation and adoption 
of continuous learning (Bernstein et al., 2015; Brooks, El-Gayar and Sarnikar, 2015; 
Demir, 2018) (This result can alleviate the gap that was mentioned the gap analysis 
section about lack of literature on literature focusing mainly or solely on the management 
side of the healthcare system maturity, continuous learning, and its socio-technological 




and transparency followed by training take place with 20% and 19% respectively. As for 
culture and transparency which is defined as “The extent to which a research center’s 
employees have adopted and are committed to a culture of continuous learning and 
practice transparency to safeguard stakeholder trust in order to improve the health of 
individuals, communities, and diverse populations.”, the resulted weight is in agreement 
with the literature demonstrating this criterion as an important factor on the maturity of 
healthcare organizations (Institute of Medicine (IOM), 2007; Saunders and Smith, 2013; 
Bernstein et al., 2015; Curcin, 2016; Kraft et al., 2017). Examples of the importance of 
training can be seen in health organizations training teams to train health medical and 
nursing students and residents, together in cross-functional teams to enforce a more 
effective transformation culture (Lynch et al., 2000; Gopee, 2002; Grossmann, Goolsby, 
Olsen and McGinnis, 2011).  
In terms of the Social perspective, Stakeholders’ engagement was found to be the most 
important one with 30% of the local weight in the social aspect. This aligns with the 
literature emphasizing the importance of healthcare organizations ability to engage 
stakeholders (patients, providers, payers, policymaker, purchasers, and families) with 
continuous learning and maturity initiatives with goals of improving patient satisfaction, 
quality of care, reducing the costs (Mandl et al., 2014; Price-Haywood, 2015; Kraft et al., 
2017). Closely following is the talent acquisition and retention with 28%. 
From the regulatory perspective, “Policy Preparedness and Adaptation” takes the top spot 
with 29%. As expected, this criterion is very important as it is related to research centers’ 




legislations, and policies in terms of anticipation and readiness. This readiness and 
anticipation can be in terms of resources, policies, strategies, and management. Moreover, 
side by side to complying with policies and regulations (24%), academic health research 
centers can have a significant impact on research and evidence-informed health policy 
through taking part in new collaborative models of research (24%). In the second place, 
due to the diffusion of meaningful use at state and federal levels, compliance with 
standards is a big part of health organizations endeavors in continuous improvement and 
maturity as the Quality Payment Program creates a new framework for rewarding 
organizations/clinicians who provide higher-value care (HealthIT.gov, 2018).  The close 
range of percentages in perspectives such as regulatory shows how important each of the 
criteria is for pursuing goals of maturity and continuous learning. As an example, 
although the privacy aspect holds 23% of the local weight in this perspective (lowest 
among the four), is crucial for every research center. In the world of healthcare, data 
scientist and business intelligence professionals should guarantee the privacy of data such 
as demographic information, medical histories, test and laboratory results, mental health 
conditions, insurance information among others when analyzing, visualizing, or 
publishing protected health data. For this reason, for actions such as data analysis, 
visualization, creating predictive models, etc., there is a need for departments to request 
those specific protected data/database/servers, etc. Again, as there is a good chance that 
the data used in healthcare organizations is PHI data, it is critical for health organizations 
or research centers to make sure that the privacy of data such as demographic information, 
medical histories, test and laboratory results, mental health conditions, insurance 




attacks. Penalties for HIPAA violations are tiered which is shown in Figure 66. In 
conclusion in healthcare organizations, especially the ones which have the aim of 
increasing their technology management maturity through continuous learning and 
constant transformation of data into knowledge, privacy plays a pivotal part and a 
backbone to a functioning knowledge-producing health system. 
 
Figure 66: HIPAA Violation Penalty Tiers (compliancy-group, 2018)   
In the Financial perspective, “Funding and Mission Alignment” was selected as the most 
important criterion with 30% followed very closely by “Financial Synergy with Policies 
and Priorities with 29%. Based on these results, the alignment of incentives and funding 
with the encouragement of continuous learning and technology maturity and rewarding 
high care value is important while there is a need for research centers to invest time and 
skills into accessing funds such as grants and ensuring that they meet reimbursement 
programs’ goals. 
Last but not least, in the Technology Perspective, Real-time Knowledge Access and 
Sharing was selected as the most important criterion with 28%. This criterion was mined 
from the literature review and it is significant especially in the case where the focus of 




criterion was defined as “Data systems and tools used to capture, share, and integrate data, 
information, and knowledge gained from biomedical, clinical, and managerial research 
into the organization in real-time”  (Saunders and Smith, 2013; Bernstein et al., 2015; 
Cahan and Cimino, 2017; Morain, Kass and Grossmann, 2017). The advances in 
technology (tools and data systems) which expedite the transformation of data into 
knowledge can bolster this element. In healthcare organizations, since many data 
elements are patient-related, the access and sharing of these data can be tricky and more 
research into the opportunities and implications caused by this criterion should be studied 
further. Protected health information (PHI), also known as personal health information, 
generally refers to demographic information, medical histories, test and laboratory 
results, mental health conditions, insurance information, and other data that a healthcare 
professional collects to identify an individual and determine appropriate care (Rouse, 
2018). It should be stressed that a criterion such as data management (27%) and 
supporting infrastructure (22%) are critical to the real-time knowledge access and sharing 




















7.  Case Studies 
 
Following the validation, and quantification of the model and its desirability curve/state 
values, the model is now applied to actual case studies in order to showcase the practical 
side of the model. Two research centers in the United States were selected to take part in 
this part of the research. The goal of this section is to show how the model can be applied 
to real-life health research centers, pinpoint their strengths and opportunities, and look at 
some ways that they can improve in terms of technology management maturity and 
continuous learning. Experts within each of these two health research centers helped with 
the quantification of the desirability scores based on their centers’ performance in the 
relative criteria. Following this, the desirability scores for each criterion is multiplied by 
the global weight of that criterion and the sum of these calculations for all of the criteria 
would result in the center’s maturity score. This score is important in the sense of the 
dialogues and initiatives it starts within the organization with goals of improving the 
center’s maturity and continuous learning. These organizations will remain anonymous 
to respect the privacy of these centers. Both centers are research centers within university 
hospitals. 
Meetings occurred with the people in these centers that had sufficient knowledge about 
their centers’ performance in these specific criteria. The metrics within each criterion 
helped these experts to be able to quantify where their center stands. These experts 
included titles such as research center director and project managers. 
The research gaps, questions, and goals were explained during these meetings and the 




and their values were given to them in advance as well in order to give them more time 
to think about them concerning the centers they are involved in. Figure 69 shows the way 
these experts could quantify each criterion’s desirability value/state. 
 
 
Figure 70:Snapshot of the Desirability Value Selection as a Part of the case study for testing the results. 





Table 60: Case Study I Results 
 
 
The second studied project’s maturity score and desirability values is shown in the table 
below: 
Perspective P Weight Criteria Local W Global W D score Score= GW*D Comments
Data Management 0.264 0.052 36.82 1.904
Supporting Infrastructure 0.223 0.047 37.55 1.748
Real-time Knowledge Access and Sharing 0.275 0.054 25.55 1.392
User Experience 0.235 0.047 72.82 3.390
Stakeholder Trust 0.226 0.052 45.73 2.381
Accessibility 0.196 0.042 47 1.961
Stakeholder Engagement 0.295 0.064 49.18 3.154
Talent Acquisition and Retention 0.281 0.060 55.73 3.363
Leadership 0.188 0.043 74.09 3.168
Strategic Management 0.238 0.057 15.91 0.900
Culture and Transparency 0.200 0.046 51.45 2.360
Training 0.191 0.042 40.36 1.698
Governance 0.181 0.040 13 0.524
Standards Compliance 0.240 0.045 83.64 3.778
Policy Preparedness and Adaptation 0.289 0.052 0 0.000
Privacy 0.232 0.043 73.73 3.178
Informing Policy 0.237 0.040 35 1.388
Resource Allocation 0.217 0.038 39.45 1.483
Funding and Mission Alignment 0.302 0.055 39.45 2.163
Cost Reduction 0.190 0.032 44.55 1.444
Financial Synergy with Policies and 
Priorities















Table 61: Case Study II Results 
 
 
As can be seen from the table above, the maturity scores were calculated at 44.89 and 
32.27 for cases I and II, respectively. This score, however, on its own is not the value of 
this model. This initially calculated score can serve as a reference point for improving the 
maturity of this organization/group. By referring to these values, organizations can get a 
sense of self-awareness of where they are and what needs to be done in order for them to 
increase their technology management maturity and continuous learning focus. 
7.1. Strengths and Opportunities 
In this section, the strengths, and opportunities for the two studied cases will be briefly 
reviewed. 
 
Perspective P Weight Criteria Local W Global W D score Score= GW*D
Data Management 0.264 0.052 73.91 3.823
Supporting Infrastructure 0.223 0.047 37.55 1.748
Real-time Knowledge Access and Sharing 0.275 0.054 25.55 1.392
User Experience 0.235 0.047 72.82 3.390
Stakeholder Trust 0.226 0.052 45.73 2.381
Accessibility 0.196 0.042 47 1.961
Stakeholder Engagement 0.295 0.064 49.18 3.154
Talent Acquisition and Retention 0.281 0.060 27.73 1.673
Leadership 0.188 0.043 29.09 1.244
Strategic Management 0.238 0.057 15.91 0.900
Culture and Transparency 0.200 0.046 17.36 0.796
Training 0.191 0.042 15.27 0.642
Governance 0.181 0.040 13 0.524
Standards Compliance 0.240 0.045 83.64 3.778
Policy Preparedness and Adaptation 0.289 0.052 63.27 3.294
Privacy 0.232 0.043 27.91 1.203
Informing Policy 0.237 0.040 35 1.388
Resource Allocation 0.217 0.038 39.45 1.483
Funding and Mission Alignment 0.302 0.055 39.45 2.163
Cost Reduction 0.190 0.032 44.55 1.444
Financial Synergy with Policies and 
Priorities










7.1.1. Case Study I 
In this case, study, based on the obtained results, the performance in the social and 
financial perspectives are higher compared to the technology and organizational 
perspectives. There is a particularly high improvement for this center in terms of criteria 
such as policy preparedness and adaptation and governance. At the same time, this center 
is performing well based on financial synergy with policies and priorities as they have a 
good record with accessing government and state grants for their research. Moreover, 
their products and research conduct tools are designed with user-friendliness in mind 
leading to a good performance from the user experience criterion. Their leadership 
provides good support and advocacy for goals of continuous learning and increasing 
organizational maturity. The leadership in this center has even encouraged the use of 
third-party firms to help with the assessment and improvement of organizational and 
technology maturity in order to navigate the complex and multi-disciplinary nature of 
healthcare organizations to mitigate challenges in terms of process and people 
management, and information technology and systems. 
One of the biggest opportunities for this center is to focus on its strategic management. 
Currently, they are interested and aspire to strengthen their strategic management and 
have a vision of positioning themselves as a top research center in their field in terms of 
state and federal recognition. They are, however, lacking in an action plan and a roadmap 
to take them from where they are to where they want to be. Initiatives to improve the 
implementation, realization, and management of these steps can increase the technology 




criterion based on the model’s outputs. Setting strategic plans for different scenarios in 
cases of policy changes can improve the center’s policy preparedness and adaptation as 
well. 
Another field that this center can increase its maturity score is through increasing its 
stakeholder trust and engagement. Scientists, clinicians, funders, journals, academics, 
regulators, and professional societies can make research more trustworthy and useful 
through collaborations (Strech, Weissgerber and Dirnagl, 2020). As it can be seen 
improvement in the strategic management section can improve the social aspect of this 
research center through increased trustworthiness and engagement. Moreover, it is 
important for research centers and healthcare organizations to realize that merely 
providing access may not be enough, and efforts are needed to be in place to earn the trust 
of communities (trust in vaccine racial and ethnic minorities as an example (Sinha, 2021). 
From the patient's side as one of the stakeholders, some of the engagement hesitancy 
regarding accessing healthcare or partaking in research can be imputed to lack of 
information, fear of discrimination, and legal problems (such as undocumented 
immigrants) which can be mitigated through ensuring that sufficient, transparent, and 
comprehensive information about the research or health services are provided and are 
accessible to patients. As it was discussed in the literature review section of this research 
the United States is facing an increase in racial, ethnic, and socio-economic diversity 
which makes these issues even more important. Health institutions should commit to 
identifying ways to make sure that research learnings are used to improve care for all the 




knowledge from their research. When the stakeholders such as patients are ensured that 
their contribution and engagement will lead to findings that will benefit them and their 
community, they will deem the research center more worthy of their trust and engagement 
(Morain, Kass and Faden, 2018). 
Lastly addressing their governance shortages can improve their maturity scores by having 
documented and periodically updated governance and stewardship in the research center. 
Moreover, engaging the right stakeholders, being on the same page in terms of objectives, 
aligning incentives, engage in continuous improvement, and strategic management can 
improve the governance of the center as it can set the grounds for better decision making, 
resource allocation, and prioritization (LeSueur, 2017). 
Here we will simulate the model to see what will happen if the organization addresses 
some of the opportunities explained here. Improvements in strategic management, 
governance, policy preparedness, while improving on their stakeholder trust and 
engagement are provided to mitigate the center’s weaker points while improving on some 
opportunities. The results increase the maturity score to almost 58 which is around 14 








Table 62: Recommended Improvements for Case Study I Simulation I 
Criteria Potential Improvement Action 
Stakeholder Trust 
Increasing the trustworthiness of the research center (majority 
trusting). This trustworthiness can increase through research 
results, dissemination, transparency, informing policy, 
partnerships, … 
Stakeholder Engagement 
Planning and implementation of initiatives aimed at increasing 
the engagement of stakeholders. The stakeholders can range from 
patients, providers, payors, policymaker, purchasers, families. 
Policy Preparedness and 
Adaptation 
The research center has plans for different policy change 
scenarios in terms of readiness and adaptation. 
Strategic Management 
Developing clear strategic vision/plan and 
management/implementation of technology maturity and 
organizational learning 
Governance 
Documented and periodically updated governance with some 
communication among departments towards management of 
inputs, structures, processes with goals of improving outcomes 
 
Table 63:Case Study I, Simulation I 
 
In another simulation, only the top five weighted criteria are improved by one curve value 
and as it can be seen it will take the maturity score to from 45 to 55.5 (23% increase). 
Some of the proposed improvements for simulation II are shown in Table 64. 
Perspective P Weight Criteria Local W Global W D score Score= GW*D
Data Management 0.264 0.052 36.82 1.904
Supporting Infrastructure 0.223 0.047 37.55 1.748
Real-time Knowledge Access and Sharing 0.275 0.054 25.55 1.392
User Experience 0.235 0.047 72.82 3.390
Stakeholder Trust 0.226 0.052 99.55 5.183
Accessibility 0.196 0.042 47 1.961
Stakeholder Engagement 0.295 0.064 83.09 5.329
Talent Acquisition and Retention 0.281 0.060 55.73 3.363
Leadership 0.188 0.043 74.09 3.168
Strategic Management 0.238 0.057 59 3.337
Culture and Transparency 0.200 0.046 51.45 2.360
Training 0.191 0.042 40.36 1.698
Governance 0.181 0.040 71.64 2.890
Standards Compliance 0.240 0.045 83.64 3.778
Policy Preparedness and Adaptation 0.289 0.052 63.27 3.294
Privacy 0.232 0.043 73.73 3.178
Informing Policy 0.237 0.040 35 1.388
Resource Allocation 0.217 0.038 39.45 1.483
Funding and Mission Alignment 0.302 0.055 39.45 2.163
Cost Reduction 0.190 0.032 44.55 1.444
Financial Synergy with Policies and 
Priorities










Table 64:Recommended Improvements for Case Study I Simulation II 
Criteria Potential Improvement Action 
Real-time Knowledge Access 
and Sharing 
Initiatives and projects towards enabling of data capture, access, 
and sharing of real-time data. There is still room for improvement 
towards the integration of learned knowledge. 
Stakeholder Engagement 
Planning and implementation of initiatives aimed at increasing 
the engagement of stakeholders. The stakeholders can range from 
patients, providers, payors, policymaker, purchasers, families. 
Talent Acquisition and 
Retention 
Working with other departments and leaders to find diverse skills, 
looking internally for candidates, assigning mentors, recognition 
programs, and supporting advancement opportunities. 
Strategic Management 
Planning and implementation of initiatives aimed at increasing 
the engagement of stakeholders. The stakeholders can range from 
patients, providers, payors, policymaker, purchasers, families. 
Financial Synergy with Policies 
and Priorities 
Initiatives aiming at grants (training, grants writing workshops, 
partnerships…) or reimbursement programs and incentives 
(closely monitoring the metrics and planning for hitting the 
goals). 
 
Table 65: Case Study I, Simulation II 
 
As it was shown in the simulations, it is important to not only focus on the high weighted 
criteria based on the model, but it is also important to address the weakest areas in the 
research center to reach a higher maturity score. In this model especially, since the criteria 
Perspective P Weight Criteria Local W Global W D score Score= GW*D
Data Management 0.264 0.052 36.82 1.904
Supporting Infrastructure 0.223 0.047 37.55 1.748
Real-time Knowledge Access and Sharing 0.275 0.054 59.18 3.224
User Experience 0.235 0.047 72.82 3.390
Stakeholder Trust 0.226 0.052 45.73 2.381
Accessibility 0.196 0.042 47 1.961
Stakeholder Engagement 0.295 0.064 83.09 5.329
Talent Acquisition and Retention 0.281 0.060 100 6.034
Leadership 0.188 0.043 74.09 3.168
Strategic Management 0.238 0.057 59 3.337
Culture and Transparency 0.200 0.046 51.45 2.360
Training 0.191 0.042 40.36 1.698
Governance 0.181 0.040 13 0.524
Standards Compliance 0.240 0.045 83.64 3.778
Policy Preparedness and Adaptation 0.289 0.052 0 0.000
Privacy 0.232 0.043 73.73 3.178
Informing Policy 0.237 0.040 35 1.388
Resource Allocation 0.217 0.038 39.45 1.483
Funding and Mission Alignment 0.302 0.055 39.45 2.163
Cost Reduction 0.190 0.032 44.55 1.444
Financial Synergy with Policies and 
Priorities










weights are closer to each other, this becomes more important. At the same time, it shows 
how connected are many of these criteria and addressing some may bolster other criteria 
as well (the case of stakeholder trust and engagement or strategic management and policy 
preparedness). The decision makers need to initiate conversations based on the results of 
the model when creating a roadmap as the model can give them a better sense of 
organizational self-awareness of where they, where they want to be, and how to better get 
there. 
 
7.1.2. Case Study II 
In this case, study, based on the obtained results, this center is performing with less 
success in criteria such as financial synergy with policies and priorities, privacy, policy 
preparedness, and talent acquisition and retention, and with their organizational criteria 
in general. This research center can increase its maturity score by starting projects and 
improvement initiatives around training, governance, and strategic management. The 
creation of routine multidisciplinary training in the research center around continuous 
learning and encouraging its culture not only will improve the center's curve/state value 
on training but also it will potentially improve it in the culture and transparency section. 
From another aspect, training around grant writing and grant writing seminars can 
increase the center’s success in terms of financial synergy with policies and priorities. 
Financial synergy with funding and policies in this center can increase with initiatives 
aiming at grants or reimbursement programs and incentives. As an example, the Oregon 
Health Authority is using quality health metrics to show how well Coordinated Care 




health disparities, and curbing the rising cost of health care in different areas such as 
immunization, depression screening, drug, and alcohol use, and diabetes among others 
(Oregon Health Authority, 2021). When participating health organizations meet certain 
thresholds on specific quality measures, they will be eligible for incentives. These 
different quality measures are around different data sources, patient populations, and have 
different measure stewards. Health organizations and centers aiming for any of these 
measure incentives can plan to reach the thresholds through relevant strategies and 
initiatives. As an example, for the childhood immunization status quality measures, 
initiatives such as checking immunization records at each visit, using benchmark report 
in ALERT data system to monitor the immunization rates for all patients, scheduling the 
next well visit before the patient leaving the office, implementing a well-visit 
reminder/recall system, and immunizing as part of a sick visit in order to improve that 
measure. Another example may be improving the depression screening and follow-up 
measure by screening patients for depression at least once a year with standardize 
depression screening tools and capturing structured data in their electronic health records 
(Wooden, 2021). Although these kinds of initiatives are more common in hospitals and 
health centers, health research centers may find the relevant reimbursement programs and 
plan to meet the incentive thresholds. 
In terms of talent acquisition and retention, this research center can improve its 
performance by strengthening the culture and reputation based on the values and missions 
of the center. Some of the practices within healthcare organizations for improving 




diverse skills, looking internally for candidates, assigning mentors, recognition programs, 
and supporting advancement opportunities. 
In general, based on the organizational perspective performance of this research, more 
excitement from the leadership and management can lead to improvements in this section 
while encouraging planning and vision for strategic management. These actions can 
significantly improve the center’s outlook on the culture of continuous improvement and 
learning. 
The simulation below will look at the results of maximizing the top highest-ranking 
criteria for this research center. As it can be seen, the maturity score increases by around 
54% alone when the top 5 criteria are maximized (maturity score of 39 to almost 60). 




Perspective P Weight Criteria Local W Global W D score Score= GW*D
Data Management 0.264 0.052 73.91 3.823
Supporting Infrastructure 0.223 0.047 37.55 1.748
Real-time Knowledge Access and Sharing 0.275 0.054 100 5.448
User Experience 0.235 0.047 72.82 3.390
Stakeholder Trust 0.226 0.052 45.73 2.381
Accessibility 0.196 0.042 47 1.961
Stakeholder Engagement 0.295 0.064 100 6.414
Talent Acquisition and Retention 0.281 0.060 100 6.034
Leadership 0.188 0.043 29.09 1.244
Strategic Management 0.238 0.057 100 5.655
Culture and Transparency 0.200 0.046 17.36 0.796
Training 0.191 0.042 15.27 0.642
Governance 0.181 0.040 13 0.524
Standards Compliance 0.240 0.045 83.64 3.778
Policy Preparedness and Adaptation 0.289 0.052 63.27 3.294
Privacy 0.232 0.043 27.91 1.203
Informing Policy 0.237 0.040 35 1.388
Resource Allocation 0.217 0.038 39.45 1.483
Funding and Mission Alignment 0.302 0.055 39.45 2.163
Cost Reduction 0.190 0.032 44.55 1.444










Table 67: Recommended Improvements for Case Study II Simulation I 
Criteria Potential Improvement Action 
Real-time Knowledge Access 
and Sharing 
Real-time data and information capture, access, and sharing 
concurrent to integration of learned knowledge 
Stakeholder Engagement 
Planning and implementation of initiatives aimed at increasing 
the engagement of stakeholders. The stakeholders can range from 
patients, providers, payors, policymaker, purchasers, families. 
Talent Acquisition and 
Retention 
Working with other departments and leaders to find diverse skills, 
looking internally for candidates, assigning mentors, recognition 
programs, and supporting advancement opportunities. 
Strategic Management 
Planning and implementation of initiatives aimed at increasing 
the engagement of stakeholders. The stakeholders can range from 
patients, providers, payors, policymaker, purchasers, families. 
Financial Synergy with Policies 
and Priorities 
Initiatives aiming at grants (training, grants writing workshops, 
partnerships…) or reimbursement programs and incentives 
(closely monitoring the metrics and planning for hitting the 
goals). 
 
It is important to note that even by achieving the maximum curve values for the five top 
factors in the model, case study II is still far from the desired 100 points. Two lessons can 
be learned from this: 
• As mentioned in the first case study, it is not sufficient to focus solely on the most 
important criteria and expect to achieve excellence in the whole process. This is 
even more important in this model and in the world of healthcare where criteria 
are more connected and are closer to each other in terms of weights in the model 
output. 
• The model can be seen as a maturity model, as it shows the maximum level of 
performance for each factor as the most desirable outcome. Reaching the 
maximum level of curve value for every single criterion may not be feasible, 
realistic, or even worthwhile (in terms of resources and efforts) for research 




research centers in terms of leading and guiding them towards continuous 
improvement and learning. 
It is important to note that this model assists decision makers in their decision-making 
process and it should not be used as the sole decision-making factor. Each research center 
should have discussion and dialogues based on the results of this model and choose the 
path and create the roadmap they see to be the best fitting based on the research center’s 
resources, improvements’ feasibility, and other unique factors pertaining to that specific 
healthcare research center. This research used arbitrary simulations to showcase how the 





8. Scenario Analysis 
In this model, in order to analyze the impacts of potential changes in the values at levels 
of the model, Scenario Analysis is used. The scenario-focused sensitivity analysis used 
here is a method that can be used to perform analysis on how different 
perspectives/criteria of the model will change in scenarios where there is a change in 
value/weight of model elements. In other words, this type of analysis helps decision-
makers determine how much a given model depends on its input factors (Saltelli, 
Tarantola and Chan, 1999). It also facilitates the process of understanding model behavior 
and the extent to which its different factors interplay. Lilburne and Trantola (2008) define 
sensitivity analysis as “the study of how uncertainty in model predictions is determined 




For this purpose, using the maturity scores calculated in the case study section as the 
baseline score, five different extreme situations are analyzed for both case studies in this 
section. In each of these five extreme scenarios, the maximum available weight is given 
to one perspective and the maturity score is calculated based on the desirability scores 
obtained by the studied health department. In other words, in each of these 5 scenarios, 
one perspective gets 96% of the importance while the other four only get 1% each. 
For “Case Study I”, the research center will yield better results in social and financial 
extreme scenarios since they had a better average performance in those perspectives. In 
“Case Study II”, the center’s maturity score will decrease in the organizational focused 
extreme scenario since the center had the biggest opportunities in that perspective while 
it seems to be most ready for regulatory and technology-heavy extreme scenarios due to 
having more strengths in those areas. Tables 65 to 67 demonstrate the detailed results for 
each of the mentioned scenarios. 
 
Table 68: Scenario Analysis Allocated Weights 
Scenarios Technology Social Organizational Regulatory Financial 
Baseline 0.20 0.22 0.23 0.18 0.18 
Tech 0.96 0.01 0.01 0.01 0.01 
Social 0.01 0.96 0.01 0.01 0.01 
Org 0.01 0.01 0.96 0.01 0.01 
Reg 0.01 0.01 0.01 0.96 0.01 










Table 69: Scenario Analysis for Case I 
Scenarios Technology Social Organizational Regulatory Financial Maturity 
Score 
Change 
Baseline 0.20 0.22 0.23 0.18 0.18 44.89 0 
Tech 0.96 0.01 0.01 0.01 0.01 58.82 13.92 
Social 0.01 0.96 0.01 0.01 0.01 65.25 20.35 
Org 0.01 0.01 0.96 0.01 0.01 55.23 10.34 
Reg 0.01 0.01 0.01 0.96 0.01 61.60 16.71 
Fin 0.01 0.01 0.01 0.01 0.96 65.05 20.15 
 
Table 70: Scenario Analysis for Case II 
Scenarios Technology Social Organizational Regulatory Financial 
Maturity 
Score Change 
Baseline 0.20 0.22 0.23 0.18 0.18 38.93 0 
Tech 0.96 0.01 0.01 0.01 0.01 64.45 25.52 
Social 0.01 0.96 0.01 0.01 0.01 55.70 16.77 
Org 0.01 0.01 0.96 0.01 0.01 35.19 -3.73 
Reg 0.01 0.01 0.01 0.96 0.01 65.40 26.47 




The biggest value these scenario analyses offer the decision-makers is to inform them on 
how to proceed with their efforts towards improving their path towards technology 
management and continuous learning goals. These will also help health centers with better 
preparation in terms of criteria such as strategic management and policy preparedness and 











As mentioned in the problem statement of this research, there is a need for a tool that 
gives health organizations a sense of self-awareness in terms of continuous integration, 
implementation, and management of the learned knowledge and new technologies. This 
tool needs to be able to identify potential common factors that have a major impact on the 
maturity of continuous learning while being able to assess the health organizations’ 
performance against each of those factors. Moreover, this model can help these 
organizations in identifying the opportunities while giving the organization a sense of 
self-awareness and direction. This direction can eventually assist decision-makers in their 
strategic management and roadmaps. As a result of the conversation and dialogues based 
on the results of the model, health organizations (health research centers in the case of 
this study) can get a better sense of direction in order to prioritize their improvement paths 
and agenda while having a better grip on their performance and maturity in terms of 
continuous learning leading them to be more mature organizations. 
As part of the gap analysis (gaps I and II specifically), it was discussed that the criteria 
for assessing technology management maturity and continuous learning in healthcare 
organizations are not organized and classified into categories/perspectives while there is 
no quantified, validated, multi-dimensional, and repeatable way of assessing maturity in 
healthcare organizations. Discussion with experts from each of the validation and 
quantification panels confirmed these findings as many of them confirmed the need for 
such a model for assessing technology management maturity and continuous learning in 




healthcare organizations, health-related academic institutes, and research centers, 
including directors, officers, vice presidents, project managers, data scientists, academic 
researchers, public health experts, and academicians.  
From the usability perspective of this model in other sectors, although the criteria and 
perspectives identified in this research may apply to measuring maturity and continuous 
learning in other fields, the literature review and subject matter experts in this model are 
heavily focused on the field of healthcare. However, this model can be used as a base of 
research for other areas with more discussions (validation) and pair-wise comparison of 
the model elements with the relative expert domain based on the research goal at hand. 
 
9.1.Research and Practical Implications  
 
One of the interesting findings of this research is the fact that it shows although there are 
some perspectives and criteria that ranked higher than the rest, it shows that each 
identified criterion is very important to the maturity of the center and its goal towards 
continuous learning. This confirms that not only the external factors in different 
perspectives related to healthcare organizations are interconnected (chapter 2.2.2), but 
also the internal factors affecting the success and maturity of healthcare organizations are 
interconnected as well. This interconnectedness was briefly discussed in the case studies 
analyses. Although these criteria are in different perspectives, initiatives around one 
improvement opportunity may improve the center’s performance in other areas (either 
within the same perspective or not). As an example. increased stakeholder trust may 
trigger an increase in their engagement and the increased stakeholder engagement 




their regulatory and financial goals. An example of this can be a scenario where the 
increase in stakeholder engagement bolsters the collaboration to generate evidence that 
informs health policy. This can create creates a very powerful and exciting research path 
forward. As a result of the research centers and health organizations being part of these 
new collaborative models of research, there will be an inevitable rise in the impact of 
healthcare research entities in optimizing evidence-informed health policy. As the result 
of this bolstered impact, stakeholder trust and health center’s trustworthiness can increase 
completing one of the many possible continuous improvement circles. 
In this section, each of the top five criteria will be reviewed in the context of this research. 
Many of these findings align with the literature review done in this research. Among the 
top-ranking criteria, some are the factors that were introduced to the model during the 
validation process which shows the importance of perspective and criteria validation as a 
part of the research framework of this study. The elements of this model were fine-tuned 
through different validation phases and filters through the literature review and validation 
in the comprehensive exam, proposal, and dissertation phases. 
9.1.1. Stakeholder Engagement 
The most important criterion based on the expert panel is “Stakeholder engagement” 
which was defined based on the literature defined as: “The degree to which a health 
research center can engage stakeholders (patients, providers, payors, policymaker, 
purchasers, families) to participate in continuous improvement and learning projects and 
initiatives.” (Price-Haywood, 2015; Kraft et al., 2017). As much public health-related 




criterion’s importance of expected. There was a strong emphasis from the experts on the 
social aspect of technology management maturity in healthcare. Although some of the 
experts participating in validating and quantifying this model were public health 
professionals, the stress on the stakeholders’ role was not solely based on their results. In 
contrast, many technology management professionals and project managers gave higher 
weights to stakeholders’ engagement as a critical factor in health organization's maturity 
and continuous learning initiatives.  
9.1.2. Talent Acquisition and Retention 
The Second highest weighted criterion was “Talent acquisition and Retention”. The word 
retention was added to the title and the definition of this criterion in the validation process. 
This  
criterion was surprising as there is not a lot of literature around it. A limited supply of 
skilled individuals was mentioned as one of the six challenges discussed by (Morain, Kass 
and Grossmann, 2017) as origins of continuous learning and learning health systems 
transformations for healthcare organizations. Moreover, it is very important for health 
research centers and health organizations, in general, to not only acquire skilled and 
diverse workforce but also to retain them in the organizations. Based on the results of this 
research, centers’ ability to acquire and retain talented and diverse staff in different areas 





9.1.3. Strategic Management 
The Third important weight shown by the data is strategic management. Nowadays, 
hospitals and healthcare organizations are operating in an extremely competitive 
environment, with ever-increasing pressure to better their quality and reduce expenses. In 
response to this dynamic environment, organizations require to have the drive and plan 
to organize delivery around the needs of patients (Speziale, 2015). Successful health care 
organizations have leaders who understand the nature and implications of external 
change, the ability to develop effective strategies that account for change, and the will as 
well as the ability to actively manage the momentum of the organization. Activities such 
as strategic decisions, management of competing priorities, internal and external 
partnerships/collaborations, problem identification, and finding solutions are collectively 
referred to as “strategic management.” Strategic management is pivotal in leading 
organizations in volatile environments. Strategic management provides the momentum 
needed for change (Ginter, Duncan and Swayne, 2013). 
9.1.4. Funding and Mission Alignment 
The fourth important criterion is from the financial perspective and is defined as “The 
extent to which incentives and funding are aligned with the encouragement of technology 
maturity, continuous learning and improvement, waste elimination, and rewarding high 
care value.”. Based on the literature, securing grants that are aligned with the 
encouragement of continuous learning is important in the realization of learning health 
systems rather than inspiring it (Morain, Kass and Grossmann, 2017). Furthermore, 




from the scientific pillar, with more flexible, rapid cycle and applied research funding 
programs serving as accelerators (Menear et al., 2019). External funding and its alignment 
with goals of continuous learning were also mentioned in the literature as one of the 
themes related to the creation of learning health systems. 
9.1.5. Real-time Knowledge Access and Sharing 
The fifth-highest ranking is from the technology perspective. It is defined as “Data 
systems and tools used to capture, share, and integrate data, information, visualizations, 
and knowledge gained from research into the organization in real-time”. As reviewed in 
the literature review section about learning health systems, the technology side, and 
especially the real-time capabilities that allow best practice knowledge in different areas 
to be captured, compiled, protected, learned from, integrated, and disseminated. As 
revised in the validation phase, health centers need to ensure the learned knowledge is 
subsequently integrated into practices and processes to bolster the path towards aimed 
and promised improvements. Although the learned knowledge is valuable, it is not 
enough for research centers to put it out in the world and hope someone will do something 
with it. This sharing of knowledge can be within a healthcare organization or with external 
groups of research clusters in order to strengthen efforts in instances such as infection 
prevention efforts during viral outbreaks such as Covid-19 (Nathavitharana et al., 2020). 
9.2.Generalizability 
 
This external validation determines whether the created model in this research can be used 
for different types of healthcare departments. In other words, although this research 




within university hospitals and used two research centers as case studies, is it possible to 
use this for other research centers or other types of healthcare departments? 
 Generalizability was addressed in two ways: 
• Panels of subject matter experts from different types of healthcare organizations, 
in a spectrum of positions, took part in the validation of this model’s perspectives, 
criteria, and desirability/value curves. 
• During some communications with some of the participating experts, they 
confirmed that this model may be used for any type of healthcare organization. 
The use of desirability/value curves allows for the model to be reused without the 
need for subject matter experts as these values allow the model to be reusable. 
This assessment tool can be taught in academic settings (or in form of organizational 
training within centers) to be used in different healthcare settings instead of using third-
party firms for maturity assessment. 
It is important to note that while the model is validated and reusable due to subject matter 
experts and value curves, it is important to update the model’s criteria and their weights 













Following the research results, case studies, and discussions, this chapter will focus on 
addressing the research objective, questions, and gaps while discussing the research and 
practice contributions. Moreover, the limitations and future research will be reviewed. 
 
10.1. Conclusion and Contributions 
The objective of this research is to develop a framework for assessing technology 
management maturity in research institutes within university hospitals in the United 
States. Initially, literature research was performed in areas ranging from performing a 
landscape analysis on the external forces affecting the healthcare organizations in the 
United States, Learning Health Systems, and Maturity Models, to Healthcare Research 
Centers. As a result of these reviews, an initial hierarchical model was created consisting 
of the elements which have an impact on technology management maturity and 
continuous learning in health research centers. This model was later validated, finalized, 
and quantified by healthcare experts. Desirability curves/values were used as an extension 
to the HDM model to allow for the model to be used multiple times without the need to 
recreate the expert panels and re-quantify the model. Moreover, two case studies are 
provided to see to the model in practice followed by scenario analyses to observe the 
model’s sensitivity to extreme perspective conditions. 
 
This research contributes to the technology management body of knowledge on 
technology management maturity assessment in the healthcare industry while delving 




of where they are and where they need to be in dealing with their technology management 
and continuous learning issues. More specifically, this research aims at increasing the 
knowledge on how healthcare research centers assess their maturity and maintain 
continuous learning in the whole organization by proposing a technology management 
maturity model assessment tool. According to the literature review and gap analysis 
conducted in this study, there is a lack of structured and comprehensive understanding of 
the managerial issues around the maturity assessment of technology management in 
healthcare generally and more specifically in the growing and imminent field of learning 
health systems which can bolster the continuous quality improvement goals of the 
healthcare organizations. This research will provide a quantified, validated, repeatable, 
and multi-perspective tool for measuring technology management maturity in healthcare 
research centers with a focus on continuous learning. This maturity model may result in 
better decision-making in healthcare research centers (and healthcare organizations) and 
can be used as a step in the right direction in reaching better results regarding patient 
satisfaction, quality care, cost of care, and resource allocation. This model can assist 
healthcare managers and decision-makers in identifying strength and opportunity areas 
within the firm (in the context of maturity in continuous learning), while helping health 
organizations in classifying and organizing their priorities and bolsters their judgment in 
terms of proactiveness in achieving the goals of continuous learning and improvement. 
Knowledge of the health care system and its development is essential for the effective 
management of health care organizations. By keeping up to date on community needs, 




in a better position to fulfill their organizational missions to enhance access, improve 
service quality, and achieve efficiency in the delivery of services. 
COVID-19 is a great example that shown how important mature continuously learning 
healthcare systems are as they need to rapidly collect data, learn from it and for 
communities to address the problems they are facing through combining discovery, data 
analysis, and taking action (Ellis, 2021). 






Table 71: Addressing the Research Gaps 
 
This study’s responses to the research questions posed earlier in this dissertation are 









Research Gaps Addressed By 
RG I: The criteria for assessing technology 
management maturity and continuous learning 
healthcare research centers are not organized and 
classified into categories/perspectives. 
This study identified and categorized 
the most important factors influencing 
technology management maturity and 
continuous learning while 
demonstrating their relative 
importance/weights.  
RG II: There is no quantified, validated, multi-
perspective, and repeatable way of assessing 
maturity in healthcare research centers. 
The proposed hierarchical model 
offers a quantified, validated, multi-
perspective, and repeatable tool for 
assessing maturity and continuous 
learning in healthcare research 
centers. 
RG III: Despite technology management’s 
importance in healthcare, there is a lack of studies 
on the technology management side of healthcare 
maturity and continuous learning 
The literature review, model 
components, identified weights, and 
case studies add to the literature 
surrounding the technology 
management side of healthcare 
maturity and continuous learning, 
especially in research centers. 
RG IV: There is very little to no literature around 
the structure and management of research centers 
within university hospitals. 
This study’s focus on health research 
centers, its literature review, and 
results, add to the body of knowledge 
on the structure and management of 




Table 72: Addressing the Research Questions 
Research Questions Addressed By 
RQ I: What are the main perspectives and 
criteria in the assessment of technology 
management maturity in healthcare research 
centers? 
The literature review followed by the 
hierarchical decision-making model created 
in this research identifies the main 
perspectives and criteria in the assessment 
of technology management maturity in 
healthcare research centers. 
RQ II: What are the weights of criteria and 
sub-criteria related to the assessment of 
maturity and continuous learning in 
healthcare research centers? 
The results of the HDM model demonstrate 
the weights of criteria and sub-criteria 
related to the assessment of maturity and 
continuous learning in healthcare research 
centers. 
RQ III: Does the proposed framework offer 
an effective and practical way to assess 
technology management maturity in 
research centers within university hospitals? 
The validated model and the demonstration 
of its use in the form of two case studies and 
the following analysis offer an effective and 
practical way to assess technology 
management maturity in healthcare research 
centers. 
 
In summary, this research offers both research and practical implications. From the 
research side, this research contributes to the technology management body of knowledge 
and maturity models in healthcare while focusing on the management of continuous 
learning and focusing on a more specific unit of study (healthcare research centers). 
Furthermore, from the practical aspect, this study offers a framework and tool to 
healthcare research centers in particular and healthcare organizations in general to assess 
their maturity and continuous learning. The results of this research and the framework it 
offers can help healthcare managers to pinpoint their center’s strengths points and 




As mentioned before, this tool can serve as a helping tool to decision-makers and should 
not be treated as the main decision-making factor. The results of this model can create 
and spark dialogues between the decision-makers, managers, and stakeholders on the 
organization’s next steps. 
 
10.2. Limitations 
The first limitation of this study is imputed to the fact that this model was created, 
validated, and quantified with a focus on healthcare organizations (healthcare research 
centers specifically) and the help of healthcare experts. This means that, if there is an 
intent to use the model in other fields, the model elements and their weights need to be 
re-validated and re-quantified with experts from intended sectors and fields. 
The Seconds limitation is caused by the use of expert panels. Although the experts who 
participated in this research were selected systematically and carefully to make sure that 
their expertise is relevant, experts are humans and as such, their judgment could be 
affected by bias and subjectivity that cannot always be detected. In order to address this, 
the results of the model were validated in terms of disagreement and inconsistency 
analysis. Furthermore, user-friendly instructions and further clarification (where needed) 
were provided to the experts to minimize this potential limitation. 
Thirdly, as mentioned in the methodology section, when using HDM, in scenarios that 
there is a difference of more than 1 between the number of criteria under different 
perspectives it may lead to smaller weights for the criteria under the perspectives with a 




each perspective close to the others. The perspectives in this research contain 4-5 criteria 
which minimize this limitation. The methodology-related limitations of this study have 
been discussed in detail in the HDM limitations section (4.1.2). 
Lastly, although this model can detail the weights related to technology management and 
continuous learning based on the specific perspective they are in, it is not able to 
numerically address the effect of changes in one criterion on other criteria. This issue is 
discussed in both the case study and discussion sections of this research. Although the 
consequences of changes in criterion may be hard to pinpoint numerically, decision-
makers and managers can address this potential change in their strategic plans and 
roadmaps during the important conversations following the results of this model. Further 
studies can focus on addressing this research opportunity. 
 
10.3. Future Research 
The discussions around the limitations of this study pose research opportunities for future 
research. Firstly, the creation of this maturity assessment model can be iterated in other 
fields and sectors with a focus on continuous learning and technology management 
maturity. Following this, it will be interesting to compare the resulting models with the 
model created in this research and discuss the similarities and differences. Even without 
changing industries, there is a great opportunity to study this maturity assessment tool in 
the context of other healthcare entities such as different departments, administrative, and 
information technology groups within hospitals and compare the results and model 




As mentioned before, the healthcare environment in the United States is a very dynamic 
one and there will be a need to refresh this model’s elements and weights periodically to 
maintain its usefulness and relevance. 
From the methodology standpoint, there are opportunities to investigate and mitigate 
some of the methodology limitations which were discussed in the previous section. As an 
example, the creation of a mathematical coefficient based on the number of criteria within 
each perspective may mitigate that limitation in cases where there are big differences (±2) 
in the number of criteria within perspectives. 
Moreover, additional research with a focus on each of the identified perspectives and their 
criteria can shed additional light on the nuances of each of these perspectives, and their 
impact on continuous learning and centers’ maturity. Another route to pursue with future 
research in the context of this research is to study the impact of the model’s criteria on 
each other. One possible opportunity may be to create the mental landscape of continuous 
learning in healthcare organizations (or more specifically, healthcare research centers) 
and understand more about the strength of the impact of these criteria on each other 
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Appendix D- Qualtrics Surveys and ETM HDM Software 
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